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Abstract
Notch signalling is implicated in a wide range of developmental processes such as
neurogenesis, haematopoiesis and T cell development. Peripheral T cells continue to express
Notch components suggesting a role for them also after their development. Furthermore,
activation of the Notch pathway can be modulated by the presence of cytokines, induce
proliferation and influence the decision between cell survival and apoptosis. These events are
crucial for the induction and modulation of an immune response.
Therefore the expression and the role of Notch receptors and ligands during the induction of
an immune response were investigated. I have shown that components of the Notch pathway
were present in peripheral CD4 and CDS T cells. Upon cultunng and activation in vitro, many
Notch components were differentially expressed, in particular targets of Notch activation. In
contrast, bone marrow-derived dendritic cells (DCs) expressed only low levels of Notch
targets. However, the Notch ligand Jagged 1 was strongly upregulated upon maturation of DCs
with TNFa or LPS.
By regulating the expression of the ligands, a role for antigen presenting cells (APCs) as the
"signalling cells" is likely, whereas T cells expressing Notch receptors and Notch target genes
may be the "receiving cells". To investigate this hypothesis in vivo, transgenic mice with
inducible overexpression of Jagged 1 or Delta 1 in DCs were generated.
An in vitro approach to study the role of Notch ligands on APCs was carried out using an I-
Ab transfected murine fibroblast cell line (I-Ab L cells) with endogenous B7.1 expression. I-
Ab L cells co-transfected with Jagged 1 or Delta 1 (JaggedL or Delta 1b L cells, respectively)
were used as APCs in a mixed lymphocyte reaction (MLR) in vitro. Jaggedl+ and I-Ab L
cells induced similar levels of allogeneic T cell proliferation, whereas Deltal+ L cells had a
slightly increased capacity to activate T cell proliferation. There were no phenotypical
differences or changes in the level of apoptosis observed between T cells activated by
Jagged 1 , Deltal or I-Ah L cells. However, IFNy secretion by T cells in response to
Jagged 1 L cells was strongly reduced, whereas Delta 1 and I-Ab L cells induced normal
levels of IFNy secretion. There were no significant differences neither in the level of
intracellular IFNy nor of IFNy transcripts between T cells in response to Jaggedl+, Deltal or
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I-Ah L cells. Therefore I hypothesise that Jagged 1-induced Notch signalling may be involved
at the level of IFNy secretion.
In summary I have shown that Notch components are expressed and differentially regulated in
DCs and T lymphocytes and that APCs can act as the "signalling" cell by activating the Notch
pathway in the "receiving" T cells. Jagged 1 expressed on APCs led to decreased secretion of
IFNy by T lymphocytes during a MLR. These findings may have important implications in the
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bp base pairs
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BM bone marrow
C cytidine
C. elegans Caenorhabditis elegans
CBF1 C promoter binding factor 1
CD cluster of differentiation
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I Introduction
The immune system has developed to protect organisms against invading pathogens. It can be
divided into the non-specific innate immune system and the specific adaptive immune
response. Invertebrates are protected only by innate immunity. This includes anatomical (e.g.
the skin) and physiological barriers (e.g. extreme pH values), soluble factors (e.g. antibacterial
enzymes, interferons and the complement system), as well as phagocytes and natural killer
cells (NKs). In addition to the innate immune system, vertebrates have an adaptive immune
system. The major differences to the innate immune system are antigen specificity,
immunological memory and the ability to discriminate between self and non-self.
Two main groups of cells are required for an effective adaptive immune response:
Lymphocytes and antigen presenting cells (APCs). Lymphocytes are leukocytes that develop
during haematopoiesis in the bone marrow and afterwards circulate through the lymph and
blood system. There arc two groups of antigen-specific lymphocytes: B cells and T cells (Raff
1971). A variety of cells can function as APCs. The distinguishing feature of APCs is their
ability to express gene products encoded by the class II major histocompatibility complex
(MHC) and to deliver costimulatory signals. APCs present antigenic peptides bound to the
MHC molecules. Antigens coming from intracellular replicating agents (e.g. viruses) are
presented to CD8f T cells by MHC class I molecules, whereas antigens from extracellular
agents (e.g. bacteria) are presented to CD4+ T cells in the context of MHC class II molecules
(reviewed in Androlewicz, 2001; Pieters, 2000; Thery and Amigorena, 2001). Three cell types
are classified as professional APCs: dendritic cells (DCs), macrophages and B lymphocytes.
These cells differ in their mechanisms of antigen uptake, in whether they constitutively express
class II molecules and in their costimulatory activity.
I will discuss the development and function of DCs in detail as the work on APCs presented in
my thesis has focused on this cell type; this will be followed by a brief overview of T cell
activation and a more detailed review of the Notch signalling pathway.
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1.1 Dendritic cells
1.1.1 Development of DCs from haematopoietic precursors
DCs arise from haematopoietic progenitor cells with myeloid differentiation potential. They
can be differentiated in vitro from human monocytes by incubation with granulocyte-
macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-4 (Romani et al., 1994;
Sallusto and Lanzavecchia, 1994; Zhou and Tedder, 1996). Myeloid-committed precursors
from murine bone marrow (BM) give rise to granulocytes, monocytes and myeloid DCs under
the influence of GM-CSF (Inaba et al., 1992a; Scheicher et al., 1992). This suggests that
DCs belong to the myeloid lineage. However, common lymphoid and common myeloid
progenitors (CLP and CMP, respectively) have been identified in murine BM (Akashi et al.,
2000; Kondo et al., 1997). IL-7 receptor a chain (IL-7Ra) expression is a main marker to
distinguish these two progenitors. CLPs are IL-7Ra and generate all lymphoid cells and
certain DCs, but not myeloid or erythroid cells (Kondo et al., 1997). CMPs are IL-7Ra and
give rise to precursors for megakaryocytes/erythrocytes, granulocytes, macrophages and DCs
(Akashi et al., 2000; Traver et al., 2000). In conclusion, DCs can arise from both myeloid
and lymphoid precursors, but the picture remains confused.
After production in the bone marrow, DC precursors of the myeloid line enter non-lymphoid
tissues where they reside transiently before migrating to secondary lymphoid tissues. In
contrast, lymphoid DC progenitors probably enter the thymus and develop into DCs that play
a crucial role in the induction of thymic (central) tolerance. Mouse thymic DCs and a
subpopulation of DCs in spleen and lymph nodes express several markers of lymphoid cells,
such as CD8a, CD2 and CD25 (Vremec et al., 1992; Wu et al., 1995). Unlike the bone
marrow precursors, which can produce both CD8a and CD8a DC populations in mouse
spleen, the intrathymic precursor population only generates CD8a+ DCs (Wu et al., 1996)
suggesting that they represent a lymphoid-related DC lineage (Fairchild and Austyn, 1990;
Wu et al., 1996). The similarity in phenotype between thymic DCs and CD8a DCs from
spleen and lymph nodes (LNs) suggests a common origin (Vremec and Shortman, 1997).
However, recent publications have discussed the controversial origin of lymphoid DCs, with
some reports suggesting that myeloid-derived DCs and lymphoid DCs originate from the same
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precursor (Merad et al., 2000; Traver et al., 2000). Table 1.1 summarises features of
lymphoid and myeloid-derived DCs.
In humans, at least two subsets of DC precursors circulate in the blood: CD14+ CDlIc+
monocytes and CD4 IL-3Ra CDI lc precursor DCs (Grouard et al., 1997; Olweus et al.,
1997; Romani et al., 1994; Zhou and Tedder. 1996). Although there is controversy as to
whether the latter DC precursors arc myeloid or lymphoid in origin, this human DC subset is
often referred to as "lymphoid" or "plasmacvtoid" DCs. A third precursor cell type, CDI
CDllc cells, has also been described in blood, which quickly acquires Langerhans cell
characteristics if cultured in the presence of GM-CSF, 1L-4 and transforming growth factor
(TGF)-P (Ito et al., 1999). Lymphoid precursors in the thymus giving rise to DCs. T
lymphocytes and NKs were also identified in the human system (Res et al., 1996). A large
body of literature has recently accumulated concerning the origin and differentiation pathways
of human DCs (reviewed in Banchereau et al., 2000; Bell et al., 1999; Liu, 2001). However,
my thesis will concentrate mainly on murine DC development and function.
Table 1.1. Murine DC subsets in secondary lymphoid organs.*
Postulated lineage Lymphoid Myeloid
CD8oc+ DCs CD8a DCs LC-dcrived DCs
Phenotype
Precursor IL-7Ra+ IL-7Ra ?
Mature DCs CDI lc+ CDI lc+ CDI lc+
MHC class IT MHC class If MHC class If
CD8a+ CD8a CD8a+/_ (?)
CD4 CD4+ (subsets) CD4
DEC-205+ DEC-205duU/" DEC-205+
CDI lbduD/" CDI lb+ CDI lb+
CD40+ CD40+ CD40+
B7.2+ B7.2+ B7.2+
Birbeck granule" Birbeck granule" Birbeck granule*
Localisation T cell zones of Marginal zones of spleen Immature LCs in
lymphoid organs, (move to T cell zones when epithelia; LC-derived
thymic cortex activated); sub-capsular sinus DCs in T cell zones of
of LNs? LNs
Function
Antigen capture + ++ ++
Antigen processing ++ ++ ++
IL-12 secretion II 1 1 +/- I I I I
IFNy secretion 1 1 i 1 - ?
CD4+ T cell polarisation TH1 TH0/TH2 7




The epidermis contains a special subset of DCs called Langerhans cells (LCs) (Table 1.1;
Davis et al., 1988). They contain Birbeck granules and are characterised by the expression of
CD la and the cutaneous lymphocyte-associated antigen (CLA) (Davis et al., 1988; Koszik et
al., 1994). CD la DCs have also been identified in other epithelial surfaces such as the
urothelium and gut epithelium (Hussain and Lehner, 1995; Troy et al., 1998). The
relationship between murine LCs and lymphoid and myeloid DCs is not completely
understood.
Mouse peripheral blood mononuclear cells generate DC-like cells when cultured in GM-CSF
(Inaba et al., 1992b), suggesting circulating DC precursors. These are destined to provide
interstitial DCs in non-lymphoid tissues (Matsuno et al., 1996). In humans, several subsets
of blood DCs have been identified (Egner et al., 1993; Olweus et al., 1997). Interstitial DCs
are found in almost all organs including liver (Prickett et al., 1988), kidney (Hart et al.,
1981), heart (Spencer and Fabre, 1990) and other connective tissue (Hart and Fabre, 1981).
Like the epithelial associated LCs, interstitial DCs are believed to form a sentinel network of
antigen-receptive cells, which subsequently move antigen centrally to provide activated APCs
and generate T lymphocyte responses.
Tissue damage/inflammation, so-called "danger" signals (Matzinger, 1994), mobilise tissue
DCs to migrate from skin, other non-lymphoid interstitial sites and the mucosal surfaces into
the afferent lymph, where they are recognised as veiled cells (Bujdoso et al., 1989; Roake et
al., 1995a). Peripheral DCs migrate as veiled cells towards afferent lymphatics and traffic in
the draining lymph to the lymph nodes (LNs) where they enter the T lymphocyte-rich
paracortical areas (Fig. 1.1; Fossum, 1988).
It has been assumed (there have been few direct comparisons) that DCs isolated from intact
lymphoid tissues (Steinman et al., 1974) represent the interdigitating DCs observed by
immunohistochemistry, light and electron microscopy (Veerman and van Ewijk, 1975).
Phenotypically distinct populations of interdigitating DCs are found in the mouse spleen.
Double staining for CD8a and CD1 lc identified two DC subsets (Suss and Shortman. 1996),
whereas staining of splenocytes of Flt-3L treated mice for CD8a and CD1 lb divided DCs into
five distinct subsets (Maraskovsky et al., 1996). This complexity suggests that stages of
activation contribute to the phenotypic diversity which will be discussed later.
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1.1.3 Recruitment
Lipopolysaccharide (LPS), GM-CSF, IL-6 and probably other stimuli recruit DC precursors
from the blood to the tissues (Fig. I.I; Kaplan et al., 1992; Roake et al., 1995b). The basal
rate of tissue entry is boosted 5- to 10-fold by "danger" signals such as pathogens,
inflammation, tissue damage and necrosis (Matzinger, 1994). DCs accumulate rapidly (within
an hour) at the sites of antigen (MeWilliam et al., 1994). This accumulation likely represents
recruitment of circulating DC precursors, in response to the production of classical
chemoattractants (formyl peptides and complement derivative C5a) and of chemokines upon
local inflammation (Adams and Lloyd, 1997; Sallusto and Lanzavccchia, 2000; Sozzani et
al., 1995). Chemokines play a role not only in extravasation, but also in the subsequent
process of migration within the tissues to the final target. Different chemokines provide codes
for areas that are undergoing different types of inflammatory reactions or are sites of
constitutive traffic. A current view is that the whole migration process occurs in distinct steps,
each driven by a particular chemokine-chemokine receptor pair (Table 1.2; Foxman et al.,
1997).
DCs provide a striking example of this so-called muitistep navigation, since they use different
sets of chemokine receptors to migrate from blood to inflamed tissues and from there to the
lymphatics by which they reach their final destination in the T cell areas of lymph nodes.
However, the expression of a particular receptor docs not always indicate that DCs
demonstrate chemotaxis in response to all chemokines that bind that receptor (Sozzani et al.,
1995). Besides being attracted by inflammatory chemokines, DCs also produce these
chemokines in large amounts. The production of chemokines by DCs is rapidly triggered after
exposure to various maturation stimuli and/or upon encounters with T cells, which can take
place not only in the secondary lymphoid organ but also at the site of tissue injury. This
enhances recruitment of lymphocytes and immature DCs, which is important to sustain antigen
sampling at later time points and downregulates the expression of the cognate receptors on
maturing DCs, thus allowing them to leave the inflamed tissues (Dieu et al., 1998; Sallusto et
al., 1998; Sozzani et al., 1999; Tang and Cyster, 1999).
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Table 1.2. Expression of chemokine receptors by dendritic cells.
Receptor Ligands
Immature DCs*
CCR1 MIP-la, RANTES, MCP-3, MIP-5
CCR2 MCPs
CCR4 TARC, MDC






* Note that expression of chemokine receptors on immature DCs also depends on the DC subset.
ELC: Epstein-Barr virus-induced molecule 1 ligand chemokine; LARC: liver and activation
regulated chemokine; MIP: macrophage inflammatory protein; RANTES: regulated on activation,
normal T expressed and secreted; MCP: monocyte chemoattractant protein; TARC: thymus and
activation-regulated chemokine; MDC: macrophage-derived chemokine; SDF: stromal-derived
factor; SLC: secondary lymphoid-tissue chemokine. Based on Cascieri & Springer (2000).
During their migration, DCs are involved in several adhesion events. For instance, E-cadherin
is present on both mouse and human LCs and is downregulated upon antigen encounter
allowing LC migration out of the skin (Blauvelt et al., 1995; Tang et al., 1993). Although
sclectins have not yet been described on DCs, blood DCs do express a glycosylated form of P-
sclectin glycoprotein ligand-1 (PSGL-1) that binds to P- and E-selectins, which are expressed
at low levels on endothelial cells and are uprcgulated by inflammatory stimuli (Adams et al.,
1996; Robert et al., 1999). LCs express the E-selectin ligand CLA (Koszik et al., 1994),
which may be involved in cell interaction during trafficking. Interaction between DCs and the
connective tissue is stabilised by isoforms of the CD44 molecule, which is expressed in high




Figure LI. T cell priming by DCs.
Recruitment of DC precursors (monocytes) into peripheral tissues and maturation of DCs in response
to pathogens or cytokines result in migration to the draining lymph node of large numbers of DCs
carrying high levels of peptide-MHC complexes and B7. By physical interaction through an
immunological synapse, naive T cells (green) achieve stimulation and become committed to
proliferate in response to IL-2. Sustained TCR stimulation by continuous contact with DCs and
polarising cytokines (1L-12 and IL-4) promote T cell differentiation to non-lymphoid tissue-homing
effector cells (red). T cells receiving a shorter stimulation do not acquire effector function and retain
lymph node-homing capacity (yellow). Mature DCs have a short life-span and die within 2-3 days.
As a consequence, the composition of DCs in the lymph nodes dynamically reflects what is occurring
in the peripheral tissues. Reprinted from Lanzavecchia & Sallusto (2001a) with permission from
Elsevier Science.
25
1.1.4 Antigen capture and presentation
Immature DCs are very efficient in antigen uptake and can use several pathways, such as
macropinocytosis, phagocytosis and receptor-mediated endocytosis.
Macropinocytosis is an actin-driven endocvtic process in which plasma membrane fuses to
form vesicles that non-selectivcly include solutes and antigens present in the fluid phase
(Sallusto et al., 1995). This process allows cells to continually take up large amounts of
extracellular fluid containing soluble antigens. Immature DCs are particularly active at
macropinocytosis, accumulating nearly an entire cell volume over one-hour period (Sallusto et
al., 1995).
Phagocytosis is a process by which particles, microbes or fragments of dead cells are
engulfed and internalised, usually by specific membrane receptors. The process is actin-
mediated and requires the action of a number of small GTP-binding proteins (Franc et al.,
1999). Fc receptors are involved in the uptake of antibodv-coated bacteria by macrophages.
Antibody-mediated phagocytosis of bacteria has not been directly shown for DCs, even though
two Fey receptors, FcyRI (CD64) and FcyRII (CD32), are found on fresh blood DCs (Fanger
et al., 1996). Complement receptors can stimulate phagocytosis of C3bi-opsonised bacteria,
either alone or together with Fc receptors (Carroll, 1998). Some complement receptors (CRs)
have been described on DCs: CD lib and CD 11c, which are subunits of CR3 and CR4,
respectively, arc found on several DC subsets (Egner and Hart. 1995; Mctlay et al., 1990;
Shibaki et al., 1995). Receptors suggested to mediate uptake of apoptotic bodies by DCs are
certain integrin receptors and the scavenger receptor CD36 (Bellonc, 2000; Larsson et al.,
2001).
During endocytosis. soluble antigens can be captured by a wide variety of specific receptors,
which are then internalised in clathrin-coated vesicles. The mechanism of uptake is distinct
from phagocytosis or macropinocytosis, in that it does not require actin filaments, but does
depend on certain Ras proteins (Cox et al., 2000). In addition to Fey receptors, immature DCs
also express the high-affinity receptor for IgE (FcsRI) as well as the low-affinity receptor
FeeR11 (CD23), which can induce immune responses to allergens (Bieber et al., 1989; Kahlert
et al., 2000; Maurer et al., 1996). The pattern-recognition receptors (PRRs) bind a range of
molecules with structural patterns common to the surface of many microorganisms (so called
pathogen-associated molecular patterns, PAMPs) but which are absent from the surface of
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mammalian cells (reviewed in Akira et al., 2001). PAMPs include LPS, lipoproteins,
peptidoglvcan and lipoteichoic acids, which are all made by bacteria, but not by cukaryotic
cells. Several members of the Toll-like receptor (TLR) family are expressed on DCs (Muzio et
al., 2000). TLR4 plays a crucial role in LPS signalling (Poltorak et al., 1998), which leads to
DC activation (see below). Another family of receptors important for the recognition and
uptake of complex carbohydrates are lectin-like molecules. Human monoevte-derived DCs
express the macrophage mannose receptor (Sallusto et al., 1995), the DC-specific 1CAM-
grabbing non-mtcgrin (DC-SIGN) (Geijtcnbeek et al., 2000) and the DC immunoreceptor
(DC1R) (Bates et al., 1999). Expression of these molecules on other DC populations remains
to be established. The DEC-205 molecule is related to the macrophage mannose receptor and
probably acts as an antigen receptor (Jiang et al., 1995). It is present on both mouse and
human DCs (Guo et al., 2000; Jiang et al., 1995).
Soluble and particulate antigen are efficiently captured by immature DCs and targeted to
MHC class II compartments (reviewed in Pieters, 2000). DCs constantly accumulate MHC
class II molecules in lysosome-related intracellular compartments identified as MHC class II-
rich compartments (MIICs). Whereas, in immature DCs, class II molecules are rapidly
internalised and have a short half-life, maturation/inflammatory stimuli lead to a burst of class
II synthesis and translocation of MHC II-peptide complexes to the cell surface where they
remain stable for days and are available for recognition by CD4 T cells. To generate CD8
cytotoxic T cells (CTLs). DCs present antigenic peptides on MHC class 1 molecules, which
can be loaded through both an endogenous and an exogenous pathway (reviewed in
Androlewicz, 2001; Thcry and Amigorena, 2001). The endogenous MHC class 1 pathway
operates through the degradation of cvtosolic proteins and the loading of peptides onto newly
synthesised MHC class I molecules within the endoplasmic reticulum. DCs arc also capable of
transporting exogenous antigens from the endocytic compartment to the cytosol, leading to
"cross-presentation" on MHC class I molecules to CD8 T cells (Albert et al., 1998a;
Androlewicz. 2001).
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1.1.5 Migration to draining LN and maturation
Activation of DCs by a "danger" signal triggers immature DC to undergo phenotvpic and
functional changes that culminate in the complete transition from antigen-capturing cell to
APC (Matzinger. 1994). However, a small fraction of tissue DCs "spontaneously" mature and
migrate to the draining lymph nodes, carrying apoptotic antigens taken up in peripheral tissues
(Huang et al., 2000). DC maturation is a continuous process initiated in the periphery upon
antigen encounter and/or inflammatory cytokines and completed during the DC-T cell
interaction. For simplicity, molecules involved in subsequent activation of T cells are
discussed later.
Maturation of DCs turns off their response to chemokines specific for immature DCs through
either receptor downregulation or receptor desensitisation dependent on autocrine chemokine
production. Maturing DCs upregulate CCR7, which recognises secondary lymphoid tissue
chemokine (SLC) and Epstein-Barr virus-induced molecule 1 ligand chemokine (ELC/MIP-
3P), both present in LNs (Gunn et al., 1998; Sallusto et al., 1998). Therefore, CCR7 is
thought to encourage migration of DCs to secondary lymphoid organs. Morphological changes
accompanying DC maturation include a loss of adhesive structures, cvtoskeleton
reorganisation, and acquisition of high cellular motility (Winzlcr et al., 1997). Maturing DCs
rapidly lose endocytic activity, increase surface expression and stability of MHC class 1- and
class Il-peptide complexes, upregulate surface expression of adhesion and costimulatory
molecules such as CD40, ICAM-1, B7.1 (CD80) and B7.2 (CD86) and secrete pro¬
inflammatory cytokines such as 1L-1, 1L-6, IL-12. 1L-18 and IL-23. The involvement of these
molecules in T cell activation and/or polarisation is discussed in the following sections.
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1.2 DC-T cell interaction
1.2.1 T cell priming
The ability to prime naive CD4' T cells constitutes a unique and critical function of DCs both
in vitro and in vivo. DCs pulsed with antigen elicit potent CD4 T helper (TH) responses when
injected into mice suggesting direct antigen presentation (Inaba et al, 1990). In the presence
of soluble antigen, T[f cells primed by DCs can interact with B cells and stimulate antigen-
specific antibody production (Sornasse et al., 1992). DCs are equally important in priming
naive CD8+ T cells. In vitro, DCs can stimulate the proliferation of allogeneic CD8 T cells in
the absence of T cell help (Young and Steinman, 1990). However, for the in vivo generation of
CTL responses to exogenous antigen, which must be taken up, processed and presented on
class I MHC (a process termed cross-presentation), the DCs require to be "licensed" to
activate CD8 T cells by T helpers via upregulation of CD40 on the DCs (Bennett et al.,
1998; Schoenberger et al., 1998). Thus, a "licensed" or "conditioned" DC becomes a transient
bridge between a TH cell and a CTL (Ridge et al., 1998).
It remains to be determined whether the unique ability of DCs to prime naive T cells results
from the expression of molecules unique to DCs or from the high density of molecules
involved in DC-T cell interactions. The number of MHC molecules and MHC/peptide
complexes is 10- to 100-fold higher on DCs than on other APCs such as B cells and
monocytes (Inaba et al., 1997). Recognition of MHC-peptide complexes on DCs by antigen-
specific T cell receptors (TCRs) constitutes "signal 1" in DC-T cell interactions. Subsequent
DC-T cell clustering is mediated by several adhesion molecules. The Ig superfamily members
ICAM-1 (CD54). ICAM-2 (CD50) and ICAM-3 (CD 102). which are all ligands for the p2
integrin. leukocyte function antigen-1 (LFA-1. CDlIa/CD18), are expressed on DCs, but
show differential regulation. ICAM-1 is expressed at low density on blood DCs and LCs but
is quickly upregulated upon activation, whereas ICAM-2 and ICAM-3 showed little change in
expression level with activation (Starling et al., 1995). The recently identified lectin DC-SIGN
has been shown to bind ICAMs expressed on T lymphocytes and on endothelia and is
important for stabilising DC interaction with T cells (Geijtenbeek et al., 2000).
The crucial factor, that constitutes "signal 2", required to sustain T cell activation, is the
interaction between costimulatory molecules expressed by DCs and their receptors/ligands
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expressed by T cells. B7.2/CD86 on DCs is so far the most critical molecule for amplification
of T cell responses (Caux et al., 1994). Although both B7.1/CD80 and B7.2 deliver a strong
costimulatory signal via CD28 on T lymphocytes, blocking of B7.2 inhibits the MLR to a
greater extent than blocking B7.1 (McLellan et al., 1995) and B7.2 blockade reduces DC
primary antigen specific responses (Fagnoni et al., 1995).
T cells can activate DCs via CD40L-CD40 signalling, which leads to increased expression of
B7.1/B7.2 and cytokine release (IL-1, TNFa, chemokines. and 1L-12) (Bennett et al., 1998;
Cella etal., 1996; Ridge etal., 1998; Schoenberger et al., 1998). Triggering of CD40 on DCs
results in upregulation of OX40 ligand (OX40L), which then signals naive T cells to express
1L-4 (Brockcr et al., 1999; Flvnn et al., 1998). Mature DCs also express 4-1BB ligand (De
Benedette et al., 1997). 4-1BB is a costimulator expressed primarily on activated CD4 and
CD8 T cells. 4-IBB costimulation preferentially induces CD8 T cell proliferation and
production of IFNy (but not of IL-4) (Kim et al., 1998). Engagement of RANK (receptor
activator of NF-kB), a member of the TNF receptor family, by its ligand TRANCE (TNF-
related activation induced cytokine) expressed on activated T cells, stimulates the secretion of
cytokines such as IL-1, IL6, and IL-12 by DCs. This results in increased DC survival, by
inhibition of DC apoptosis and. in turn, in enhanced proliferative T cell responses in mixed
lymphocyte reactions (Josien et al., 1999; Wong et al., 1997).
1.2.2 DC polarisation
Differentiation of naive CD4+ T cells into IFNy-producing effector TH1 cells or IL-4, IL-5 and
IL-13-producing effector TH2 cells depends on the antigen, cytokines and the molecular
microenvironment (reviewed in Murphy et al., 2000). Accumulating data suggest that
migrating DCs not only carry antigenic and costimulatory signals, but also are well equipped
to transmit an additional "signal 3" from the periphery to the lymph nodes. Signal 3 is less
defined than signal 1 and 2, but it is thought to contribute to the polarisation of naive Tn cells
towards TH1 or TH2, or to the induction of tolerance as discussed later (see section 1.2.3).
Possible candidates able to mediate signal 3 in the polarisation process are summarised in
figure 1.2.
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In humans, monocyte-derived DCs (DC1) polarise naive T cells predominantly towards a TH1
profile, whereas the plasmacytoid DC subset (DC2) induces T cells to predominantly produce
Th2 cytokines (Rissoan et al., 1999). However, myeloid DCs can give rise to either DC1 or
DC2, depending on the nature of the maturation stimulus influencing 1L-12 production
(Kalinski et al., 1999). IL-12, the critical TH1 polarising cytokine (Trinchieri, 1995), is
produced by DCs after stimulation with LPS, unmethvlated bacterial CpG containing DNA.
double-stranded viral RNA, CD40 activation and IFNy signalling (Cella et al., 1999; Cella et
al., 1996; Hartmann et al., 1999; Rescigno et al., 1999), but is not produced in response to
TNFa, IL-1, fungal hyphae and nematode products (Cella et al., 1996; d'Ostiani et al., 2000;
Whelan et al., 2000). Anti-inflammatory molecules such as IL-10, TGF-p, prostaglandin E2
(PGE2) and corticosteroids (Kalinski et al., 1997; Piemonti et al., 1999; Steinbrink et al.,
1997; Strobl and Knapp, 1999) inhibit DC maturation and IL-12 production, thereby inducing
Th2 or regulatory T (Treg) cells (see section 1.2.3). Skewing is not restricted to CD4 T cells,
but also applies to CD8 T lymphocytes and NK T cells (Croft et al., 1994; Kadowaki et al.,
2001; Morelli et al., 2000).
In contrast to human plasmacytoid DCs which primarily induce TH2 responses, murine splenic
CD8cr lymphoid DCs prime naive CD4! T cells to make TH1 cytokines, whereas splenic
CD8a myeloid DC subsets and DCs isolated from Peyer's patches or the respiratory tract
elicit a TH2 response (Table 1.1; Iwasaki and Kclsall, 1999; Maldonado-Lopez et al., 1999;
Pulendran et al., 1999; Stumbles et al., 1998). DCs from IL-12-deficient mice fail to induce
Th1 responses, confirming a critical role for IL-12 in TH1 responses induced by DCs
(Maldonado-Lopez et al., 1999). A similar THl-deficient phenotype can be found in mice
lacking IL-18. However, IL-18 appears to act mainly as a factor supporting ongoing TH1
responses, rather than inducing TH1 differentiation hi the naive TH-cell population (reviewed in
O'Garra, 1998). Lymphoid but not myeloid DCs can be induced to make large amounts of IL-
12 and IFNy (Maldonado-Lopez et al., 1999; Ohteki et al., 1999). The mechanism by which
myeloid DCs induce TH2 cytokines is not clear, although IL-13 (McKenzie et al., 1998), IL-6
(Rincon et al., 1997a), and OX40L are good candidates (Flynn et al., 1998). Interestingly, a
recent report suggests a crucial role for CD40 in inducing a TH2 response in vivo (MacDonald
et al., 2002), even though CD40 signalling is known to induce IL-12 production in DCs (see
1.2.1). The involvement of B7.1 and B7.2 in TH1/TH2 polarisation remains unclear, but, in
31
some experimental systems. B7.1 was shown to promote TH1 responses, whereas B7.2 ligation
tended to skew toward TH2 responses (Freeman et al.. 1995; Kuchroo et al., 1995).
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Figure 1.2. A model showing the stages of learning and teaehing in the life cycle of DCs.
Activation of immature DCs in peripheral non-lymphoid tissues instructs them to take up antigen
and migrate to the lymph nodes. Apart from collecting information about the antigenic stmcture of
the pathogen, immature DCs learn about its pathogenicity, inferred from its DC-activating
properties. At the same stage, DCs are susceptible to pathogen-derived or pathogen-induced factors
that modulate their ability to produce IL-12. The ability of DCs to take up antigen and their
susceptibility to functional modulation is either lost or is strongly reduced in fully mature DCs. This
might help to restrict the acquisition of antigenic and polarising signals to the relevant site of
pathogen entry, thereby limiting the risk of acquiring irrelevant signals at later stages. Within the
lymph nodes, polarised mature DCs provide naive TH cells with: an Ag-specilic "signal 1"; a "signal
2", which informs about the Ag -related pathogenic potential; and a "signal 3", which is the DC-
dependent component of the initial polarisation of naive TH cells to a preferential production of TH1-
or TH2-type cytokines. Reprinted from Kalinski et al. (1999) with permission from Elsevier Science.
Recently, a new concept for the generation of TH2-polarising DCs was introduced (Fig. 1.3).
In response to LPS, DCs produce IL-12 only transiently (Langenkamp et al., 2000).
Consequently, soon after stimulation DCs prime a TH1 response, whereas at later time points
the same cells preferentially prime TH2 and non-polarised T cells. Thus, the subsets, the
differentiation and the maturation state of the DCs influence the polarisation of the T cell
response. Overall, distinct DC subsets exist in mice and humans that differentially skew TH
responses depending on their maturation state.
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6-16 h After 24 h
Figure 1.3. Plasticity and kinetics of DC activation.
Some maturation stimuli fail to induce or inhibit IL-12 production (upper part). Consequently the
mature DCs that are elicited (DC2) induce TH2 responses, which are dependent on IL-4 produced by
the responding T cells. Most pathogens or their products (e.g. LPS or double-stranded RNA), as well
as T cells (via CD40L). stimulate IL-12 production (lower part). IL-12 is produced by DCs within a
narrow time-window (8-16 hours), so that only recently stimulated DCs can induce TH1 responses
(DC1) whereas at later time-points (after 24h) the same DCs induce TH2 responses. Nonviable DCs
are shown in grey. Reprinted from Lanzavecchia & Sallusto (2001b) with permission from Elsevier
Science.
1.2.3 DCs and tolerance
Evidence for a role of DCs in maintenance of peripheral tolerance
Tissue-specific DC types
In vitro, liver-derived DCs induce only weak proliferative or cytotoxic responses in allogeneic
T cells compared with mature, bone marrow-derived DCs (Lu et ai, 1994). The liver appears
to provide a microenvironment that might be important in modulating the function of DCs.
Interestingly, hcpatocytes and other liver cell types produce TGF-p. This cytokine has been
implicated in the immunological privilege of the eye and is believed to induce tolerogenic
APCs that migrate from the anterior chamber of the eye to regional lymphoid tissue, thus
mediating systemic antigen-specific tolerance (Wilbanks and Streilein. 1992). TGF-p permits
growth but suppresses the maturation of GM-CSF stimulated DCs (Yamaguchi et al., 1997).
If these TGF-p-treated DCs are injected prior to the transplantation, they prolong cardiac
allografts survival in an antigen-specific manner (Lu et al.. 1997). Furthermore, TGF-p
increases production of IL-10 by hepatocytes (Ishizaka et al.. 1996). The effects of IL-10 on
DCs will be discussed in more detail later. Recently, a novel population of mouse liver-derived
DCs. propagated in response to IL-3 and CD40 ligation has been described (Lu et al., 2001).
These DCs appear to induce Treg in vitro and prolong allograft survival. Taken together, these
data indicate that immature liver-derived DCs may regulate peripheral immune responses by
the induction of a Treg cell population (Thomson and Lu. 1999; Thomson and Takayama.
1999).
The mucosal immune system has a unique immunological milieu that is based on two
tolerance-inducing cytokines, IL-10 and TGF-p, and the milieu acts, in part, via the DCs to
induce different phenotypes of Treg cells. Pulmonary DCs that were isolated after respiratory
exposure to antigen produced IL-10 and induced IL-10-expressing CD4 Treg cells, whereas
DCs isolated from the gut produced TGF-p upon oral antigen administration and induced
TGF-p expressing CD4' Treg cells (Akbari et al., 2001).
Thymic DCs are capable of mediating negative, but not positive selection of thymocytes and
therefore play a pivotal role in the induction of central tolerance (Brocker et al., 1997).
However, it is beyond the scope of this thesis to discuss the involvement of DCs in mediating
central tolerance.
DC subsets
In vitro work suggests that in mice, both lymphoid and myeloid DCs can stimulate T cells, but
that the lymphoid DC subset can limit the proliferation of T cells (Kronin et al., 1996; Kronin
et al., 2000; Suss and Shortman, 1996). The lymphoid DCs appear to kill a proportion of the
activated CD4 T cells in a Fas ligand dependent manner (Suss and Shortman, 1996), whereas
they limit cytokine production of C'D8 T cells (Kronin et al., 1996). However, these effects
were debated by others (McLellan and Kampgen. 2000). Lymphoid DCs seem to be unable to
process complex protein antigens. When loaded with the appropriate peptide, however, these
cells will stimulate potent T cell responses. Their inability to process protein antigens, together
with the discovery that lymphoid DC in the T cell areas express high amounts of MHC class
II/self-peptide complexes (Inaba et al., 1997) makes lymphoid DCs ideal candidate APCs for
tolerance induction (dc St Groth. 1998; Inaba et al., 1998). It is proposed that lymphoid DCs
in the T cell area of LNs present antigen to T cells in a tolerogenic fashion, before the
immunostimulatory myeloid DC (placed outside of the T cell area at the marginal zone)
migrate into the T cell area and present antigen. Adjuvants, such as LPS, stimulate the
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migration of the myeloid DC into the T cell area where they present their antigens in a
stimulatory fashion, perhaps dominating over tolerance induction by the lymphoid-dcrivcd DC
subset (Inaba et al., 1998).
DC maturity
Recent data suggest a role for immature DCs in mediating tolerance presumably by the
induction of Treg cells (Fairchild and Waldmann. 2000). Repetitive stimulation of naive CD4
T cells with allogeneic immature DCs in vitro resulted in alloreactive Treg cells that produced
high amounts of IL-10 and proliferated poorly after stimulation (Jonuleit et al., 2000). The
IL-10-producing Treg cells can act directly on activated TH1 cells and inhibit their antigen-
specific proliferation and cytokine production in a cell contact-dependent manner. The
suppressive activity of these Treg cells, in contrast to the anergic T cells induced by IL-10
modulated DCs (see below), is non-specific and can be partially inhibited by the addition of
exogenous IL-2 (Jonuleit et al., 2000). Therefore, the functional activities of these Treg cells
induced by DCs in vitro are very similar to the described properties of the thymus-derived
murine and human CD4 CD25 Treg cells ex vivo (Jonuleit et al., 2001; Takahashi et al.,
2000; Thornton and Shevach. 1998).
Immature DCs are highly adapted to phagocytose apoptotic bodies (Albert et al., 1998a;
Albert et al., 1998b). However as discussed, these DCs require to be "licensed" for efficient
induction of cytotoxic T cell responses. One concept is that the stimulation of T cells by
immature DCs will lead to tolerance because they only transmit "signal 1" from interaction
with the MHC-peptide complex, whereas mature DCs produce immunity because they
transmit an additional "signal 2" from costimulatory molecules (Guerder and Matzinger,
1992; Kurts et al., 1997). Albert and colleagues challenged this concept by favouring the idea
that a special "third signal", as described for T cell polarisation, is required to produce CD8
T cell tolerance. They found that mature but quiescent DCs induced tolerance, whereas mature
DCs activated via CD40 ligation induced immunity (Albert et al., 2001). The activation of
mature DCs was mediated by CD4 T cells probably via CD40 crosslinking. They proposed
the "third signal" for the regulation of priming vs. tolerising. which is active at the DC-CD4
T cell interface. Another report recently demonstrated the requirement for mature rather than
immature DCs to induce tolerance (Menges et al., 2002). Repetitive injections of TNFa-
matured DCs pulsed with antigen but not immature or LPS/anti-CD40-treatcd DCs prevented
induction of experimental autoimmune encephalomyelitis (EAE) in vivo, which was partially
dependent on IL-10 produced by CD4 T cells. In summary, although immature DCs may
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have been described to induce tolerance, it seems likely that they require a degree of maturity
to interact with T cell and therefore, they would better be referred to as 'modulated".
Transplantation tolerance
The first important clue that certain subtypes of DC are involved in peripheral tolerance
induction in vivo stems from liver transplant studies (Calne et al., 1969; Kamada et al.,
1981). The APCs that are thought to mediate the immune privilege of liver allografts are
immature DCs. Donor interstitial DCs migrate to host secondary lymphoid tissue following
organ transplantation, where they interact with specific, donor-reactive T cells (Thomson et
al., 1995). Immature myeloid-derived DCs propagated from normal murine liver are deficient
in costimulatory molecules, although their expression of MHC and costimulatory molecules
can be upregulated in response to appropriate factors in vitro (Lu et al., 1994). They migrate
in vivo to the T cell areas of secondary lymphoid tissue, where they persist for weeks in
allogeneic recipients, a process called 'microchimerism" (Anderson and Matzinger, 2001).
Consistently, it has been reported that depletion of donor APCs prevented the induction of
transplantation tolerance (Josien et al., 1998; Sun et aL, 1995). Furthermore, in some cases
tolerance was re-established if donor-type DCs were cotransferred with APC-depleted grafts
(Josien et al., 1998). This suggests that DCs of the allografts, in addition to their proposed
immunogenicity (Stemman. 1991), may also be important in establishing transplantation
tolerance.
Strategies for DC modulation in inducing/maintaining peripheral tolerance
IL-10 modulated DCs
Originally, IL-10 was identified as a cytokine-synthesis-inhibiting factor, particularly with
regard to the suppression of lFNy production by TH1 cells (Moore et al., 2001). Stimulation
of T cells in vitro was significantly reduced in the presence of IL-10 (Groux et al., 1996).
However, this effect was dependent on the presence of APCs (Groux et al., 1998).
Subsequently, the effects of IL-10 on APCs and in particular on DCs were identified. The
immunosuppressive properties of IL-10 on DCs are caused by a reduction in the upregulation
of expression of MHC class II molecules and several costimulatory and adhesion molecules
and, in the human system, also the DC-specific marker CD83 (Beilinghausen et al., 2001;
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Buelens et al., 1995; Chang et al., 1995; Sato et al., 1999; Stcinbrink et al., 1997). 1L-10
treated DCs did not produce inflammatory cytokines such IL-ip. IL-6 and TNFa or IL-12
(Bellinghauscn et al., 2001; Brossart et al., 2000; Buelens et al., 1997; Koch et al., 1996;
Takenaka et al., 1997). However, the effect of IL-10 on DCs was only seen if IL-10 was
added to immature DCs, indicating that IL-10 modulates the function of immature DCs and
inhibits their terminal differentiation, whereas mature DCs are resistant to IL-10 (Steinbrink et
al., 1999; Steinbrink et al., 1997). Furthermore, immature DCs produce low amounts of IL-
10, which in vitro prevents spontaneous maturation (Corinti et al., 2001). In vivo, IL-10
producing DCs have been showu to suppress EAE (Yang et al., 2000) and mediate tolerance
to intranasally administered antigens (Akbari et al., 2001).
Human IL-10-trcated DCs from peripheral blood induce an antigen- and alloantigen-specific
anergy of CD4 and CD8" T cells in vitro (Steinbrink et al., 1999; Steinbrink et al., 1997).
This state of anergy was characterised by an inhibited T cell proliferation and reduced
production of IL-2 and IFNy and lack of cytotoxic function by the CD8+ T cells. The
induction of anergy requires direct cell cell contact between T cells and DCs as well as soluble
factors produced by lL-10-treated DCs. In contrast to Treg cells, anergic T cells induced by IL-
10-treated DCs are characterised by a markedly reduced expression of CD25. Furthermore,
these anergic T cells did not produce immunomodulatory cytokines such as IL-10 or TGF-p
(Steinbrink et al., 1999; Steinbrink et al., 1997). Comparisons of the stimulatory capacity of
human DCs isolated from responding or progressing melanoma metastases demonstrated that
the latter induced a markedly decreased T cell proliferation in a MLR resulting in alloantigen-
specific anergy. This is consistent with the high amount of IL-10 produced by melanoma cells
of the progressing metastases (Enk et al., 1997). As a consequence, this finding supports
earlier data showing that the production of IL-10 by tumour cells and/or tumour-infiltrating
lymphocytes might serve as a mechanism for tumour-induced anergy. The ultraviolet (UV)
irradiation resulting in immunosuppression appears to be mediated by the induction of IL-10
in keratinocytes and macrophages (Elmets et al., 1983; Kang et al., 1994). After migration to
the draining LNs, the UV or IL-10 modified Langerhans cells induce tolerance in T cells
(Elmets et al., 1983; Enk et al., 1993).
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Designer DCs
Genetically engineered DCs that for example express 1L-10 (Takayama et al., 1998), TGF-P
(Lee et al., 1998), FasL (Min et al., 2000) or CTLA-4-Ig (O'Rourke et al., 2000) can induce
alloantigen-specific T cell hyporesponsiveness and enhance the survival of allografts.
However, these approaches have not yet succeeded in establishing the long-term allograft
survival that would be indicative of a more robust form of tolerance. The use of techniques
such as serial analy sis of gene expression (SAGE) or oligonucleotide microarrays and their
application to populations of DCs have already begun to reveal novel differentially expressed
genes whose overexpression or mutation would permit the generation of 'designer" DCs with
previously unexplored properties (Granucci et al., 2001; Hashimoto et al., 1999).
1.3 T cell signalling and polarisation
Activation and function of T lymphocytes are tightly regulated by signal transduction
pathways that include specific cell-surface receptors, intracellular signalling molecules and
nuclear transcription factors. As mentioned earlier, T cells require two signals to become
activated, "signal 1" being the TCR triggering and "signal 2" being costimulation. The "signal
3" leading to polarisation or tolerance of the T cells is less defined (Fig. 1.2). Here I will give a
brief overview about the signalling pathways downstream of the TCR and the development of
T helper subsets, which are reviewed in more detail by (Acuto and Cantrell, 2000; Chambers,
2001; Kuo and Leiden, 1999; Murphy et al., 2000).
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1.3.1 Signal 1/TCR signalling pathway
The TCR is a heterodimer of an a and p chain and interacts with the MHC/peptide complex.
The affinity, avidity and stability of the MHC/peptide-TCR interaction vary over a wide
range. This explains the variable requirement for stabilisation by CD4 and CD8. These
coreceptors present on CD4 and CD8+ T cells, respectively, are important to deliver the
protein tyrosine kinase (PTK) Lck, which is associated with the intracellular end of CD4 and
CDS (Fig. 1.4; Kuo and Leiden, 1999).
The TCR is associated with the CD3 cluster, which is composed of subunits y, 8, s and the ££
homodimer chains (Weiss, 1993). These chains display in their cytoplasmic tails motifs
termed ITAMs (immuno-receptor tyrosine-based activation motifs). Upon engagement of the
TCR by antigen presented on MHC molecules, the protein tyrosine kinases (PTKs) of the Src
family (Lck and Fyn) are activated and phosphorylate ITAMs of the CD3 complex, which in
turn promotes the recruitment and subsequent activation of another tyrosine kinase ZAP-70
(zcta/C, associated protein of 70kD) (Fig. 1.4; Chan et al., 1992; Straus and Weiss, 1992;
Zenner el al., 1996). Upon activation ZAP-70 phosphorylates adapter proteins LAT (linker
for activation of T cells) and SLP-76 (src homology 2 domain-containing leukocyte
phosphoprotein of 76kD), which transduce signals further resulting in the activation of the
Ras/MAPK pathway, calcium mobilisation and cytoskeletal reorganisation (Acuto and
Cantrell, 2000; Pivniouk and Geha, 2000). These early events appear to be crucial for the
triggering of the signalling cascades that stimulate nuclear transcription factors that regulate
the production of several cytokines, including IL-2. IL-2 gene transcription, a key event in T
cell activation and proliferation, is regulated by the coordinate action of multiple factors
including NF-AT, AP-1 and nuclear factor kB (NF-kB) (Herndon el al., 2001; Kuo and
Leiden, 1999). Activation of these different transcription factors regulating IL-2 gene
transcription results from at least two synergising transduction pathways triggered at the
TCR. as well as from costimulatory pathways ("signal 2") discussed later.
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The Calcium-Calcineurin pathway
One of these cascades involves phosphorylation and activation of phospholipase Cy (PLCy),
which cleaves the membrane lipid phosphatidylinositol bisphosphate to generate diacylglycerol
(DAG) and inositol trisphosphate (IP?). These second messengers are essential for T cell
activation. DAG activates protein kinase C (PKC), whereas IP? triggers an increase in the
concentration of intracellular calcium (Fig. 1.4; Weiss and Imboden, 1987). The increased
Ca2+ level then activates the protein phosphatase Calcineurin by disrupting the inhibitor}
effects of Calmodulin. Calcineurin activation leads to the dephosphorvlation of the nuclear
factor of activated T cells (NF-AT), allowing it to enter the nucleus, where it cooperates with
other transcription factors to bind to variety of promoters such as, for example, the IL-2
promoter (Rao et al., 1997; Wulfing et al., 1997). In in vitro studies, the effect of this
necessary- calcium signal for activation of gene transcription factors can be induced by the
action of calcium ionophores such as ionomycin. In combination with phorbol esters, which
stimulate PKC such as phorbol myristate acetate (PMA), ionomycin fully activates IL-2 gene
transcription.
The MAPK Pathways
Mitogen activated protein kinases (MAPKs) are important in many signalling pathways, e.g.
growth hormone, TNFa or IL-1 signalling, leading to cell growth and to stress responses.
"Signal 1" activates several MAPKs: DAG and PKC activate Ras. which subsequently
stimulate a number of serine/threonine kinases and dual-specificity kinases leading to the
activation of the MAPKs ERK (extracellular signal receptor regulated kinase) (Robbins et al.,
1994), JNK (Jun N terminal kinase) and p38. These MAPKs directly phosphorylate
transcription factors involved in the formation of the heterodimeric transcription factor AP-1
(Jun/Fos).
Another transcription factor important for the generation of IL-2 is NF-kB. Activation of NF-
kB is dependent on stimulation of the TCR and costimulation via CD28. The serine/threonine
kinase Akt and the MAPKs participate in the induction of IkB degradation Free from its
association with IkB, NF-kB can move into the nucleus and activate transcription (Kane et
al., 2001).
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Many recent studies have focused on functional and physical interactions between the TCR
and cytoskclcton such as TCR clustering at the site of APC contact and reorientation of the
microtubule-organising centre. Aggregation of several TCRs on the T cell surface promotes
concentration of lipid- and kinase-rich "rafts'' or '"microdomains" thereby facilitating
signalling (Acuto and Cantrell, 2000; Viola et al., 1999).
TCR/CD3
complex CD4
Figure 1.4. T cell receptor signalling.
The TCR/CD3 complex is a substrate for the Src family of protein tyrosine kinases (PTKs) Lck and
Fyn, which phosphorylate tyrosine residues on the intracellular tail of the subunits. These sites,
known as immuno-receptor tyrosine-based activation motifs (ITAMs, black boxes), are the docking
sites for proteins with Src homology 2 (SH2) domains. One such protein is the PTK ZAP-70. Initial
activation of PTKs is followed by phosphorylation activation of downstream components as
delineated in the figure. These events ultimately lead to regulation of gene expression by the
activation of transcription factors such as NF-AT, AP-1 and NK-kB. Arrows indicate activation of
the target molecule. This activation can be direct or involve other proteins. Dashed arrows: Direct
biochemical evidence for this pathway is still missing. Targets of mitogenic stimuli PMA/ionomvcin
are indicated bv bold grey arrows.
41
1.3.2 Signal 2/CD28 cosignalling pathway
In addition to the TCR/CD3 associated signalling cascade, a costimulatory "signal 2" is
required for lull T cell activation and proliferation (Chambers, 2001). TCR ligation without
costimulation can result in functional inactivation and anergy and in cell death (Boise et al.,
1995; Gimmi et al., 1993; Harding et al., 1992). The best-characterised costimulatory
receptor expressed on a resting T cell is CD28. CD28 is a homodimeric glycoprotein
expressed on 95% of CD4 T cells and on approximately 50% of CD8 T lymphocytes (June
et al., 1994). Upon interaction with its ligands B7.1 and B7.2 expressed on the APC, CD28
enhances 1L-2 synthesis and T cell proliferation (reviewed in Chambers, 2001). Evidence has
been foimd showing that the role of CD28 signalling is not to costimulate the initial activation
of naive T cells but to sustain the late proliferative response and enhance long-term cell
survival (Sperling et al., 1996).
CD28 ligation triggers PLCy activation and Ca mobilisation (Ledbetter and Linsley, 1992).
Although CD28 does not display any obvious intrinsic enzymatic activity, tyrosine residues on
its cytoplasmic tail can be phosphorylated, allowing the binding of different signal transducing
molecules. The signalling cascade that bridges these early CD28-triggered events with the
later activation of nuclear factors regulating cytokine gene transcription is still unresolved.
The guanine exchange factor Vav associated with activated CD28 may link TCR and CD28
stimulation by activating the Ras/MAPK pathway (Fig. 1.4; Klasen et al., 1998; Villalba et
al., 2000). Further it was suggested that NF-kB and AP-1 are direct targets for CD28 signals
(Edmead et al., 1996), the latter via JNK signalling. It is noteworthy that activation of JNK in
T cells requires ligation of both TCR and CD28 (Su et al., 1994). This result led to the
conclusion that JNK activation could be a nodal event between the TCR-induced signalling
pathway and the CD28-mediated costimulation pathway, resulting in 1L-2 production. CD28
signalling also stabilises 1L-2 mRNA post-transcriptionally by an unknown mechanism
(Lindsten et al., 1989), which is an important mechanism of costimulation (Umlauf et al.,
1995).
When CD28 and TCR are both triggered, the T cell does not proliferate indefinitely. The
membrane-spanning tyrosine phosphatase CD45, which plays an essential role in T cell
activation, is also involved in the termination of the T cell response via dephosphorylation of
the CD3^ chain (Furukawa et al., 1994). Furthermore, the engagement of TCR activates the
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expression of CTLA-4, a cell surface molecule structurally related to CD28 (reviewed in
Chambers et al., 2001). Like CD28, CTLA-4 also recognises B7.1 and B7.2. However,
CTLA-4 provides a crucial and unique negative signal that inhibits IL-2 secretion (Blair el al.,
1998). CTLA-4 is a critical negative regulator, which means that "signal 1" and "signal 2"
will result in the T cell eventually being turned off under physiological conditions.
Another mechanism to limit TCR signalling is its downregulation, which is an inhibitory
feedback regulation characteristic of many receptor systems. Internalisation of the TCR from
the cell surface begins a few minutes after initiation of TCR signalling and is followed by
degradation (Valitutti el al., 1997). Additionally, there exist biochemical interference of TCR
signalling by downstream molecules such as c-Cbl or SHP-1 (reviewed in Gennain and
Stefanova, 1999).
1.3.3 Polarisation from the view of T cells
Th1 and TH2 subsets were originally defined by Mosmami & Coffman (Mosmann et al.,
1986). Th1 cells secrete the cytokines IL-2 and IFNy, activate phagocytes and promote
protection against intracellular pathogens. TH2 cells secrete the cytokines IL-4. IL-5, IL-10
and IL-13, which affect humoral immunity to extracellular parasites and are responsible for
immune responses to persistent antigens, for instance allergens (reviewed in Constant and
Bottomly, 1997). The two T helper subsets also cross-regulate each other, so the balance
between TH1 and TH2 cytokines can determine whether the immune response is appropriate for
the host or may result in the generation of pathological responses. Overproduction of Tul
cytokines has been implicated in delaved-type hypersensitivity reactions and autoimmune
diseases. TH2 cytokines recruit eosinophils and activate mast cells; thus dysregulation of TH2
cytokines can lead to allergic and inflammatory conditions. CD8+ T cells can also be polarised
to effector subsets with distinct cytokine production profiles similar to those found in CD4+ T
cells (Croft et al., 1994). This polarisation has been observed both in vitro and in vivo
(Morclli et al.. 2000; Sad et al., 1995), and it is likely that CD8 T cells also play an
important regulatory role during immune responses.
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The TCR signalling, the nature of costimulation and the cytokine milieu influence the
polarisation of T cells (see also section 1.2.2). IL-12 promotes IFNy production and TH1
development via signalling pathways that lead to activation of STAT4 (signal transducer and
activator of transcription 4) (Murphy el al., 2000). Ligation of the 1L-4 receptor by IL-4.
leading to STAT6 activation, can drive a naive TH cell down a TH2 differentiation pathway.
Thus, cytokines have emerged as critical inducers of T([ subset development (Fig. 1.5).
Overall, the mutually antagonistic effects of 1L-4 and IFNy regulate TH1/TH2 balance and
subsequent polarisation. Understanding the transcriptional regulation of IFNy as a hallmark




























Figure 1.5. Overview of TH ceil differentiation.
A naive GD4 T cell is activated via the TCR when it encounters antigen presented by an APC. Once
activated, the Th cell starts to proliferate, secrete IL-2, and express the IL-12 receptor consisting of a
Pi and a p2 chain. On encountering IL-12 secreted by macrophages and/or DCs, a Th1 differentiation
programme is initiated. The expression of IL-12R|L chain increases in the developing Th1 cell and
ligation of the IL-12R by IL-12 leads to the activation of STAT4 and initiation of the Th1
differentiation program. IL-4 produced by several cell types namely other Th2 cells, mast cells,
basophils and eosinophils induces differentiation into the Th2 subset and downregulation of IL-
12Rp2 expression. Reprinted from Rengarajan et al. (2000) with permission from Elsevier Science.
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1.3.3.1 Tnl development
Although STAT4 is expressed by T([l and TH2 cells (Szabo et al., 1995), STAT4 activation
by IL-12 occurs only in TH1 cells because of the TH1 -restricted expression of the 1L-12RP:
subunit (Fig. 1.6; Szabo et al., 1997). Even though STAT4 activation was correlated with the
capacity to promote IFNy production (Szabo et al., 1995), not all lFNy production appears to
depend on STAT4 (Kaplan et al., 1998). CD8 T cells, for example, exhibit STAT4-
independent TCR-induced IFNy production (Carter and Murphy, 1999).
Members of the interferon regulatory factor (IRF)-l family have been suggested to participate
in Th1 development and IFNy production. IL-12 signalling induces IRF-1 expression in T
cells through STAT4 activation, which is required for lL-12-induced IFNy production (Coccia
et al., 1999; Lohoff et al., 1997). Thus, IRF-1 expression may be downstream of IL-12, but
direct actions in the IFNy promoter are not clear. Another protein induced by IL-12 via
STAT4 in TH1 is ERM, an Ets family transcription factor (Ouyang et al., 1999). However,
ERM expression did not restore IFNy transcription in STAT4-deficient T cells. T-bet (T-box
expressed in T cells), a member of the T-box family of transcription factors that regulate
several developmental processes, was identified as THl-specific (Szabo et al., 2000). T-bet
strongly activates IFNy production when expressed in naive and type I or type 2 polarised
CD4+ and CD8 T cells and simultaneously represses the TH2 cytokines IL-4 and IL-5 (Szabo
et al., 2000). Finally, the homeodomain transcription factor Hlx was found to be THl-specific,
with transgenic overexpression enhancing THl-type responses (Flavell et al., 1999; Murphy et
al., 2000).
While TCR signalling was considered a required stimulus for IFNy production by CD4 T
cells, recently Robert et al. discovered a second pathway for induction. The cytokines IL-12
and IL-18 together induced full IFNy production by TH1 cells, independent of stimulus
through the TCR (Robinson et al., 1997). IL-18 receptor is a new member of the IL-1
receptor family and its signalling pathway shares several components with the IL-1 and TLR
pathway (reviewed in Akira et al., 2001). Molecular mechanisms of IL-18R signalling in TH1
cells involves recruitment of IL-1R associated kinase (IRAK) and MyD88 which induce NF-
kB activation through TNF receptor associated factor 6 (TRAF6) (Adachi et al., 1998;


















T-bet ERM? NFAT ATF2
Hlx *
\ / pathway t
w/t^kjJ
IFN-y
IFN-y gene HS sites 1 III
Putative cis-acting elements
Figure 1.6. Pathways and transcription in IFNy production by TH1 ceils.
Tnl-specific components (asterisks) include the receptors for IL-12 and IL-18 and recently identified
transcription factors. A number of putative c/.v-acting elements are shown, but none are known to
interact with THl-specific transcription factors. STAT4 activation is restricted to TH1 cells, but alone
is not sufficient to transactivate the IFNy gene. HS sites: DNase I hypersensitivity sites. Reprinted
from Murphy el at. with permission from the Annual Review of Immunology, Volume 18, © 2000,
by Annual Reviews www.AnnualReviews.org.
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The stability of the TH1 phenotype is not clear, but recently 1L-4 signalling impairment was
reported for TH1 cells (Huang and Paul, 1998). Diminished 1L-4 signalling in ThI cells may
involve suppressor of cytokine signalling (SOCS) proteins (Losman et al., 1999). SOCS
family members modulate signalling by several mechanisms, which include inactivation of the
Janus kinases (JAKs), blocking access of the STATs to receptor binding sites and
ubiquitination of signalling proteins and their subsequent targeting to the proteasomc
(reviewed in Krebs and Hilton, 2001).
1.3.3.2 Th2 development
Following priming with IL-4, TH2 populations become progressively less susceptible to
reversal by TH1 -inducing cytokines, and IL-4 production becomes independent of extrinsic 1L-
4 (Huang et al., 1997; Murphy et al., 1996). Loss of IL-12R expression by TH2 cells may
explain early TH2 stability (Szabo et al., 1995).
IL-4R signalling involves the IL-4-specific a chain and common gamma chain (yc).
Engagement of IL-4R leads to activation of STAT6 by Janus kinases. Jakl and Jak3 (Fig. 1.7;
reviewed in Nelms et al., 1999). The expression of transcription factor GATA-3, which is
selectively expressed in TH2 cells, is induced in a STAT6-dependent manner and increases
expression of TH2 cytokines (Chtanova et al., 2001; Ouyang et al., 1998; Zheng and Flavell,
1997). Additionally, it blocks IL-12R expression and prevents TH1 development independently
of the induction of IL-4 (Ouyang et al., 1998). Further, the TH2-specific transcription factor
c-Maf also attenuates TH1 differentiation by both IL-4-dependent and independent
mechanisms in addition to directly augmenting IL-4 promoter activity through cooperative
interactions with NF-AT and JunB (Ho et al., 1996; Ho et al., 1998; Rincon et al., 1997b).
Several factors are known to inhibit IL-4-induced transcription of type 2 cytokines. As
previously mentioned, SOCS-1 is likely to inhibit Jakl and Stat6 activation in response to IL-
4 signalling in TH1 cells (Losman et al., 1999). Bcl-6 was found to repress TH2 cytokines by
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Figure 1.7. Pathways and transcription in IL-4 production by TH2 ceils.
TH2-specific components (asterisks) include the transcription factors GATA-3, c-Maf, and JunB.
Acute transcriptional activation by NF-AT, c-Maf, JunB, and perhaps other factors may require prior
chromatin remodelling of the IL-4 locus or enhancer activity provided by GATA-3. TH2-specific
DNase-hypersensitive (HS) sites are indicated with asterisks. Reprinted from Murphy et al. with
permission from the Annual Review of Immunology, Volume 18, © 2000, by Annual Reviews
www.AnnualReviews.org.
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After primary activation, cytokines are expressed for several days. Recent studies have linked
cell division with the acquisition of effector cytokine expression (Bird et al., 1998; Gett and
Hodgkin, 1998; Richter et al., 1999). Although T cells were immediately capable of making
IL-2, production of IFNy and IL-4 correlated with the number of cell divisions following
activation. In particular, IFNy appeared to require one to two cell divisions, and IL-4
production was delayed until four cell divisions (Bird et al., 1998; Gett and Hodgkin. 1998).
The expression of cytokines is "memorised" by TH cells. When restimulated, they recall
expression of those cytokines they had been instructed to express earlier, without requirement
for the original costimulator (Murphy et al., 1996; Szabo et al., 1995). Recently, several
groups have provided evidence for somatic imprinting of cytokine genes as a molecular basis
for cytokine "memory" in TH lymphocytes. Analysis of DNA methylation and DNase I
hypersensitivity of the genomic regions of various cytokine genes has shown that those
cytokine genes, which the T cells had originally expressed, remained "accessible" later, and
that accessibility is correlated with the ability for expression of the cytokines upon recall
stimulation (Agarwal and Rao, 1998; Bird et al., 1998). Cells committed to the type 1 or type
2 phenotypes demonstrate changes in chromatin structure around IFNy and IL-4, respectively.
Such structural changes are believed to begin the process by which the cytokine expression
repertoire is stabilised, such that effector functions become passed on to daughter cells.
1.4 The Notch Pathway
In many situations in development, the choice between alternative cell fates is controlled by
cognate interactions between cells mediated via the transmembrane receptor Notch. Vertebrate
Notch and its Caenorhabditis (C.) elegans homologues LIN-12 and GLP-1 comprise a family
of receptors that participate in cell fate decisions throughout embryonic development. The
basic signalling mechanism of the Notch family of receptors shows a striking evolutionary
conservation. In spite of this conservation in mechanism, the Notch family of receptors are
extraordinarily adaptable and have been co-opted to function in many diverse developmental
processes.
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1.4.1 Notch receptors and ligands
Human Notch was first identified as a gene involved in chromosomal translocation detected in
some T-ccll leukaemias. This gene, called TAN-1, was shown to generate an intracellular
activated form ofNotchl (1CN1) (Ellisen et al., 1991), and can induce T-cell leukaemias with
high frequency when expressed in murine bone marrow cells (Capobianco et al., 1997). To
date, four mammalian Notch homologues (Notch 1-4), which interact with transmembrane-
bound ligands such as Jagged 1. Jagged2. Delta-like 1, Delta-like3 and Delta-like4 (Delta-like 1,
3, 4 proteins are referred to as Deltal, 3, 4, respectively) have been identified (Table 1.3;
Fleming, 1998; Yoneya et al., 2001). Notch receptors share a high degree of structural
homology between members as well as across species as diverse as flies and humans.
The Notch extracellular domain contains a variable number (29-36) of tandem epidermal
growth factor (EGF)-like repeats and three Lin/Notch repeats (LNR), which function in ligand
binding and Notch activation (Fig. 1.8; Lardelli et al., 1994; Rebay et al., 1993; Rebay et al.,
1991). The conserved cysteines between the LNR and the transmembrane domain (TM) are
probably involved in disulphide bonding of the heterodimcric receptor. The intracellular
domain of Notch receptors consists of a RAM domain, 6 ankyrin (ANK) repeats, 2 nuclear
localisation sequences (NLS), a glutamine-rich domain (OPA), a transcriptional activation
domain (TAD) and a C-terminal proline-glutamate-serine-threonine-rich (PEST) domain,
which is thought to be a degradation signal (Rogers et al., 1986). Notch4 is an exception in
that it has a shorter intracellular domain that lacks one of the two NLS (Uyttendaele et al.,
1996). The RAM domain is the primary binding site for the CSL (CBF1, Su(H). LAG-1)
effectors (Tarnura et al., 1995). However, the TAD and the ANK repeat domain can also
interact with C promoter binding factor-1 (CBFl)/recombination signal binding protein Jk
(RBP-Jk) (Aster et al., 2000; Fortini and Artavanis-Tsakonas. 1994; Kurooka et al.. 1998).
ANK repeats are characteristic motifs involved in protein-protein interactions; the ANK
repeat domain is the most highly conserved region and is essential for Notch signal
transduction. In addition to CBF1, the ANK domain also interacts with proteins such as
Deltex and Mastermind, which modulate Notch signalling. Recently, a NF-kB binding domain
(NBD) has been identified, which overlaps with a NLS and parts of the RAM domain (Wang
et al., 2001).
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The two distinct but related classes of Notch ligands, Jagged/Serrate and Delta, encode
transmembrane proteins, which contain 16 and 8 EGF repeats, respectively, on the
extracellular side (Bettenhausen et al1995; Luo et al., 1997; Oda et al., 1997; Shimizu et
al., 1999) In addition, they harbour a modified EGF repeat at the N-terminal region referred
to as the DSL (Delta/Serrate/Lag-2) domain, which is probably involved in receptor binding.
The principal difference between the two types of ligand is that Serrate-like ligands contain a
cysteine-rich (CR) region, whereas Delta-like ligands do not. The intracellular domains of
Delta and Serrate are short and show little structural conservation.
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Figure 1.8. Schematic structure of Notch and the ligands Jagged and Delta.
ANK, 6 ankyrin repeats; CR, cysteine-rich domain; DSL, Delta/Serrate/Lag-2; EGF, epidermal
growth factor-like repeals; ICN. intracellular activated form of Notch; LNR. 3 Lin/Notch repeats.
NBD, NF-kB binding domain; NLS, nuclear location sequence; PEST, proline-glutamate-serine-
threonine-rich domain; RAM, RBP-J association molecule; TAD, transcriptional activation
domain; TM, transmembrane domain.
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1.4.2 Notch processing and signalling
The Notch precursor is proteolytically cleaved into two fragments, one containing most of the
extracellular domain and the other containing the transmembrane region and the intracellular
domain. Tire cleavage is mediated by furin-like convertases in the trans-Golgi compartment
(Blaumucller et al., 1997; Logcat el al., 1998). The two fragments are non-covalently linked
to form the heterodimeric mature Notch receptor found on the plasma membrane. The
glycosyltransferase Fringe modifies the extracellular EGF repeats in the Golgi, which most
probably regulates the specificity of Notch for its ligands (Bruckner et al., 2000; Hicks et al.,
2000; Ju et al., 2000; Moloney el al., 2000). Three vertebrate honrologues of Drosophila
Fringe have been identified with different expression patterns: Lunatic Fringe, Manic Fringe,
and Radical Fringe. Ligand binding at the cell surface is thought to induce endocytosis and a
conformational change in the Notch heterodimer, exposing an extracellular site just outside the
transmembrane domain to ADAM mctalloprotease cleavage and shedding of the extracellular
portion (Brou et al., 2000). Once the extracellular domain of Notch has been removed, the
remaining carboxy-terminal portion consisting of a short extracellular stalk, the
transmembrane domain and the complete intracellular domain, is efficiently proteolysed in a
Presenilin-dependent manner releasing the intracellular activated form of Notch (ICN; De
Strooper et al., 1999; Song et al., 1999b; Struhl and Greenwald, 1999). This domain interacts
with transcriptional effectors of the CSL family, resulting in transcriptional activation of
target genes such as Enhancer of split (E(spl)).
An isoform of cell surface Notch 1 has recently been identified that does not undergo
proteolytic processing or heterodimer assembly (Bush et al., 2001). Its activation upon ligand
binding is thought to be CBF1-independent. Further analysis will be needed to determine
whether this pathway corresponds to the CSL-independent Notch pathway inferred from
genetic studies in Drosophila and mammalian cells (see below).
ICN interacts with a number of cytoplasmic and nuclear proteins, permitting signal
transduction through at least two pathways, one involving CSL proteins and one independent
of CSL.
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The CSL-dependent pathway involves association of intracellular domain of Notch with the
CSL protein CBF1. the mammalian homologue of Drosophila Su(H). and transcriptional
activation of Hairy/Enhancer of Split (Hes) through binding of Notch/CBFl to the Hes
promoter (Jarriault et al., 1995). The precise molecular mechanisms of how Notch can
transactivate CBF1-regulated genes are unknown. CBF1 is ubiquitously expressed in most
mammalian cells. In the absence of activated Notch, it functions as a transcriptional repressor
and has been shown to interact with the corepressor/histone deacetyiase complex (HDAC)
(Fig. 1.9; Hsieh et al., 1999; Kao et al., 1998; Kurooka and Honjo, 2000; Oswald et al.,
1998). ICN is thought to replace HDAC and possibly recruit coactivator/hlstone
acetyltransferases (HAT) or unknown transcription factors resulting in the expression of
Notch target genes. Drosophila Mastermind and its human homologue Mastermind-like-1
(MAML1) are transcriptional coactivators of Notch signalling, which bind to the ANK
repeats of ICN and have been shown to stabilise the ICN-CBF1 complex (Schuldt and Brand,
1999; Wu et al., 2000). The negative regulator Numb inhibits Notch signalling, probably by
preventing ICN translocation into the nucleus (Frise et al., 1996). However, it is not known
whether Numb is expressed in haematopoietic cells.
CSL-independent signalling also results in transcriptional regulation, but is mediated by
different effector molecules, such as Deltex, and may regulate distinct target genes (Matsuno
et al., 1997; Nofziger et al., 1999; Ordentlich et al., 1998; Shawber et al., 1996). Three
closely related members of the Deltex family (Deltex 1-3) have also been identified in
mammals (Kishi et al., 2001; Matsuno et al., 1998; Pampeno and Meruelo, 1996). Deltex has
three distinct motifs: a binding site for ICN. a SH3 binding domain and a zinc-finger domain,
which is known to be involved in protein-protein interactions in various systems (Freemont,
1993; Matsuno et al., 1995). The SH3 binding domain of Deltex is shown to interact with the
adapter protein Grb2 in a yeast two-hybrid system (Matsuno et al., 1998). However, it is not
known if the SH3 binding domain of Dcltex can link ICN and Grb2 in vivo. Deltex is a
positive regulator of Notch signalling (Diederich et al., 1994; Matsuno et al., 1995).














Pax5 => B cell development
Figure 1.9. Regulators of CBFl-dcpcndcnt Notch signalling.
Ligand-induced Notch activation inhibits cell differentiation in neurogenesis myogenesis and in B
cell development by repressing cell-lineage specific genes MASH1, MyoD and Pax5, respectively.
CBF1, C promoter binding factor 1; HAT, histone acetyltransferases; HDAC, histone deacetylase
complex; Hes. hairy/enhancer of split; MAML1. Mastermind-like-1; MASH1. mammalian achaete-
scute homologue-1
1.4.3 Targets of Notch signalling
The ICN-CBF1 complex induces transcription of the Hes genes, the mammalian homologues
of E(spl) (Fig. 1.9 & 1.10). Hes proteins are basic helix-loop-helix (bHLH) transcription
factors and inhibit activity of other bHLH proteins, thereby suppressing transcription of
lineage-spccific genes. There arc seven described members in the mammalian Hes family.
Among these seven, only Hesl, Hes5, Hes6 and Hes7 are known to be involved in Notch
signalling (Table 1.3; Bac et al., 2000; Bessho et al., 2001; Ohtsuka et al., 1999).
Hesl is known to inhibit the DNA-binding activity of E47, a product of the E2A gene (Sasai
et al., 1992). MyoD and MASH1, two transcription factors important in myogenesis and
neurogenesis, respectively, interact with E47 and activate transcription Hesl also inhibits the
transcriptional activity of these factors probably by depleting E47 from the complex (Kuroda
et al., 1999; Sasai et al., 1992). A bHLH protein in Drosophila related to MASH1, the
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Achaete-Scute complex (Ac-Sc), is inhibited by Notch, and recent studies in rat neuroblasts
have shown that Hcsl also inhibits MASH1 expression (Castella et al., 1999). Hcs proteins
interact with transducin-like E(spl) (TLE) proteins, the mammalian counterparts of
Drosophila Groucho. corepressors likely to be important in Hes-mediated transcriptional
repression (Grbavec and Stifani, 1996). Recent data suggests that Groucho negatively
regulates the transcription factor Pax5, which is required for B cell development (Ebcrhard et
al., 2000). Interaction of Hesl with other Hes members may be important. Hes6 does not have
DNA binding activity but directly binds to Hesl and inhibits its function (Bae et al., 2000).
Targets of the CSL-independent pathway are less characterised. Deltex interferes with the Ras
signalling pathway and inhibits E2A-cncoded transcription factors (Fig. 1.10; Ordcntlich et














Figure 1.10. Molecular control of T cell fate specification by Notch 1 signalling.
In this hypothetical model, the interaction of ligands such as Jagged 1 and/or Jagged2 expressed on
thymic epithelial cells with the Notch 1 receptor expressed on common lymphoid precursors (CLPs)
leads to activation and cleavage of the Notch 1 receptor at (or close to) its transmembrane domain.
Two signalling pathways are simultaneously activated. Translocation of the intracellular subunit of
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the Notchl receptor into the nucleus and its heterodimerisation with RBP-Jk converts RBP-Jk from a
transcriptional repressor into an activator, thereby leading to transcription of T-lineage-specific
target genes (still to be identified) and instruction of CLPs towards the T-cell lineage.
Simultaneously, a second pathway is activated through Dcltex leading to inhibition of E2A-encoded
transcription factors such as E47. which are essential for B-cell development. This pathway involves
the inhibition of Ras-activated INK.
1.4.4 Lateral specification/inhibition and lateral induction
Notch receptors mediate two different processes: lateral specification/inhibition and lateral
induction. Notch signalling can occur either among a group of equivalent cells (homotypic
interactions) or between non-equivalent cells (heterotypic interactions), both of which are
essential during development.
1.4.4.1 Homotypic interactions: lateral specification/inhibition
Lateral specification events are often responsible for the segregation of specific lineages from
clusters of precursor cells.
In a group of initially equivalent cells, stochastic events and/or extrinsic factors single one cell
out to express more Notch ligands than the others (Fig. 1.11). This cell signals to neighbouring
cells through Notch. Activation of Notch in the receiving cells inhibits expression of lineage-
commitment gene products thereby inhibiting their differentiation (lateral inhibition).
Additionally, Notch signalling inhibits production of the Notch ligand. Consequently, a cell
that produces more ligand forces its neighbours to produce less. This enables the cell to
increase its ligand production even further, because it receives a weakened inhibitory signal
back from its neighbours. The effect of this feedback loop is to drive neighbouring cells into
different developmental pathways: any initial difference between them is intensified and
maintained.
The most thoroughly studied examples of Notch signalling are in the control of neurogenesis
in Drosophila and in vertebrates (Fig. 1.11). Notch signalling here controls the commitment of
equivalent progenitor cells to differentiate. The major target gene for Notch signalling in
Drosophila neurogenesis is the Ac-Sc complex, which is essential for the differentiation of
progenitors into neural cells. Notch suppresses the Ac-Sc complex in neural progenitors
56
through E(spl) and thereby inhibits their differentiation into neurons (Heitzler et al., 1996).
Because Ac-Sc is also a transcriptional activator of Delta (Kunisch et al., 1994), Delta
expression is suppressed in response to Notch activation. Therefore, the nascent neurons, by
expressing Delta, deliver lateral inhibition to the Notch 1-expressing progenitors to prevent
them from differentiating prematurely into neurons. This lateral inhibition mechanism has
been confirmed inXenopus (Chitnis et al., 1995), chick (Austin et al., 1995; Henrique et al.,
1997). mouse (de la Pompa et al., 1997) and zebrafish (Dornseifer et al., 1997). Many cells
during development can choose a "default" pathway of differentiation (neurons in the case of
neurogenesis), and in general, Notch is thought to inhibit selection of the default cell fate,











































Figure 1.11. Neurogenesis in Drosophila as an example of lateral inhibition.
All cells in a cluster of equipotent cells initially express the same amount of Notch. Su(H). E(spl).
Ac-Sc and Delta. A small stochastic variation in Delta expression of one cell (#1) stimulates Notch
in the neighbouring cells (#2) leading to E(spl) activation that represses Ac-Sc activity and thereby
lineage-commitment and Delta expression. Cell #1 does not receive any inhibitory signals through
Notch from neighbouring cells (#2) anymore and differentiate along the primary or "default"
pathway into a neuron.
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1.4.4.2 Heterotypic interaction: lateral induction
Notch signalling also occurs between Notch and Notch ligands expressed on different cell
types (Fig. 1.12). Inductive signalling through these heterotypic interactions is regulated
primarily by ligand expression, limiting Notch activation to those cells in direct contact with
ligand-exprcssing cells. Interactions between Notch receptors and ligands can also be
modulated by other molecules, such as Fringe (Fleming et al., 1997; Panin et al., 1997), and
further regulated by a feedback loop, which results in increased ligand expression (de Celis
and Bray, 1997). Inductive signalling thus permits the establishment of finely demarcated
boundaries between cell types, exemplified by dorsal-ventral boundary formation during fly
wing margin specification and vertebrate limb development (Ju et al., 2000).
Figure 1.12. Development of the dorsal-ventral border of Drosophila wing as an example of
lateral induetion.
Serrate signals from dorsal cells to Notch on ventral cells and is inhibited from signalling to Notch
on other dorsal cells by Fringe. Delta signalling from ventral cells to dorsal cells is potentiated by
Fringe associated with dorsal Notch. The expression of the ligands is maintained by a positive
feedback loop as Serrate signalling to Notch in ventral cells induces expression of Delta, while Delta
signalling to Notch in dorsal cells induces expression of Serrate.
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1.4.5 Notch signalling in the immune system
1.4.5.1 Notch signalling and myelopoiesis
Expression of Notch receptors and ligands was observed in cells and tissues of the immune
system and there is accumulating evidence that endogenous Notch signalling regulates the
differentiation of immune cells. Notch is expressed in human and mouse CD34
haematopoietic precursors (Milncr et al., 1994; Varnum-Finney et al., 1998). Notch ligands
are expressed on bone marrow stromal cells as well as in haematopoietic precursors (Han et
al., 2000; Jones et al., 1998; Karanu et al., 2001; Li et al., 1998; Nomaguchi et al., 2001;
Tsai et al., 2000). Many groups have made use of myeloid progenitor cell lines as a model
system for haematopoietic differentiation (Migliaccio et al., 1989); 32D cells proliferate as
blasts in the presence of IL-3, but they differentiate and undergo granulopoiesis in the
presence of G-CSF or GM-CSF. Coculture with Notch ligands or transfection with activated
Notch inhibits differentiation of 32D cells and CD34 haematopoietic progenitors (Carlesso et
al., 1999; Jones et al., 1998; Li et al., 1998; Milncr et al., 1996; Varnum-Finney et al., 1998)
rather than promotes their differentiation (Schroeder and Just, 2000a; Schroeder and Just,
2000b; Walker et al., 1999). Additionally, Notch activation promotes survival and expansion
of haematopoietic precursors in vitro and in vivo (Han et al., 2000; Karanu et al., 2001; Tsai
et al., 2000), consistent with the ability of ICN1 to induce immortalised, cytokine-dependent
progenitor cell lines from murine bone marrow cells (Varnum-Finney et al., 2000). In other
situations, however, ICN1 has been inhibitory for proliferation (Schroeder and Just, 2000a;
Schroeder and Just, 2000b). The inhibition of differentiation by Notch is consistent with the
lateral inhibition model (section 1.4.4.1), whereby Notch activation retains the cells in an
undifferentiated pluripotent state. However, in the haematopoietic system. Notch interactions
may be either homotypic or heterotypic, since both haematopoietic precursors and stromal
cells express Notch ligands. Different extrinsic factors such as cytokines or growth factors
may be responsible for distinct regulatory mechanisms and increase the diversity of Notch
function.
It has been reported that Notch 1 inhibits myeloid differentiation of 32D cells in response to G-
CSF, whereas Notch2 inhibits in response to GM-CSF (Bigas et al., 1998). This cytokine
specificity is associated with the NCR region mentioned above (Fig. 1.8). Furthermore, Delta 1
promotes differentiation of bone marrow cells to myeloid DCs at the expense of other lineages
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in the presence but not absence of GM-CSF (Mizutani et al., 2000; Ohislii et al., 2001) and
induces apoptosis in peripheral blood monocytes cultured with M-CSF. but not GM-CSF
(Ohishi et al., 2000). Notch signalling promotes enhanced entry of 32D cells in the presence
of G-CSF into granulopoiesis and increased survival in a CBF1-dependent manner. Elevated
numbers of viable cells during G-CSF treatment were also observed in 32D cells
overexpressing Hesl, consistent with activation of the CBF1 pathway (Tan-Pertel et al.,
2000).
1.4.5.2 Notch signalling and lymphopoiesis
BM-derived common lymphoid progenitors (CLPs) give rise to either B or T cells, in addition
to NKs and lymphoid dendritic cells (see section 1.1.1). Following commitment to the T-cell
lineage, immature pro-T cells begin to rearrange and express their TCRy, 8 and p genes
(Kisielow and von Boehmer, 1995). Pro-T cells that successfully rearrange TCRy and TCR5
will express a TCRy5 and be eligible to develop further as y8T cells. By contrast, productive
TCRp gene rearrangement will lead to expression of a pre-TCR (consisting of a TCRp chain
associated with an invariant pTa chain), which is compatible with further development as
apT cells, ap lineage-committed pre-T cells expand and progress to the CD4CD8 double-
positive (DP) stage of development. At this point, successful TCRa rearrangement leads to
expression of a TCRaP that can be positively or negatively selected as DP thymocytes
progress to the mature CD4 CD8 single-positive (CD4 SP) and CD4 CD8+ SP (CD84 SP)
stages. The TCRaP on mature CD8 SP and CD4 SP cells recognises peptides presented by
MHC class I or class II. respectively. Therefore, it is possible that specific TCRaP signalling
(in conjunction with related signalling through Lck-associated CD4 or CD8 coreceptors) is
sufficient in itself to direct DP cells to the CD4 or CD8 T cell lineage. Alternatively, it is
possible that CD4/CD8-lineage determination in DP cells occurs independently of TCR-MHC
interactions, and that the latter are required only to ensure the survival of cells with an
appropriate match of coreceptor and TCR specificity.
T/B cell-lineage commitment
Recent studies indicate that Notch signalling controls the lineage choice between B and T cell
fates. Mice w ith conditional inactivation of the Notch 1 gene in BM precursors display a block
in T cell development at an early stage, before expression of T cell lineage markers. B220f
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cells, however, develop in the thymus of these mice (Radtke et al., 1999; Wilson et al., 2000).
This suggests that early lymphoid precursors may choose a B cell fate in the absence of
Notch 1 signalling. Similar results were obtained with chimeras in which Hesl null foetal liver
was injected into irradiated RAG2 null mice: B cells developed normally while thymic T cell
development was arrested at the CD4 CD8 double negative (DN) stage (Tomita el al., 1999).
Further, it has been shown that expression of constitutively active Notch 1 in bone marrow
precursors using retroviral mediated gene transfer results in the development of immature DP
T cells in the bone marrow. This completely prevents development of B220 cells (Pui et al.,
1999).
Taken together, these complementary gain-of-function and loss-of-function studies clearly
indicate that Notch 1 provides a critical signal that determines the outcome of a binary (T or
B) cell fate decision by a common lymphoid progenitor (CLP, Fig. 1.10 & 1.13). By analogy
with the role of Notch genes in invertebrate systems, one interpretation of these data would be
that B cell development from the CLP might represent the "default" pathway that occurs in the
absence of Notchl signalling (Fig. 1.11). Alternatively, BM cells, which express several
ligands (Jones et al., 1998; Li et al., 1998), may induce CLPs to choose the T cell fate (Fig.
1.12).
The mechanism by which Notchl controls T/B-cell-fate specification in a CLP remains
unclear. Notch activation in T cell precursors induces transcription of Hesl (Chang et al.,
2000), which is consistent with the finding that CBF1 is associated with ICN in T cells but not
in B cells (Callahan et al., 2000). However, the CBF1 -independent pathway involving Deltex
also plays an important role in suppressing B cell development. Signals through the
Notch/Deltex pathway can result in repression of E47 (Fig. 1.10), which is a bHLH
transcription factor encoded by the E2A gene (Ordcntlich et al., 1998; Pui et al., 1999). E47
is required for proper B cell development (Bain et al., 1997) and is sufficient to activate
transcription of the Ig heavy-chain gene locus (Schlisscl et al., 1991). In addition to the
inhibition of E2A-dependent transcription (Pui et al., 1999), constitutively activated Notchl
and Notch2 repress Ig heavy-chain gene transcription (Morimura et al., 2001). The
mechanism leading to repression of E47 activity is thought to occur via inhibition of Ras
and/or JNK signalling (Ordcntlich et al., 1998). in Drosophila, Su(H)-indcpcndent Notch
signalling has already been shown to downregulate signalling through the JNK pathway
(Zecchini et al., 1999). Thus, in addition to an instructive role in promoting T-cell-lineagc
commitment via CBF1, Notchl might simultaneously repress the expression of B-lineage-
spccific genes via Dcltex.
61
Figure 1.13. Notchl signalling during T cell development.
Common lymphoid progenitors (CLPs) make a first cell-fate decision giving rise to either pro-B cells
or pro-T cells. The DN pro-T cell then matures further to a pre-T-cell stage, where commitment to
either ap or y5T cell lineage occurs. Finally, a.p lineage committed DP thymocytes must choose
between the mature CD4 or CD8+ T cell fates. Gain-of-function studies suggest a decisive role for
Notchl in T/B- and ap-lineage decisions, whereas recent loss-of-function studies support a more
restricted role for Notchl in T cell development. The role of Notch signalling in survival and
differentiation of DP thymocytes is much debated (see discussion below).
qp/yS T cell-lineage commitment
Notch activity has also been suggested to control the ap versus y5 lineage choice (Washburn
et al., 1997) as well as the CD4 versus CD8T lineage choice during thymocyte development
(Robey et al., 1996). The experiments looking at the effect of Notch activity on ap versus y8
lineage choice used mice with a chimaeric haematopoietic system populated by a mixture of
Notchl - and NotchT 1 cells. Notchl - BM precursors contribute less to the ap lineage than
Notch precursors. Also, ovcrexprcssion of ICNl under the control of the proximal Lck
promoter in transgenic mice overcomes the block in apT cell development imposed by the
absence of TCRp. Collectively, these data suggest that Notchl signalling favours the
development of apT cells at the expense of y5T cells (Washburn et al., 1997). However, this
was debated by Kaneta el al. because Hes 1-deficient thymocytes did not display a perturbed
ap/y5 T cell ratio (Fig. 1.13; Kaneta et al., 2000). These results suggest a possibility that
Notchl signal and Hesl signal are not always identical, at least in developing T cells.
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CD47CD8 T cell-lineage commitment
The first evidence for a role of Notch in CD47CD8+ cell fate decision came from experiments
conducted with transgenic mice earning the activated Notch 1 transgene under the control of
the Lck promoter (Robcy et al., 1996). These mice have increased numbers of CD8
thymocytes and a decreased number of CD4 T thymocytes. However, these T cells were
short-lived and could not be detected in secondary lymphoid tissue. Consistent with Robey's
data. Kim and Siu found that ovcrexprcssion of Hesl or 1CN1 silences CD4 transcription
(Kim and Siu. 1998).
The interpretation of these results has been challenged by several groups. Deftos and
colleagues found that transgenic mice expressing 1CN1 transgene under the control of the Lck
promoter promoted the maturation of DP thymocytes into both CD4 and the CDS SP
thymocytes (Deftos et al., 2000). The reason for the differences between these two lines of
transgenic mice, both expressing ICN1 under the control of the Lck promoter, is not clear.
However, Robey et al. were using a slightly shorter form of ICN1, which lacks the C-terminal
portion TAD, which is important for enhancing Notch function (Fig. 1.8; Aster et al., 2000).
Lethallv irradiated mice reconstituted with BM cells retrovirally transduced with the same
ICN1 transgene used by Deftos and colleagues did not develop SP thymocytes (Izon et al.,
2001). Instead a developmental arrest at the DP stage was observed. Izon et al. argued that
the Lck promoter used in the previous reports decreases in the activity during DP thymocytes
maturation (Allen et al., 1992), whereas the retroviral LTR promoter is active throughout T
cell development. Therefore, ICN1 in the previous reports was likely to be expressed at a
lower functional dose explaining the different outcome. Pear's group extended these results
further by showing that Notch 1 is required for T cell commitment but insufficient to rescue a
block in pre-TCR signalling necessary for either T cell expansion or DP development (Allman
et al.. 2001: Pui et al., 1999).
In summary, several reports have implicated Notchl signalling either in the CD4/CD8-lineage
commitment event or in the subsequent maturation and survival of CD4 SP and/or CD8 SP
cells. These studies (summarised in Table 1.4) are largely based on gain-of-function
approaches in which Notch IC is overexpressed.
However, a recent report debated the involvement of Notchl in the development of DP or SP
thymocytes. Inactivation of Notchl in DN thymocytes did not perturb the development of
mature CD4 and CDS T cells (Wolfcr et al., 2001). Additionally, in contrast to conclusions
reached using thymoma cell lines (Table 1.4; Deftos et al., 1998; Jchn et al., 1999), Notchl
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deficiency in DP thymocytes does not affect their sensitivity to spontaneous or glucocorticoid-
mduced apoptosis.
The discrepancy between Wolfer's data and earlier reports may be explained by the activation
of signalling pathways by ICN1 that are not normally controlled by Notch 1 under
physiological conditions. For example, Notch IC might activate signalling that is normally
mediated via Notch2 or Notch3, both of which are expressed in the thymus (Felli et al., 1999).
In this context, overexpression of the cytoplasmic domain of Notch3 in immature thymocytes
of transgenic mice under the control of the Lck promoter does not affect CD4 /CD8 lineage
commitment, although it does result in increased expansion of thymocytes leading to T cell
lymphomas (Bcllavia et al., 2000).
Table 1.4. Evidence for Notch 1 influences on CD4+/CD8+ lineage commitment, maturation and
survival.
Experimental system Result Reference
Transgenic mice overexpressing ICN1 Selective increase in CD8+ SP (Robey et al.,
under the control of the Lck promoter thymocytes 1996)
Transgenic mice overexpressing ICN1 Increased maturation of CD41 and (Deftos et al.,
under the control of the Lck promoter CD8+ SP thymocytes 2000)
Mice reconstituted with BM cells
overexpressing ICN1
Developmental arrest of thymocytes
at the DP stage
(Izon et al., 2001)
Mice reconstituted with BM cells
overexpressing ICN1
Immature DP T cells in the BM (Pui etal., 1999)
Mice reconstituted with BM cells from
RAG mice overexpressing ICN1
Immature DN T cells in the BM (Allman et al.,
2001)
Thymoma transfected with ICN1




Thymoma transfected with ICN 1
Increased resistance to activation-
induced apoptosis (Jehnero/., 1999)
Notch 1 inactivation in BM cells in Accumulation of B cells in the (Radtke et al.,
vivo thymus 1999)
Notch 1 inactivation in DN thymocytes No effect on subsequent T cell (Wolfcr et al..
in vivo development 2001)
Antiscnse Notch 1 in FTOC




FTOC: Foetal thymus organ culture
64
1.4.6 Concluding remarks
In conclusion, Notch signalling has been shown to interfere with the Ras/JNK signalling
pathways (Ordentlich et al., 1998; Zecchini el al., 1999) and NF-kB signalling (see section
III. 1). Additionally, Notchl activation inhibits TCR-mediated or PMA/ionomycin-induced
NF-AT/AP1 promoter activity in Jurkat cells (Izon et al., 2001). These pathways are cmcial
during T cell activation. Therefore, it seems likely that Notch signalling is able to modulate a
peripheral T cell response, provided that CD4 and CD8 T cells do express components of
the Notch pathway.
Indeed, a role for Notch signalling in the differentiation of CD4+ T cells into regulatory T cells
has been reported by our laboratory. Murine APCs retroviraily transduced with human
Jagged 1 and pulsed with peptide were transferred into naive mice, which were subsequently
challenged to induce productive immunity. T cells from these mice were hvporesponsive to the
antigen in vitro and, upon adoptive transfer into naive mice, induced antigen-specific tolerance
in vivo (Hoyne et al., 2000). Furthermore, regulatory CD4CD25 T cells differentially
regulate Delta 1, Notch4, Hesl and Deltex upon TCR stimulation, whereas their CD25-
negative counterparts do not (Ng et al., 2001).
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1.5 Aims
Notch plays a crucial role in both the development and differentiation of haematopoietic cells.
It acts by activating or inhibiting lineage-specific genes and affects several signalling
pathways that are crucial during the induction of an immune response such as the NF-kB or
the MAPK pathway. It has been shown that APCs transfcctcd with Jagged 1 induce the
differentiation of naive T cells into regulatory T cells in vivo, suggesting an important role for
the Notch pathway in immunity (Hovne et al., 2000). Therefore, the aim of my PhD was to
investigate the role of Notch signalling during the induction of an immune response.
The question that I addressed was whether and to what extent the components of the Notch
signalling pathway are expressed in peripheral CD4 and CD8 T cells of naive mice (chapter
III). It has been reported that Notch can activate or inhibit NF-kB activity (Bellavia et al.,
2000; Guan et al., 1996; Wang et al., 2001) and that activation of NF-kB can induce the
expression of the Notch 1 and Jagged 1 (Bash et al., 1999; Li et al., 2001). To investigate
whether Notch components are differentially expressed during NF-kB activation in T cells,
expression of Notch receptor, ligands and downstream components was examined in CD4
and CD8 T cells activated by ligation of their TCR and CD28 or by PMA/ionomycin
stimulation. Further, Notch activation in T cells during a mixed lymphocyte reaction (MLR)
was studied, by using a MFIC class II-transfected murine fibroblast cell line co-transfected
with the Notch ligands Jagged 1 or Delta 1 (chapter V). The influence of Notch signalling on
proliferation, cytokine production, phenotype and apoptosis in activated T cells was also
investigated.
APCs play an instructive role during an immune response. They have the capacity to activate,
anergise, polarise and even to kill T cells. Many soluble and membrane-bound molecules have
been identified in APCs to be important for these events. However, a lot remains unclear such
as, for example, the molecular mechanism by which immature or IL-10 treated DCs induce
regulatory or anergic T cells, respectively. Expression of Notch components in DCs was
therefore investigated (chapter IV). T cells are able to condition or "license" DCs (Ridge et
al., 1998; Vendetti et al., 2000). Thus T cells are able to instruct DCs and vice versa. If
Notch is involved at the DC-T interphase, it is important to determine whether signalling is bi-
or unidirectional and in the latter case, to identify the signalling and the receiving eeli by
looking at the induction of downstream target, such as the Hes genes, of Notch signalling.
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Finally, transgenic mice have been generated with inducible expression of Jagged 1 or Delta 1
in DCs (chapter VI). These mice will allow the future study of Notch signalling during an
immune response in vivo.
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II Materials & Methods
II.1 Materials and Buffers
• CFSE (5-(and -6)-carboxvfluorescein diacetate succinimidvl ester)
CFSE (Molecular Probes) was dissolved to a concentration of 5mM in DMSO. Aliquots were
prepared and stored at -20°C.
• Complete HAT+MX Culture Media ± Geneticin
500mls RPMl 1640 with 10% heat-inactivated foetal calf serum (FCS) lOOIU/ml
penicillin/streptomycin (Gibco), 2mM L-glutamine (Gibco), 15pg/ml hypoxanthine (Gibco),
0.2pg/ml aminopterin (Gibco), 5pg/ml thymidine (Gibco), 6pg/ml mycophenolic acid and
250pg/ml xanthine ± 500pg/mi geneticin (Gibco). Kept at 4°C.
• Complete Iscoves culture media
500mls Iscoves 1640 (Gibco) with 10% foetal calf serum (FCS) [heat inactivated), 50pM
[3-mcreaptocthano 1 (ME), lOOU/ml penicillin/streptomycin (Gibco), 2mM L-glutamine
(Gibco). Kept at 4°C.
• Complete RPMI culture media
500mls RPMl 1640 with 10% foetal calf serum (FCS) [heat inactivated], 50pM p-
mercaptoethanol (ME), lOOU/ml penicillin/streptomycin (Gibco), 2mM L-glutamine (Gibco).
Kept at 4°C.
• DC-RPMI
As complete RPMl but without the addition of p-mercaptocthanol (ME). Kept at 4°C.
• EDTA/Trvpsin
lx Trypsin-EDTA (0.5pg/ml trypsin 0.2pg/ml EDTA, Gibco). Aliquots were prepared and
stored at -20°C.
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• EL1SA Blocking Buffer
PBS containing 1% BSA, 5% sucrose and 0.05% Tvvecn-20. Kept at 4°C.
• ELISA Reagent Diluent
For IL-2 and IFNy ELISAs: 20mM Tnzma base 150mM NaCl containing 0.05% T\vecn-20
and 0.1% BSA. For IL-4 and IL-10 ELISAs. PBS containing 1% BSA. Kept at 4°C.
• ELISA Stop Solution
0.5M H2S04. Kept at RT.
• ELISA Substrate Solution
TMB Liquid Substrate System for ELISA. Kept at 4°C.
• ELISA Wash Buffer
PBS containing 0.05% Tween-20. Kept at room temperature (RT).
• FACS Buffer
10% heat-inactivated foetal calf serum (FCS) in PBS, 0.1% NaN?. Kept at 4°C.
• FACS Fixing Buffer
2% formaldehyde in PBS. Kept at 4°C.
• Fixing Buffer for intracellular cytokine staining
4% paraformaldehyde in PBS. Kept at 4°C in the dark.
• Gev's Red Blood Cell Lvsis Buffer
155mM KHCO, and lOmM NH4C1, O.lmM EDTA (Gibco). Kept at 4°C.
• Luria-Bertani (LB) broth 150ml)
One LB Broth Tablet (Sigma) was diluted in 50ml distilled water. Sterilised by autoclaving.
Stored at RT.
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• Luria-Bertani (LB) agar (50 ml)
One LB Agar Tablet (Sigma) was added to 50ml of distilled water and heated to dissolve prior
to autoclaving for sterilisation. Stored at RT.
• MACS Buffer
0.5% BSA in PBS. Kept at 4°C.
• PBS/Tween Buffer
PBS with 0.1% Tween-20. Kept at room temperature.
• 6x PGR Loading Buffer (Sambrook et al.. 1989)
0.25% weight/volume of bromophenol blue and 40% weight/volume of sucrose in distilled
water. Stored at 4°C.
• Permeabilisation Buffer
2% FCS in PBS containing 0.1% saponin. 0.1% NaNL and 5mM EDTA (Gibco). Kept at
4°C.
• Preparation of mitogens
Escherichia coli (E.coli) lipopolysaccharide (LPS, serotype 055:B5, SIGMA) powder was
reconstituted to lmg/ml in complete RPMI medium. Phorbol 12-myristate 13-acetate (PMA)
was reconstituted to lmg/ml in DMSO. lonomycin was reconstituted to 5mg/ml in DMSO
Aliquots were prepared and stored at -20°C.
• Recombinant Proteins
Recombinant murine GM-CSF (R&D Systems) was reconstituted in filter-sterilised complete
RPMI to a final concentration of 5ug/ml. Recombinant murine TNFa (R&D Systems) was
reconstituted in filter-sterilised complete RPMI to a final concentration of lpg/ml.
Recombinant murine IL-10 (R&D Systems) was reconstituted in filter-sterilised complete




100ml of lOx TAE Buffer (Gibco) topped up with deionised water to 1 litre.
• TBE (Tris base, boric acid and EDTA) Buffer
100ml of lOx TBE Buffer (Gibco) topped up with deiorused water to 1 litre.
11.2 Molecular Biology Techniques
II.2.1 Restriction digests of DNA
0.1-1.0pg DNA, 1 pi lOx restriction buffer (Promega Corporation), 1 pi restriction enzyme
(Promega Corporation) and nuclease-free water (Promega Corporation) were added to give a
final volume of lOpl. In case of a double digest, the total volume and the restriction buffer
were doubled. If the two restriction enzymes had incompatible buffers, DNA was ethanol
precipitated after the first digest and resuspended in sterile distilled water before proceeding
with the second digest. After a 2 hrs or overnight incubation at 37°C, 2pi of a 6x loading
buffer (40% sucrose, 0.25% bromophenol blue; Sambrook et al, 1989) was added per lOpl
total reaction volume. Samples and a lkb ladder molecular weight marker (Promega
Corporation) were run in a 0.8% agarose gel (SeaKem LE agarose, FMC) containing lOpg/'ml
ethidium bromide in lx TAE buffer for 1-2 hrs at 80 Volts. DNA fragments were visualised
using the UVGrab programme connected to a white/ultraviolet transilluminator (UVP) and
isolated by QIAquick gel extraction as described in section II.2.5.
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II.2.2 Blunting of cohesive DNA ends
1 (a I Klenow DNA polymerase (Promega Corporation), Ipl lOx Klenow reaction buffer
(supplied), 0.75pl of 20mM dNTPs (supplied) and 7.25pl nuclcase-free water (Promega
Corporation) were added to 10-20pl of the restriction digest and incubated at 37°C for 30
mm.
II.2.3 Dephosphorylation of 5' phosphate of the DNA ends
To prevent compatible or blunt ends from self-religation, the vector was dephosporylated at
the 5' end. After restriction digest of the vector, lpl of lU/pl shrimp alkaline phosphatase
(Roche Boehringer Mannheim) was added per lOpl of the digestion mix. The mixture was
incubated at 37°C for 30 min and then at 65°C for 15 mm to inactivate the phosphatase.
11.2.4 Preparation of agarose gels
0.8%, 1% or 2% agarose gels (for piasmid DNA, RNA or PCR products, respectively)
(SeaKem LE agarose, FMC) containing 0.5pg/mi ethidium bromide (SIGMA) were prepared
with lx TAE buffer (Gibco). The gel was transferred to a gel tank containing lx TAE buffer.
lOpl of the sample was added to 2pl 6x PCR loading buffer and loaded into each well. The
agarose gel was run at 80 volts for 1-2 hour. The UVGrab programme connected to a
white/ultraviolet transilluminator (UVP) was used to detect the expression of PCR products.
PCR marker (50-2,000 bp. SIGMA) or lkb DNA ladder (0.25-10 kb. Promega Corporation)
was used as the molecular weight ladder.
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11.2.5 Isolation of DNA from agarose gels
Isolation of DNA products from agarose gels was performed using the QIAquick Gel
Extraction Kit (QIAGEN). Briefly, DNA bands of interest were cut from the agarose gel with
a sterile blade. 3 volumes of Buffer QC were added and gel slice was dissolved during a 10-
min incubation at 50°C. After adding one volume of isopropanoi the mixture was applied onto
a QIAquick column and centrifiiged for 1 min. The DNA bound to the column was washed
with 75(Jpi of Buffer PE. After discarding the flow-through, residual buffer was removed by
an additional centrifugation for lmin at 10,000 x g. DNA was eluted with 50pi Buffer EB.
11.2.6 Ligation of plasmid vector and insert DNA
After the vector and insert DNA have been prepared for ligation, the insert: vector molar ratio
was set approximately at 3-6 : 1 in a small volume to allow insert and vector to anneal
together efficiently. Ipl T4 DNA ligase (Promega Corporation) and lpl lOx ligase buffer
(supplied) were added to the insert/vector mixture and nuclease-free water (Promega
Corporation) was added to give a final volume of lOpl. The mixture was incubated at 16°C
for 3 hrs or overnight. The following controls were included:
Buffer Ligase Plasmid Insert
Control for restriction efficiency — — + —
Negative control for religation of the vector + + + —
11.2.7 Preparation of competent cells and transformation
II.2.7.1 Preparation of competent cells
lml of overnight Escherichia coli (E.coli) culture (XLi Blue MRF', Stratagene) was
mnoculated into 100ml LB broth in a 1-litre flask and shaken for 3 hrs at 37°C. When the
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absorbance at 600nm (Asoo) reached 0.3, lOOml of the cell suspension was aseptically
transferred to four 50ml Falcon tubes and chilled for 10 nun on ice. After centrifugation
(3.000 x g, 10 min, 4°C) supernatant was removed completely, the pellet resuspended in 20ml
ice cold 0.1M CaCl2 and kept on ice for 30 min. After centrifugation (3,000 x g, 10 min, 4°C)
supernatant was removed completely and the pellet resuspended in 4ml ice cold 0.1M CaCL.
11.2.7.2 Transformation
10pl DNA was transferred into a sterile 1.5ml Eppendorf tube and 200pl of competent cells
are added. After gentle mixing, cells were left on ice tor 30 min, then incubated at 42°C for 5
min in a water bath and again left on ice for 2-5 min. 800pl of LB broth freshly supplemented
with 20% glucose were added and incubated at 37°C shaking for at least 1.5 hrs. Cells were
spun down (10,000 x g, 15 sees, RT), 850pl supernatant was removed and the pellet
resuspended in the remaining solution. Transformed cells were spread on the LB plates
(section II.2.7.2) and incubated overnight at 37°C. As a positive control, cells were
transformed with the original vectors (pBS-CDllc or pBI-EGFP) (control for the efficiency
of the transformation). As a negative control, untransformed cells were grown on a selection
plate (control for the selection of transformed cells). Transformed colonies were picked,
cultured in 5ml LB broth containing lOOpg/mi ampicillin at 37°C shaking overnight and
plasmid extracted as described in 11.2.8. Successful insertion and correct orientation was
tested by restriction digest (II.2.1).
11.2.7.3 Preparation of LB plates
LB Agar was heated to melt and then cooled to about 50°C prior to adding ampicillin at a
final concentration of lOOpg/ml. Agar was poured into bacteriological Petri dishes (Greincr)
and stored upside dow n at 4°C after solidification.
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11.2.8 Miniprep purification of piasmid DNA
Purification of piasmid DNA from bacterial cells was done using Promega Wizard Plus SV
Miniprcps DNA Purification System, according to the manufacturer s instructions. Briefly,
5ml of bacterial culture were harvested by centrifugation at 3,000 x g for 15 min at 4°C. Cells
were resuspended in 250pl Cell Rcsuspcnsion Solution prior to lysis by addition of 250pl Cell
Lysis Solution. Cell suspension was incubated for 5 min at RT before adding lOpl of Alkaline
Protease Solution. After 5 min incubation at RT, 350pl of Neutralisation Solution was added.
The lysate was centrifuged for 10 min at 14,000 x g at RT and cleared supernatant containing
solubilised piasmid DNA was transferred into a Mmiprep Spin Column by decanting. After 1
min of centrifugation at 14,000 x g at RT, the spin column was washed twice with the
supplied Column Wash Solution. Finally, the DNA was eluted in lOOpi of RNAse/DNAse-
free water (Promega Corporation) and quantified (section II.2.14).
II.2.9 Maxiprep purification of piasmid DNA
Purification of large amounts of piasmid DNA from bacterial cells was done using Quantum
Prep Piasmid Maxiprep Kit (Bio-Rad Laboratories), according to the manufacturer's
instructions. Briefly, 5ml of bacterial culture were harvested by centrifugation at 3,000 x g for
15 min at 4°C. Cells were resuspended in 15ml of Cell Resuspension Solution prior to lysis by
addition of 23ml of Cell Lysis Solution. After 5 min incubation at RT, 15ml of Neutralisation
Solution was added. The lysate was then transferred into a QIAfilter Maxi Cartridge
(QIAGEN), incubated for 10 min at RT and filtered by inserting the plunger. 10 ml of the
Quantum Prep Matrix was added to the cleared lysate. The matrix was pelleted by
centrifugation at 3,000 x g for 5 min, the supernatant was decanted and the pellet was washed
with 25ml of Wash Buffer. The matrix was resuspended in 15ml of Wash Buffer, transferred
into a 25ml spin basket sitting in a 50ml Falcon tube and washed twice with Wash Buffer by
centrifugation at 3,000 x g for 5 min. Finally, the DNA was eluted in 5ml of RNAse/DNAse-
free water (Promega Corporation) and quantified (section II.2.14).
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II.2.10 Ethanol precipitation of DNA
Two volumes of 100% cold ethanol and 0.1 volume of 3M sodium acetate pH 5.2 were added
to the DNA and left on dry ice or at -70°C for at least 30 min. After centrifugation (10,000 x
g, 30 min, 4°C) the supernatant was decanted. The pellet was washed with 70% ethanol and
spun again at 10,000 x g for 15 nun at 4°C. Supernatant was removed and the DNA pellet
was air-dried prior to rcsuspending in either nuclcase-ffee water (Promega Corporation) and
incubated for 5 min at 65°C.
II.2.11 DNA preparation for pronuclear microinjection
Linearised DNA fragments were purified by gel extraction (section II.2.5), cthanol
precipitation (section 11.2.10) and resuspended in injection buffer at a concentration of about
lOpg/ml. 0.5pl of the resuspended DNA fragments were run in a 0.8% agarose gel (section
II.2.4) together with the lkb DNA ladder (0.25-10 kb, Promega Corporation) and
quantification standards (15-500ng, Gibco) to more accurately estimate the concentration of
the fragments.
II.2.12 Extraction of genomic DNA from mice tails
Extraction of genomic DNA from mice tails was done using QIAGEN s DNeasy Tissue Kit,
according to the manufacturer's instructions. Briefly, IXOpl of Buffer ATL and 20pl of
Proteinase K (supplied) were added to 0.5cm of tail and the tissue lysed at 55°C on a rocking
platform overnight. 400pl of Buffer AL-cthanol were added and the mixture was vortexed.
Tissue debris was spun down and the supernatant transferred into a DNeasy mini column.
After centrifugation for 1 min at 6,000 x g, flow-through was discarded and the column
washed with 500pl Buffer AW1 and subsequently with 500pl Buffer AW2. After dry ing the
DNeasy membrane by 3 min centrifugation at 12,000 x g and incubating for 10 min at 37°C,
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DNA was clutcd with 200pl of 37°C warm RNAsc/DNAse-frce water (Promcga
Corporation).
II.2.13 Preparation of total RNA
Extraction of totai RNA from cells was done using QIAGEN's RNeasy Mini Kit, according to
the manufacturer's instructions. Briefly, cells were resuspended in an appropriate volume of
the supplied RLT lysis buffer, and the samples homogenised using QIAGEN's QIAshredder
spin columns. One volume of 70% ethanol was added to the homogenised lysate prior to its
transfer onto a RNeasy spin column. After 15 sec of centrifugation at 8,000 x g at RT, the
spin column was washed with the supplied RW1 buffer, and any contaminating DNA was
digested and washed out using QIAGEN's RNAse-Free DNase according to the
manufacturer's instructions. The spin column was washed again twice in the supplied RPE
buffer. Finally, the RNA was eluted in 20-30pi of RNAse/DNAse-firee water (Promega
Corporation), quantified and its quality tested by running a RNA gel (11.2.15) or by RT-PCR
(II.2.16). DNA contamination was assessed as described in section II.2.19.
11.2.14 Quantification of nucleic acids
To determine the concentration of nucleic acids in solution, absorbance at 260 and 280nm was
measured in a spectrophotometer (Ultrospec 200, Pharmacia Biotech).
The readings were converted to concentrations using the following formulae (Sambrook et al.,
1989).
1 A260 unit of double-stranded deoxy ribonucleic acid (dsDNA) = 50pg/'mi
1 A26ounit of oligonucleotide = 20pg/ml
1 A26o unit of RNA = 40pg/ml
To determine the purity of solutions of DNA and RNA. the ratio of absorbancc at 260nm and
280nm (OD26o/28o) was measured. This value should ideally be about 1.8 for DNA and 2.0 for
RNA.
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II.2.15 Testing RNA quality by running a RNA gel
To visualise the quality of RNA, lpg RNA in a volume of lOpl were mixed with 2pi 6x PCR
loading buffer, heated at 65°C for 5 min and cooled on ice for 3 min. RNA was run on a 1 %
agarose gel as described in section 11.2.4.
11.2.16 Testing RNA quality by RT-PCR
In many situations, the amount of RNA is very limited making the running of a RNA gel
impossible. Therefore, another method requiring less RNA was established to ensure RNA
quality. The primers for p-Actin were able to amplify products in a one-tube RT-PCR
reaction from both intact and partially degraded RNA (Fig. II.IB). This was probably due to
the fact that the p-Actin primers amplify a relatively small product (153 base pairs (bp)),
which may still be intact in partially degraded RNA. The primers for HPRT amplify a larger
product (366 bp). Additionally, they span an intron and thereby ensure that only RNA and not
DNA, which is less sensitive to degradation, is amplified during a one tube RT-PCR. The
band intensity of the amplified HPRT product decreased substantially if partially degraded
RNA was used as a starting product (Fig. II.1C). Therefore, a RT-PCR (described in 11.3.19)
using the primers for HPRT was carried out instead of a RNA gel to test for quality of RNA
in cases where the amount of RNA was limited.
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Incubation at 70°C (hrs)








Figure II. 1. Tests for RNA quality.
I-A1* L cells were detached with Trvpsin/EDTA and total RNA was extracted. RNA was incubated at
70°C for 0. 0.5, 3 and 5 hours.
[A] 1 |ig of RNA was run in a 1% agarose gel.
| B1 & [C| The RNA was reverse transcribed and amplified for 25 cycles by RT-PCR. The PCR-
amplified products for p-Actin [B] and HPRT [C] were nin in a 2% agarose gel.
11.2.17 Primers
DNA sequences of interest were obtained from PubMed's DNA sequence programme
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi). All PCR primers were designed with the
following requirements: (1) not over 40-60% GC (problems with high annealing
temperatures); (2) must not form primer dimers (no possibility of more than three consecutive
bases on primers complementing and pairing with each other); (3) annealing temperatures
(Tm) of each pair of primers must not be too different (ATm < 4-5°C); (4) at least 16 bases,
optimum 20-24; (5) must not fold into hairpin loops with energy less than 1.0, and have a free
3' tail; (6) last three bases should not all be G/Cs.
Primers were designed using the Wisconsin Genetics Computer Group (gcg) version 10 primer
programme and tested using the DNA Strider programme.
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Table II.1. Sequences of the primers used for amplifying genes and transcripts.
Thev are mouse-specific unless otherwise mentioned.
Gene
















































I5-Actins 5'- CCACCAACTGGGACGACATG -3'
5'- GTCTCAAACATGATCTGGGTCATC -3'
153 58






* Specificity was confirmed by cycle sequencing of the PCR product
$ Crossreactive with the human gene
* EGFP and rtTA are engineered proteins. EGFP originates from the jellyfish Aequorea victoria and
rtTA is a fusion protein between proteins from E. coli and herpes simplex vims.
§ Length of PCR product including the intron is unknown (see VI. 3)
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II.2.18 Polymerase chain reaction (PCR)
The polymerase chain reaction (PCR) was set up according to the manufacturer's instructions
(Promega Corporation). Briefly, all reagents with exception of the Taq polymerase were
mixed together and heated at 95 °C for 10 min ("hot start") to denature the DNA. After
addition of 0.5pl of the Taq polymerase, the PCR was carried out.
Each reaction tube consisted of 50pl of the following reagents:
Reagent Volume/Tube (pi) Final Concentration
nuclease-free water 37.0
lOx Taq Buffer with MgCf (Buffer A) 5.0 lx
20mM dNTP mix 0.5 500pM of each dNTP
50 pM forward primer 1.0 lpM
50 pM reverse primer 1.0 lpM
~10ng plasmid or genomic DNA 5.0 200pg/pl
Taq Polymerase (5U/pl, Storage Buffer A)* 0.5 O.lU/pl
*Added after the "hot start"
RNAse/DNAse-ffee water (Promega Corporation) was included as a negative control for each
gene tested, to ensure that there was no DNA contamination in the reagents.
The thermocycler (Pelter Thermal Cycler (PTC)-200, MJ Research) was programmed as
followed:
1 cycle 94°C 10 min ("hot start")
30 cycles 94°C 1 min (dcnaturation)
primer-specific annealing temperature 1 min
72°C 1 min (amplification)
1 cycle 72°C 7 min
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II.2.19 One-tube reverse transcription polymerase chain reaction
(RT-FCR)
Total RNA was reverse transcribed into cDNA and amplified by PCR using the Promega
Access RT-PCR kit (Promega Corporation). The reaction was set up according to the
manufacturer's instructions.
Prior to studying expression of specific genes, different RNA samples were adjusted to equal
concentrations, by performing a RT-PCR on the house keeping genes, P-Actin and/or HPRT.
To ensure that the measurement was performed in the exponential phase of PCR
amplification, the PCR cycle number was set at 25 instead of 35 for P-Actin and HPRT.
Each reaction tube consisted of 25 pi of the following reagents:
Reagent Volume/Tube (pi) Final Concentration
5x Reaction Buffer 5.0 lx





200pM of each dNTP
Primer mix 1.0 25pmol of each primer
Avian Myeloblastosis Virus (AMV) RT
(5U/gi)








To test for DNA contamination in the RNA samples, the reaction was set up with all reagents
except the AMV reverse transcriptase.
RNAse/DNAse-free water (Promega Corporation) was included as a negative control for each
gene tested, to ensure there was no DNA contamination in the reagents.
The thermocycler (Pelter Thermal Cycler (PTC)-200, MJ Research) was programmed as
follows:
• First strand synthesis:
1 cycle 48°C 45 mm (reverse transcription)
1 cycle 94°C 2 min (RT inactivation and RNA/cDNA/primer denaturation)
• Second strand cDNA synthesis and PCR amplification:
35 cycles 94°C 30 sees (denaturation)
primer-specific annealing temperature 1 min
68°C 2 min (amplification)
1 cycle 68°C 7 min
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II.2.20 Reverse transcription for real-time PCR
RNA was extracted using RNeasy kits as described above. cDNA was synthesised using the
MultiScribe RT kit (PE Biosystems). The following reaction mix with a final volume of 1 Oj.il
was made up, vortexed and then centrifuged.
Component Volume/Tube (pi) Final Concentration
lOx TaqMan RT buffer 1.00 lx
25mM magnesium chloride (MgCf) 2.20 5.5mM
dNTP mix 2.00 500pM of each dNTP
Random hexamer 0.50 2.5pM
RNase inhibitor 0.20 0.4U/pl
MultiScribe RT (50U/pl) 0.25 1.25U/pl
200ng RNA 3.85 20ng/gl
The thermocycler (Perkin Elmer) was programmed as follows:
1 cycle 25°C 10 mm (incubation)
1 cycle 48°C 45 min (reverse transcription)
1 cycle 95°C 5 min (RT inactivation)
After reverse transcription the samples were diluted 5:1 in RNase/DNase-free water (Promega
Corporation) before proceeding to the real-time PCR step.
II.2.21 Real-time PCR
Higuchi el al. pioneered the analysis of PCR kinetics by constructing a system that detects
PCR products as they accumulate in 'real time" (Higuchi el al., 1992). Two chemistries are
available to detect PCR product accumulation. One is the use of a DNA-binding dye, which
has the disadvantage of binding to all double-stranded DNA, including non-specific reaction
products.
Here, we used the Taqman technology (PE Systems), which exploits the 5 "-3' nucleolytic
activity of AmpliTaq DNA polymerase first described by Holland and colleagues (Holland et
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al., 1991). The method uses a dual-labelled fluorogenic hybridisation probe that specifically
anneals the template between the unlabelled PCR primers (Fig. 11.2). The probe contains a
fluorescent reporter, FAM (6-carboxyfluorescein) or VIC™, at the 5 "end and a fluorescent
quencher, TAMRA (6-carboxytetramethylrhodamine), at the 3"cnd. When the probe is intact,
the emission of the reporter is suppressed by the quencher. The nuclease degradation of the
hybridisation probe releases the reporter, resulting in an increase in fluorescence emission.
The use of a sequence detector (ABI Prism 7700) allows measurement of the amplified
product in direct proportion to the increase in fluorescence emission continuously during the
PCR amplification (therefore "real-time PCR"). The amplification plot is examined early in
the reaction at a point that represents the logarithmic phase of product accumulation. The
point representing the detection threshold of the increase in the fluorescent signal associated
with the exponential growth of the PCR product for the sequence detector is defined as the
cycle threshold (CT) (Fig. II.3). CT values are predictive of the quantity of input target, the















Figure II.2. Fluorogenic 5' nuclease chemistry.
PE Biosystems makes use of fluorogenic probes, which incorporate a reporter fluorescent dye (FAM
or VIC) at the 5' end (R), and a quencher dye (TAMRA) at the 3' end (Q). 1. The probe anneals
dow nstream from one of the primer sites on the target sequence. During PCR amplification, as the
primer is extended by Taq DNA polymerase, the probe is cleaved at its 5' end and removed from the
target sequence allowing primer extension to proceed. 2. Cleavage of the probe separates the reporter
dye from the quencher dye, and the reporter emits its characteristic fluorescence. Fluorescence
intensity increases proportional to the amount of PCR product amplified.
Diagram adapted from PE Biosystems.
84
Figure II.3. Typical amplification plot.
An amplification plot is the plot of fluorescence signal versus cycle number. In the initial cycles of
PCR there is little change in fluorescence signal. This defines the baseline for the amplification plot.
An increase in fluorescence above the baseline indicates the detection of accumulated product. A
fixed fluorescence threshold can be set above the baseline.
• Ct (threshold cycle) is defined as the cycle number at which the fluorescence passes the fixed
threshold.
• R„ is the value obtained by dividing the emission intensity of each reporter dye signal with that
of an internal reference dye (ROX), which normalises for non-PCR related fluorescence
fluctuations occurring well-to-well or over time.
• R„+ is the R„ value of a reaction containing all components including the template.
• R„ is the R„ value obtained from either the early cycles of a real-time run (prior to detectable
increase in fluorescence) or from a reaction not containing template.
• ARn is the difference between the R„+ and the R„ value. It reliably indicates the magnitude of
the signal generated by the given set of conditions.
Diagram adapted from PE Biosyslems.
II.2.21.1 Real-time PCR optimisation
The following parameters need to be optimised for efficient real-time amplification of
target cDNA:
A) Primer and Probe Design and Optimisation
Primers and probes are designed using Primer Express " software, supplied by PE Biosystems.
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The primers are optimised by independently varying forward and reverse primer
concentrations (50, 300, 900nM). Optimal performance is achieved by the primer
concentrations that provide the lowest CT and the highest ARn.
The probe can also be optimised by varying the concentration from 50 to 250nM. Optimal
performance is obtained at the concentration that provides the lowest CT and the highest ARn.
However, a probe limiting concentration should be avoided when wishing to detect low copy
numbers of a target sequence.
In real-time PCR assays examined here, primer concentrations of 300nM for both the forward
and reverse primer, and probe concentrations of 200nM per reaction, were used.
B) The Comparative Method of Quantitation
Relative quantitation of gene expression can be performed using the comparative (AACT)
method This method needs:
• A target, which is the sample to be tested.
• A reference, which can be an endogenous control with its own set of primers and probe.
It is used to standardise all the cDNA samples used in a reaction, and as a control of the
PC R reaction itself.
• A calibrator, this is the positive control used in the reaction, which all the targets are
made relative to. Thus, the calibrator becomes the lx sample, and all other quantities are
expressed as an w-fold difference relative to the calibrator.
The arithmetic formulas used for the comparative method:
The amount of target, normalised to an endogenous reference and relative to a calibrator, is
given by 2 AA< T, where
• ACt is the Ct of the gene of interest - CT of the endogenous control (normalises the
amount of target to the endogenous control).
• AACt is the ACt of the target - ACr of the calibrator (makes the amount of target relative
to the calibrator).
For the AACt to be valid, the efficiency of the target amplification and of the reference
amplification must be approximately equal. This can be assessed by running dilutions of a




Multiplex PCR uses more than one mix of primer pair and probe in the same tube. This
method can be used in relative quantitation where one primer pair amplifies the target and
another primer pair amplifies the endogenous reference (e.g. a housekeeping gene) in the same
tube.
For accurate quantitation it is important that the two reactions do not compete. This can be
avoided by limiting the concentration of primers of the most abundant species. The desired
concentration is that which shows a reduction in ARn but little effect on Cx-
The following components were used throughout these studies:
• Endogenous control: PE Biosystems 18S nbosomal RNA (rRNA). This is already
primer limited to avoid competition for the amplification of the target sample. It contains
specific pnmers and a probe that is labelled with the fluorogenic dye VIC.
• Universal calibrator: This is a sample that contains transcripts of all the genes analysed
and was used as a control for the run of each individual plate. The universal calibrator for
murine genes contained cDNA from thymocytes and PMA/ionomycin-, ConA-activated
and non-activated splenocytes of different mice strains (BALB/c, C57BL/6 and Fl). The
universal calibrator for human Jaggedl contained cDNA from PMA/ionomycin-activated
and non-activated Jurkat cells.
• Internal calibrator: Within each set of experiment an internal calibrator, e.g. untreated
cells or untransfected cells, was chosen to show gene expression relative to the internal
calibrator.
• No template control for each specific gene tested, to ensure that there was no DNA
contaminating the samples.
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II.2.21.3 Reaction set-up for real-time PCR
PCR was carried out using TaqMan Universal Master Mix (PE Biosystems) containing
AmpliTaq Gold DNA polymerase, dNTPs, passive reference dye (ROX) and optimised buffer
components. Pre-optimised primer/probe mix for the 18S rRNA (PE Biosystems) was
included in each reaction as the endogenous control. All reactions were run in duplicates.
2.5pl of each cDNA was aliquoted into two separate wells of MicroAmp optical 96-well plate
(PE Biosystems). As a positive control, cDNA of the universal calibrator (described above)
was run in duplicate, as was a no-template negative control. 22.5pl of the following PCR mix
were added per well to bring the total well volume to 25pi:
Reagent Volurne/Wel! (pi) Final Concentration
lOx Universal Master Mix 2.50 lx
20x Pre-Developed 18S rRNA 1.25 lx
Primer/Probe Mix 7.00
300nM for both primers
200nM for probe
Water 1.75
MicroAmp optical caps were carefully pressed onto each well and the plate was placed in the
ABI Prism 7700 sequence detector running SDS software (PE Biosystcms) and using a heated
lid. The same cycling programme (see below) was run for all primer/probe combinations.
Real-time PCR programme: lx 50°C 2 mm
lx 95°C 10 min
40x 95 °C 15 sec
lx 60°C 1 min
All the values obtained were normalised to 18S rRNA and made relative to the universal
calibrator described above. The data was plotted relative to the internal calibrator (e.g. 1-Ab L
cells in Fig. V.3, or control CD4 T cells in Fig. V. 10).
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11.2.21.4 Significance of real-time PCR
PCR reactions were run in duplicates. Therefore, standard deviation cannot be assessed.
However, Martell and colleagues reported a high reproducibility within a real-time PCR run
(intra-assay) or between different PCR runs (inter-assay) (Martell et al., 1999). Further, genes
were considered as differentially expressed if a change of at least twofold or greater was
observed in at least two separate experiments (Chtanova el al., 2001; Granucci et al., 2001).
However, both groups used oligonucleotide microarrays for expression analysis. Generally, I
considered a change in expression of at least 3-fold or greater on at least two occasions as
significant because I observed that smaller changes were often not reproducible. Exceptions to
this rule were made if the difference in expression on RNA level was reflected on protein level
or if an alteration of a treatment, which induces strong upregulation of gene expression, leads
to a reproducible change in transcript expression compared to the original treatment.
II.2.22 Cycle sequencing of PCR products isolated from agarose
gels
Cycle sequencing (also called linear amplification sequencing) is performed by cycling the
PCR products through repeated rounds of denaturation, annealing and extension in a
temperature cycler (Murray, 1989; Sanger et al., 1977). cDNA was sequenced using the
Cyclist Taq DNA Sequencing kit (Stratagene). The PCR products were isolated from agarose
gels as described in section II.2.5.
II.2.22.1 Primer end labelling
The forward primer was labelled with |y- PJATP by incubating O.lpg primer with 1 pi T4
polynucleotide kinase (PNK, lOU/pl, Stratagene), 2.5pl lOx PNK buffer (Stratagene), 6pl [y-
P|ATP (lOmCi/ml, Pharmacia Biotech) and DEPC-treated water at a final volume of 25pi at
37°C for 45 nun.
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II.2.22.2 Sequencing reaction
The sequencing mix was prepared by adding lOpl of purified PCR product to lpi (2U/pl) Taq
DNA polymerase (supplied), 4pl lOx sequencing buffer containing all four
deoxyribonucleoside triphosphates (dNTPs) (supplied). 4pl labelled primer and adding DEPC-
treatcd water to a final volume of 30pl. 6.7pl were added to each of the four termination tubes
already containing 3pl of ddNTP (supplied) and kept on ice. As the ddNTP lacks the
necessary 3-OH group required for chain elongation, the growing oligonucleotide was
terminated selectively at A, C, G or T, depending on the respective dideoxy analog in the
reaction (Sanger et ai, 1977). The relative concentrations of dNTPs and ddNTPs were
balanced so that the majority of chains will be terminated within the desired length of
sequence.
The thermocycler (PTC-200, MJ Research) was programmed as follows:
35 cycles 95°C 20 sec (denaturation)
specific primer annealing temperature (Tm) 20 sec (annealing)
72°C 20 sec (amplification)
The reaction was stopped by addition of 5pi stop solution (supplied) to each termination tube.
The fragments were separated on a sequencing gel, and sequence information was obtained
from the order of the bands.
II.2.22.3 Sequencing gel
To prepare the 6% denaturing polyacry lamide gel, 33.6g urea were dissolved in 8ml lOx TBE
(Gibco), 16ml 30% (w/v) acrylamidc-bisacrylamide solution (Kramel Biotech), and 29ml of
distilled water (to give a final volume of 80ml), by magnetic stirring and slight heating.
150pl of 10% APS (ammonium pcroxidisulphatc) and 150pl of TEMED (N.N.N'.N'-
tetramethylethylenediamine) (Promega Corporation) were then added to initialise
polymerisation. The gel solution was poured into prepared glass plates.
Once the gel had set, it was pre-run for 30 nun at 65 watts. The samples were denatured at
95°C for 7 min and loaded into the wells. The gel was run for 2 hrs in lx TBE buffer. The gel
was transferred to filter paper (Whatmann), dried using a gel drier (Bio-Rad) for 1 hour at
80°C, and exposed for 24 hrs or appropriate time onto an autoradiograph film (Biomax MR-
1, Kodak).
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II.3 Cell Biology Techniques
11.3.1 Culturing of bone marrow (BM)-derived dendritic cells
(DCs)
11.3.1.1 Bone marrow (BM) preparation
Femurs and tibiae of BALB/c or C57BL/6 mice were cleaned from the surrounding muscle
tissue by rubbing with Bacterial Disinfectant wipes (Premier). Intact bones were dipped into
70% ethanol for disinfection and washed with PBS. Then both ends were cut with scissors and
the marrow flushed out with complete RPMI using a syringe with a 0.45mm (26-gauge)
diameter needle. Clusters within the marrow suspension were disintegrated by vigorous
pipetting and cells pelletted by centrifugation for 7 mm at 300 x g. The pellet was resuspended
in 1ml of cold Gey's red blood cell (RBC) lysis buffer and left at RT for 1 minute. Cell
suspension was then diluted down in complete RPMI to 10ml and washed as before. The pellet
was resuspended in 5ml of complete RPMI, and cells were counted. Typically 30-40x10" cells
were obtained per mouse.
11.3.1.2 Generation of BM-derived DCs based on Scheicher's protocol
The current protocol was adapted from previous publications (Lutz et al., 1999; Scheicher et
al., 1992). At day 0, BM cells were cultured in 10ml of complete Iscoves supplemented with
20ng/ml recombinant murine GM-CSF (rmGM-CSF) (R&D Systems) m bacteriological petri
dishes (Greiner) with 100mm diameter at a concentration of 2.x 10" cells/ml. Bacterial petri
dishes were used because more DC were produced than on tissue culture plastic. The modified
cell adherence condition of the plastic appears to hamper the development of macrophages,
and thus the development of DCs in suspension might be favoured (Lutz et al., 1999). At day
3. another 10ml of complete Iscoves containing 20ng/ml rmGM-CSF were added to the plates.
At days 6 and 8, half of the culture supernatant was collected, centrifuged, and the cell pellet
resuspended in 10ml fresh complete Iscoves containing lOng/ml rmGM-CSF, and added back
to the original petri dish. The majority of co-evolving granulocytes (and also contaminating B
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cells) died off by day 10, especially by reducing the doses of GM-CSF from day 6 onwards
(Lutz et al., 1999). At day 10. non-adhcrcnt cells were collected by gentle pipetting,
centrifuged at 300 x g for 7 nun at RT and resuspcnded in 10ml fresh complete Iscoves at
2.5x10" cells/ml into a new 100mm pctri dish containing lOng/ml rmGM-CSF and 50ng/ml
murine TNFa (R&D Systems) ± 50ng/ml IL-10 (R&D Systems). Cells were then cultured for
another 64 hrs.
Expected yield: 150% of starting cell number at day 10 of culture and 50% after maturation
for additional two days. Over 95% of the non-adherent cells had a classical DC morphology
on day 12 of culture (E. Jarman, unpublished data).
n.3.1.3 Generation of BM-derived DCs based on Inaba's protocol
Following a protocol based on Inaba's method (Inaba et al., 1992a), 3.75x10" cells/well were
placed into 24-well plates in 1ml of DC-RPMI supplemented with 5% GM-CSF supernatant
(see II.3.1.5). The cultures were fed at day 3 and 6 by gently swirling the plates, aspirating
80% of the medium and adding back fresh DC-RPMI with 5% GM-CSF. These washes
removed the majority of non-adherent granulocytes and B cells without dislodging clusters of
developing DCs that were loosely attached to firmly adherent macrophages. At day 7,
aggregates of attached cells were dislodged by pipetting cells and plated at 106 cells/ml/well
into a new 24-well plate for maturation with DC-RPMI containing 5% GM-CSF and 50ng/ml
murine TNFa (R&D Systems) ± 50ng/ml IL-10 (R&D Systems) or lOOng/ml LPS (SIGMA).
Cells were then cultured for up to 72 hrs.
Expected yield: 100-150% of starting cell number at day 7 of culture and 70% and 50% after
maturation with TNFa or LPS, respectively, for additional two days.
11.3.1.4 Enrichment of DCs using paramagnetic beads
Enrichment of DCs was effected by depleting contaminating granulocytes using paramagnetic
beads (Dynabeads M-450) coated with antibodies specific for rat IgG isotypcs (Dynal). These
were used in combination with other antibodies raised in rats specific for appropriate cell
surface markers (e.g. Grl).
Contaminating granulocytes of the DC culture (3-5x10" total cells) were coated with lOpg/ml
anti-Grl antibody (clone RB6-8C5, Pharmingen) in a volume of 500pl complete RPMI for 30
min at 4°C on a rotating mixer (Stuart Scientific). Excess antibodies were removed by
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washing twice with cold complete RPMI. Prior to use, the beads were washed several times
with fresh PBS to remove azide and finally resuspended in 250pl of complete medium per
2.5x106 beads. Coated cells (3-5x106) were resuspended in 500pl of the bead suspension and
incubated for 30 nun at 4°C on a rotating mixer. Beads were then collected using a strong
magnet (MPC-S, Dynal) and the supernatant containing the unbound cells removed and
retained for further processing.
11.3.1.5 GM-CSF supernatant
The GM-CSF supernatant was a kind gift of G. Perona-Wright. It was produced by
transfected hybridoma (X63-gmcsf), which was a kind gift of D. Gray (ICAPB, University of
Edinburgh; Stockmger et al., 1996). It contains 200-300ng/mI GM-CSF, 1.7ng/ml IL-10
(10-15ng/ml and 90pg/ml if used at 5%, respectively), but no detectable levels of TNFa or IL-
12 (L. Stuart, personal communication).
11.3.2 Preparation of splenocyte suspension
Spleens were removed from C57BL/6 (H-2b) or BALB/c (H-2J) female mice, aged 6-8 weeks.
The spleens were placed in a 70pm cell-strainer (Becton Dickinson) sitting on a 6cm petri dish
containing 5ml of PBS. The tissues were ground using the end of a 1ml syringe plunger.
Alternatively, tissues were ground between 2 glass slides until a homogenous cell suspension
was obtained. Cell suspensions were passed through 30pm pre-separation filters (Miltenyi
Biotech) and washed by centrifuging at 300 x g for 7 min at RT. The supernatant was
discarded and the pellet was resuspended in 2ml of cold Gey's red blood cell (RBC) lysis
buffer per spleen and left at RT for 1 minute. Cell suspensions were then diluted down in
complete RPMI to 15ml and washed as before. The pellet was resuspended in 10ml of PBS,
and the spleen cells were counted. Typically 80-120xI0b cells were obtained per spleen.
For removal of dead cells, the spleen suspension were spun down, diluted in 2ml of RT
complete RPMI and gently layered over 2ml of RT lympholytc-M (Ccdarlane, U.K.) per
spleen, and centrifuged at 1.500 x g, RT for 25 min. The interface was carefully removed and
washed 2 times with complete RPMI. The viable cells were counted using a haemacytometer
with 0.4% trypan blue exclusion. Cells were usually over 95% viable.
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11.3.3 Cell isolations by MACS (Magnetic Cell Sorting)
Cell populations were isolated from the spleens of BALB/c or C57BL/6 mice using a
magnetic cell sorting (MACS) method (Miltenvi Biotech). This technique relics on antibodies
conjugated to magnetic microbeads that recognise cell-specific surface markers, which will
bind to a magnetic column when placed in a magnetic field. Therefore, cells expressing cell
surface proteins that are recognised by the antibodies will bind to the column and can
subsequently be eluted as a highly pure population. All other cell types are collected in the
negative fraction.
The following microbead-conjugated antibodies were used:
• anti-CD4 (LT34) microbeads-antibody for separation of CD4 T cells.
• anti-CD8 (Ly-2) microbeads-antibody for the separation of CDS' T cells.
For separation of CD4 or CD8 T cells, spleens were processed as described in section II.3.2.
After cell counting, the spleen suspension was washed with cold MACS buffer and the pellet
was resuspended at a concentration of 900pl/l(T total cells in cold MACS buffer. 100pl/10s
cells of specific microbcad-conjugated antibody were added, the cell suspension was mixed
and incubated for 15 mm at 4°C. The cells were washed and the pellet resuspended in 500pl
of cold MACS buffer before loading onto a LS MACS column sitting on a VarioMACS
separator. The column was washed with 3x 3ml cold MACS buffer and the positive fraction
eluted with 5ml cold MACS buffer using the supplied plunger. The cells were counted. A
fraction was kept for measuring cell purity by flow cytometry. The rest was kept for use in
proliferation assays or RNA extraction. Purities of MACS-isoiated CD4 and CD8T T cells
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Figure 11.4. Purity of MACS-purified CD4 and CD8+ T cells.
CD4+ or CD8+ T cells were purified by MACS from lympholvte-treated BALB/c spleens, stained
with anti-CD4 or anti-CD8 antibodies, respectively, and purity assessed by flow cytometry. Forward
scatter (FSC) and side scatter (SSC) analysis and histogram of ungated MACS-purified CD4 and
CDS' T cells ([A] and [B], respectively). Shaded histogram: Isotype control, thick red line: indicated
antibody. Numbers within the histograms represent percentages within the marker bounds. Markers
were set using isotype control stainings. Details of antibodies are given in table D.4 & II.5.
II.3.4 Purification of CD4* T cells by depletion using R&D
columns
R&D depiction columns were used according to manufacturer's instruction to isolate highly
enriched CD4 T cells via high affinity negative selection. Briefly, i 0 splenocytes
resuspended in 1ml of Ix Column Buffer (R&D Systems) were mixed with 1ml of monoclonal
antibody cocktail (R&D Systems) and incubated for 15 min at RT. The cells were washed
twice before being resuspended in 2ml of Ix Column Buffer and applied onto the column
(R&D Systems), which had been rinsed previously with 10ml of lx Column Buffer. After a
10-min incubation at RT, unbound cells were eluted from the column with 10ml of lx Column
Buffer and washed once w ith complete RPM1. Purities of depleted CD4+ T cells were 84-91%
(R&D Systems).
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11.3.5 Enrichment of T cells by depletion using paramagnetic
beads
Negative depiction was used in order to isolate T cell populations from splenocyte suspension
following a similar protocol already described for enrichment of DCs (II.3.1.4). Briefly,
splenocytes were coated with lOpg/ml anti-B220, l()pg/ml anti-I-A7l-Ed and lOpg/ml anti-
Grl monoclonal rat antibodies (clones RA3-6B2, 2G9 and RB6-8C5, respectively,
Phanningen) in 1ml of complete RPMI per 5x10' splenocytes at 4°C on a rotating mixer
(Stuart Scientific) for 30 min. Excess antibodies were removed by washing twice with cold
complete RPMI. Prior to use, the beads were washed several times with fresh PBS to remove
azidc and finally resuspended in 5ml of complete medium per 10 beads. Coated cells (5x10 )
were rcsuspended in 5ml of the bead suspension and incubated for 30 min at 4°C on a rotating
mixer Beads were then collected using a strong magnet (MPC, Dynal) and the supernatant
containing the unbound cells removed and retained for further processing.
11.3.6 Enrichment of T cells using nylon wool fibre columns
Differential adherence properties of T cells, B cells and accessory cells such as macrophages
or other APCs can be employed to enrich for T cells. Nylon wool can be used as a column
matrix to which B cells and accessory cells adhere more readily than T cells (Julius el al.,
1973). Columns containing 0.5g nylon wool fibres (Polysciences) were washed and then
incubated with complete RPMI at 37°C in a humidified incubator with 5% CO2 for 1 hour.
The media was drained to the top of the nylon wool column. Lympholyte-treated splenocytes
and lymph node cells were resuspended in 1.5ml/spleen warm complete RPMI, loaded onto the
nylon wool column and another 2 ml of w arm media was added to column to ensure that the
top of the wool is covered with media. After 1 hour incubation at 37°C in a humidified
incubator with 5% C02 the non-adherent T cells were collected by washing the column with
15-20ml warm complete RPMI. Typically 20-30x10° cells were obtained for spleen and
lymph nodes from one mouse consisting of around 78±8% T cells (59±5% CD4 T cells and
20±5% CD8' T cells) (Fig. 11.5).
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Figure IL5. Purity of nylon wool-enriched T cells.
T cells from lympholvte-treatcd BALB/c spleens were enriched by passing through a nylon wool
column. The cells were double stained with anti-CD4 and anti-CD8 antibodies and the
corresponding isotype controls and analysed by flow cytometry. Details of antibodies are given in
table II.4 & 11.5.
[A] Forward scatter (FSC) and side scatter (SSC) analysis.
)B] Dot plot analysis of Rl-gated cells. Quadrant grid was set using isotype staining. Numbers in the
cross within dot plots represent percentages of the corresponding quadrant.
11.3.7 Labelling of nylon wool-enriched T cells with CFSE
CFSE (carboxyfluorescein diacetate succinimidyl ester) is a membrane-permeate dye that
covalently attaches to cytoplasmic proteins (Lyons and Parish, 1994). Approximately 99% of
the initial label is metabolised within the first 24 hrs. Only cytoplasmic proteins with a
relatively long half-life are still labelled at later time points. Upon division, CFSE is
distributed evenly between daughter cells and the mean fluorescence halves accordingly. In
this way division can be progressively analysed by flow cytometry up to 8-10 cell cycles. The
limiting factor of detectable cell cycle number is the autofluorcscence of the cells. Importantly,
cellular differentiation is unaffected by the dye because labelled lymphocytes have been shown
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to isotype switch, develop cytokine secretion potential and alter their cell surface phenotype as
normal (Gett and Hodgkm. 1998; Hasbold et al., 1998).
Nylon wool-enriched T cells were washed once in PBS. The cell pellet was resuspcndcd in
2.5pM CFSE/PBS at 5x10 cells/ml. After a l()-nunutc incubation at 37°C. the cells were
washed 3 times with cold complete RPMI.
11.3.8 Flow cytometry
11.3.8.1 Analysis of cell surface molecules by flow cytometry
Flow cytometric analysis of cell surface expression of proteins was carried out in a Becton
Dickinson FACSCalibur (BD Immunocytometry Systems). For direct antibody labelling, 1-
2.x 10 cells/sample were added to flexible 96 round-bottom well plates (Becton Dickinson),
and washed for 4 min at 300 x g, 4°C. The cells were pre-incubated in FACS buffer + 10%
mouse serum (Scottish Antibody Production Unit-SAPU) for 15 min at 4°C to decrease non¬
specific binding of the antibodies. The cells were washed and resuspended in 50pl of FACS
buffer + 10% mouse serum containing 0.5pg of FITC-labelled and/or 0.2pg of PE- and/or
Cy-Chrome-labelled antibody. The cells were incubated in the dark at 4°C for 20 min, and
washed 2 times in cold FACS buffer. Cells were resuspended in 400pl of cold FACS buffer.
Fluorescence of live cells was analysed by adding 0.5pi 7-aminoactinomycin D (7-AAD)
(eBiosciencc) prior to acquisition of the sample. Dead cells took up 7-AAD and could be
separated from the live cells due to their positive fluorescence in the FL3 channel. If the cells
were not analysed immediately, they were resuspended in 200pl of PBS, fixed by adding
200pl FACS fixing buffer and stored at 4°C for a maximum of 2 days. Fluorescence of fixed
cells was analysed without adding 7-AAD.
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Table 11.4. Antibodies used for flow cytometry.
Antibody to Clone Isotype§ Fluorochrome Supplier
anti-rat lgG N/A$ Goal (Fab'>2 PE Serotec
CD3e 145-2C11 HslgG, gpl. k PE Pharmingen
CD4/L3T4 GK1.5 rIgG2b, k Cy/FITC/PE Pharmingen
CD8a, Ly2 53-6.7 rIgG2a. k Cy/FITC/PE Pharmingen
CDllc HL3 HslgG, gpl. X PE Pharmingen
CD14 RmC5-3 rlgGl, k PE Pharmingen
CD19 1D3 r!gG2a, k PE Pharmingen
CD25 3C7 rIgG2b, k FITC/PE Pharmingen
CD40 3/23 rIgG2a, k PE Pharmingen
CD45R/B220 RA3-6B2 rlgG2a. k FITC Pharmingen
CD54/ICAM-1 3E2 HslgG, gpl, k PE Pharmingen
CD69 H1.2F3 HslgG, gpl, A. PE Pharmingen
CD80/B7.1 16-10A1 polyclonal HslgG PE Pharmingen
CD86/B7.2 GL1 r!gG2a. k PE Pharmingen
CD 152/CTLA4 UC10-4F10-11 HslgG, gpl, k PE Pharmingen
CD 169/Sialoadhestn 3D6.112 rIgG2a unconjugated Serotec
F4/80 CI:A3-1 rIgG2b FITC Caltag
H-2Kk 36-7-5 mIgG2a, k PE Pharmingen
I-A/I-E * 2G9 rIgG2a, k FITC/PE Pharmingen
IFNy XMG1.2 rlgGl PE Pharmingen
IL-4 11B11 rlgGl PE Phanningen
Ly-6G (Grl) RB6-8C5 rIgG2b, k PE/unconjugated Pharmingen
TCRB H57-597 HslgG, gp2, X PE Pharmingen
* HslgG = hamster immunoglobulin G, r!gGl/2a/b = rat immunoglobulin l/2a/b
*
Cy = Cy-Chrome, FITC = fluorescein isothiocyanate, PE = phycoerythrin
* Crossreactive with I-A/I-E from mice with haplotype H-2d, H-2b, H-2k, H-2P and H-2q
$ Not applicable
Table 11.5. Isotype controls used for flow cytometry.
Controls Clone Isotype§ Fluorochrome1 Supplier
Isotype HslgG N/A$ polyclonal PE Pharmingen
Isotype rIgG2a. k R35-95 rIgG2a. k Cy/FITC/PE Pharmingen
Isotype rIgG2b, k A95-1 rIgG2b. k FITC/PE Pharmingen
Isotype rlgGl, k R3-34 rlgGl, k PE Pharmingen
Isotype r!gG2b N/A$ r!gG2b FITC Caltag
§ HslgG = hamster immunoglobulin G, rIgGl/2a/b = rat immunoglobulin l/2a/b
T
Cy = Cy-Chrome, FITC = fluorescein isothiocyanate, PE = phycoerythrin
J Not applicable
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11.3.8.2 Defection of intracellular cytokines by flow cytometry
After primary stimulation of the nylon wool-enriched T cells in a mixed lymphocyte reaction
(MLR) with murine fibroblast transfectants (L celts), cells were rcstimulated for 4 hrs by
adding PMA and ionomycin to a final concentration of 50ng/ml and 500ng/ml, respectively.
As a control, an aliquot of the cells received no restimulation. 667pl/ml of GolgiStop
(Pharmingcn) was added for the final 3 hrs. Then cells were harvested and lympholytc-M
(Cedarlane) treated to remove dead cells and cell debris as described in section II.3.2. 2x10"
cells/sample were stained with Cy-Chromc labelled anti-CD4 or anti-CD8 antibodies
described in II.3.8.1) followed by fixation with lOOpl of 4% paraformaldehvdc/PBS for 10
min on ice. Intracellular cytokines were detected by a modified method of Pala et al. (2000).
Briefly, cells were permeabilised by washing with 200pl of permeabilisation buffer followed
by a 10-min incubation in 200pl pcrmcabilisation buffer at RT in the dark. After
centrifugation, cells were resuspended in 50pl permeabilisation buffer containing 1 pi of PE-
iabellcd anti-IFNy or anti-IL-4 antibody. After incubating for 30 min at RT in the dark, cells
were washed twice with pcrmcabilisation buffer and once with FACS buffer before being
resuspended in 200pl FACS buffer. Samples were ready to be analysed immediately or they
could be stored tor up to 3 days.
11.3.8.3 FACS (fluorescence-associated cell sorting)
Cell sorting by flow cytometry was performed for nylon-purified splenic T cells, which were
cultured with L cells. Dead cells were removed by lympholyte-M as described in section
11.3.2. The cells were double stained with 7.5pg/107 cells of FITC-CD4 and PE-CD8
antibodies in 500pl/10' cells of HBSS + 15% FCS + 10% mouse serum, and incubated for 30
min at 4°C in the dark. The cells were washed 2 times in HBSS + 15% FCS, passed through a
30pm prc-separation filter (Miltcnyi Biotech) and resuspended in HBSS + 15% FCS at
1.5xl07 cells/ml. Dead cells and remaining L cells were excluded by addition of 4pl/l 0" 7-
AAD just prior to FACS sorting (BD FACSVantagc SE, BD Immunocytometry Systems).
Cell sorting of enhanced green fluorescent protein (EGFP)-cxpressing L cells into EGFP high
(EGFPhl), EGFP low (EGFP1°) and EGFP negative cells, cells were passed through a 30pm
pre-separation filter and rcsuspended in HAT+MX medium at 5x 10" cells/ml ready for FACS
sorting.
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II.3.9 Apoptosis assay (Annexin V staining)
In the early stages of apoptosis phosphatidylscnnc (PS) translocates from the inner side of the
plasma membrane to the outer layer, by which PS becomes exposed at the external surface of
the cell. Annexin V is a Ca2 dependent phosphohpid-binding protein with high affinity for PS.
Hence this protein can be used as a sensitive probe for PS exposure on the cell surface.
Translocation of PS to the external cell surface is not unique to apoptosis, but occurs also
during cell necrosis. The difference between these two forms of cell death is that during the
initial stages of apoptosis the cell membrane remains intact, while at the very moment that
necrosis occurs the cell membrane looses its integrity and becomes leaky (reviewed in Allen et
al., 1997). Therefore the measurement of Anncxin V bmdmg to the cell surface as indicative
for apoptosis has to be performed in conjunction with a dye exclusion test such as 7-AAD to
establish integrity of the cell membrane. Ceils staining for Anncxin V alone were considered in
a stage of early apoptotic whereas cells double positive for Annexin V and 7-AAD were late
apoptotic or necrotic (Vermes et al., 1995).
Annexin V staining of cells was performed using an apoptosis detection kit following the
manufacturer's instructions (Pharmingen). Briefly, freshly isolated cells or cells that had been
in culture were washed twice in cold PBS (300 x g, 7min, 4°C), resuspended at 1 05
cells/lOOpl of the supplied Ix binding butler, and added to flexible 96 round-bottom well
plates (Becton Dickinson). 5pl of Anncxin V-FITC or Annexin V-PE and 5pi 7-AAD were
added per 10 cells and incubated in the dark at RT. Cells were washed once in 200pl of cold
PBS and resuspended in 400pl lx Binding Buffer. Cells were analysed with a Becton
Dickinson FACSCahbur (BD Immunocytometry Systems).
11.3.10 Culturing of murine fibroblasts (L cells)
Untransfected L cells were grown in complete RPMI in tissue culture flasks (75 cm , Costar).
I-A L cells were grown in HAT+MX medium (Ronchese et al., 1987). I-Ab L cells co-
transfcctcd with Jagged 1 or Delta 1 were maintained in the selective medium HAT+MX +
genetecin (section II. 1). L cell lines were passaged by 1:5 subculture twice per week after
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trypsin/ED 1A treatment. Aii L ceil transfcctants were generously provided by K. Wong
(Dept. Biology, Imperial College).
11.3.11 Trypsin/EDTA treatment of L ceils
Media was completely removed from the tissue culture flasks prior to adding warm
trypsin/EDTA (0.5pg/ml trypsin. 0.2pg/ml EDTA) for 5 nun. For subculturing. detached cells
were washed once with their respective medium. If used for experiments cells were washed
three times with complete RPMI.
11.3.12 Mitomycin C treatment of L ceils
L cells were pelleted by ccntrifuging at 300 x g for 7 min at RT and resuspended in lOOpg/ml
mitomycin C in complete RPMI at 2\ 10' cells/ml. After incubation at 37°C for 1 hour 10
nun, the cells were washed 3 times with complete RPMI.
11.3.13 Mixed lymphocyte reaction (MLR)
Bone marrow-derived DCs or mitomycin C-trcatcd L cells were used as stimulator cells and
plated out at differing cell numbers in a round bottom 96-well plate. T cells (CD4 and/or
CD8 T cells) were added in complete RPMI at 2xl05/well to a total volume of 200pl. 96-well
plates were incubated at 37°C in a humidified incubator with 5% CO2 for 72 or 96 hrs and
proliferation was measured by incorporation of 20plAvcll of tritiatcd thymidine (lmCi/ml [6-
H|Thvmidinc, Amcrsham Pharmacia) diluted 1:40 in complete RPMI 16 hrs before
harvesting using a liquid scintillation counter Bctaplate 1205 (Wallac). Each sample was
tested in triplicate or more and plotted as cpm x 10 ' ± standard deviation.
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For restimulation assays, flow cytometry and FACS, 0.5-1x10° mitomycin C-trcatcd L cells
and 3-4x10' T cells (CD4 and/or CD8 T cells) were added per 24-wcll in 2ml complete
RPMI and incubated at 37°C in a humidified incubator with 5% CO2 for 16 hrs to 5 days
depending on the experiment.
II.3.14 Mitogen proliferation
Polyclonal mitogens used in this study were PMA with ionomycin and E. coh LPS. Briefly,
single cell suspensions were obtained as previously described and plated out at 2x 10
cells/well in 96-well plates or at 2x10° cells/well in 24-well plates. Mitogens were added to the
wells at optimal concentrations, diluted in complete RPMI (PMA and ionomycin at 20ng/ml
and 500ng/ml respectively, and LPS at lpg/ml). Samples were incubated at 37°C in a
humidified incubator with 5% C02 for 72 hrs and then harvested as described in section
1.3.13.
II.3.15 Polyclonal TCR stimulation using plate bound and soluble
antibodies
Stimulation of purified T cell populations was performed using immobilised monoclonal
antibodies against CD3s and soluble monoclonal antibodies directed against CD28
(Pharmingcn). Briefly, immobilisation of anti-CD3s monoclonal antibodies onto plastic was
performed by adding 3Out of the antibody at lpg/ml in PBS per 96-well or 500pl of the
antibody per 24-well. The plates were incubated for 16 hrs at 4°C or for 2 hrs at 37°C. Wells
were washed 3 times with cold PBS to remove excess unbound antibody. Purified cells were
plated out at 2x10 per 200pl/96-well or at 2x10° per 2ml/24-well in complete RPMI. Anti-
CD28 monoclonal antibodies were added to the wells at a final concentration of 5pg/ml
diluted in complete RPMI. Cells were incubated at 37°C in a humidified incubator with 5%
C02 for 72 hrs and harvested as described.
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II.4 Biochemical Methods
II.4.1 Enzyme linked immunosorbant assay (ELISA)
Cytokine secretion was analysed by detecting soluble protein in aliquots of supernatants
collected from cultures at 24, 48 or 72 hrs using the DuoSet ELISA Development System
(R&D Systems).
Briefly, anti-cvtokine capture antibodies were diluted in PBS to the working dilution according
to the manufacturer's instruction. 50pi of diluted capture antibody was added to the wells of
enhanced protein binding ELISA plates (Corning). The plates were scaled and incubated
overnight at RT. Capture antibody was removed and wells washed 3 times with ELISA wash
buffer. 200pl of ELISA blocking buffer was added to each well and the plates incubated at
RT for one hour. Wells were washed 3 times with ELISA wash buffer and 50pl of standards
and samples were added to the wells (appropriately diluted in ELISA reagent diluent). Plates
were sealed and incubated overnight at 4°C. Wells were washed 3 times with 2Q0pl ELISA
wash buffer and 50pl of detection antibody diluted in ELISA reagent diluent (manufacturer's
instructions) was added to each well. Plates were incubated for 2 hrs at RT after which wells
were washed 3 times with 200pl ELISA wash buffer. 50pl of Strcptavidin-HRP diluted in
ELISA reagent diluent (manufacturer's instructions) was added to the wells and incubated for
20 min at RT. Wells were washed 4 times with ELISA wash buffer and 50pl of TMB liquid
substrate solution was added to wells. Plates were placed in the dark for colour change to
occur and the reaction was stopped after 20 min by adding 25pl of 0.5M H2S04. The plate
was read on a MRX Reader (Dynatech Laboratories) and data analysed with Revelation
Version 3.04 software. Data were expressed as pg/ml/10° cells.
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Ill Expression of Notch components in T cells
III.l Introduction
NF-kB exists in the cytoplasm of the majority of cell types and is important as a key
regulatory molecule in the immune response (see section 1.3), cell proliferation and cell
survival (reviewed in Ghosh et al., 1998). The DNA-binding form of NF-kB is dimeric and is
composed of various combinations of five different DNA-binding subunits: p50 (NF-kB 1),
p52 (NF-kB2), p65 (RelA), RelB and c-Rel. The most frequently observed form of NF-kB is
the heterodimer p50/p65. In unstimulated cells, NF-kB is kept as an inactive form in the
cytoplasm thorough interactions with a class of inhibitory proteins called IkBs. Recently Guan
and Wang identified a region on the intracellular portion of Notch 1 (NBD, Fig. 1.8), which
directly interacts with the p50 subunit of NF-kB and is responsible for ICN1 -mediated
inhibition of NF-kB transcriptional activity thereby displaying functional properties similar to
IkB (Guan et al., 1996; Wang et al., 2001). In contrast, transgenic mice expressing ICN3
under the control of the Lck promoter display constitutive activity of NF-kB (Bellavia et al.,
2000). These mice developed aggressive T cell lymphomas with a NF-kb-dependent anti-
apoptotic phenotype.
Furthermore, Notch can also induce expression of NF-KB-responsive genes. CBF1 normally
represses expression of the NF-kb-dependent genes IL-6 and NF-kB2 in the absence of Notch
signalling probably by competing with NF-kB for binding at overlapping sites (Cheng et al.,
2001; Oswald et al., 1998; Palmieri et al., 1999). Activated ICN1 converts CBF1 into a
transcriptional activator and increases the expression of NF-kB2 (Oswald et al., 1998). Notch
receptors and ligands are also targets of NF-kB signalling. Using DNA microarrays, Notch 1
was identified as a target of NF-kB signalling (Li et al., 2001), whereas c-Rel expression in
HeLa cells induced Jagged 1 expression (Bash et al., 1999).
Activation of T lymphocytes by triggering TCR and CD28 signalling or by stimulation with
PMA/ionomycin results in the induction of NF-kB activity (see 1.3 and Fig. 1.4). Because of
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the cross-regulation of NF-kB and Notch signalling, it is of interest to examine the expression
of Notch pathway components in activated CD4 and CD8 T cells
IL-10 controls inflammatory processes bv suppressing the production of pro-inflammatory
cvtokines, which are known to be transcriptionally controlled by NF-kB. The molecular
mechanisms involved in the IL-10 mediated inhibition of NF-kB still remain unclear. It is
thought that IL-10 suppresses the activity of IkB kinases, which are required for the
degradation of IkB and the subsequent nuclear translocation of NF-kB (Romano et al., 1996;
Wang et al., 1995). Another mechanism emerges whereby IL-10 blocks the ability of
translocated NF-kB to bind to DNA (Schottelius et al., 1999). Therefore IL-10 may interfere
with TCR/CD28 induced regulation of the expression ofNotch pathway components.
III.2 Gene transcripts of Notch pathway components are
present in CD4+ and CD8+ T cells
Several groups have detected Notch receptors, ligands and downstream components such as
the Hes and Deltex genes in thymocytes (Bellavia et al., 2000; Felli et al., 1999; Hasseijian et
al., 1996; Kaneta et al., 2000; Robev et al., 1996). Less is known about their expression in
peripheral CD4+ and CD8+ T cells. It was, therefore, of interest to investigate the expression
of the Notch pathway components in these T cell subsets isolated from peripheral lymphoid
organs.
CD4 and CD8 T cells were purified by MACS from spleens of BALB/c mice. Total RNA
was extracted and gene expression of Notch receptors and ligands were analysed by reverse
transcription-polymcrase chain reaction (RT-PCR) (Fig. III. 1 A). For most genes analysed,
there was very little difference in expression of Notch receptors and ligands between CD4
and CD8 T cells. Both expressed Jagged 1, Jagged2. Notchl and Hesl at an intermediate and
Notch2 at a high level. Differential expression was only found for Deltal and Notch4: Deltal
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transcripts were more abundant in CD4 T cells, whereas Notch4 was slightly more expressed
in CD8 T cells.
Semi-quantification by conventional RT-PCR has a number of technical difficulties. As the
PCR greatly amplifies the target, errors are also amplified. As a result, variability can be very
large. Further, semi-quantification has to be made using values of the exponential phase of the
reaction where no factor is limiting and the amplification products accumulate at a steady rate.
This is difficult to achieve by RT-PCR. Therefore, 1 made use of real-time PCR (described in
materials & methods, section II.2.21), which detects the amplification products while they are
formed.
Total RNA of CD4 and CD8+ T cells isolated from BALB/c spleens was transcribed into
cDNA and analysed by real-time PCR (Fig. III. IB). As found by RT-PCR. most of the Notch
components are present and many did not differ greatly between CD4 and CD8+ T
lymphocytes. Again Deltal expression was consistently higher in CD4+ T cells. Notch4
transcripts were 3-fold increased in CD8+ T cells compared to CD4+ T cells.
Notch receptor and ligands, as well as downstream components are present in peripheral CD4+
and CD8+ T cells. This raises the question as to whether the Notch pathway is important not
only for T cell development but also in the regulation of immunity in the adult perhaps by
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Figure III. 1. Gene transcripts of Notch pathway components arc present in CD4+ and CD8+ T
cells.
CD4 and CDS T cells were MACS purified from BALB/c spleens. Total RNA was extracted and
quality was tested by RT-PCR as described in materials & methods, section 11.2.16.
[A] The RNA was reverse transcribed and amplified by RT-PCR. The PCR-amplified products were
run in a 2% agarose gel. p-Actin was used as a house keeping gene to normalise all the RNA
samples to the same amount of starting template and as a control for the PCR reaction itself.
[B] RNA was reverse transcribed to cDNA and amplified by real-time PCR as described in materials
& methods, section II.2.21. Levels of mRNA transcripts are shown relative to the levels of the
internal calibrator which were CD4 T cells. A change in expression of at least 3-fold or greater was
considered significant.
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III.3 Activation of CD4+ T cells leads to differential gene
expression of Notch pathway components
It has been reported that the activated form of Notch 1 is a specific inhibitor of NF-kB
complexes containing the p50 subunit (Guan et al., 1996; Wang et al., 2001). Thus. Notch
signalling through its effect on NF-kB could play a role in regulating an immune response.
Furthermore, c-Rel and RelA, both members of the NF-kB family, induced Jagged 1
transcription in a HeLa-derived cell line (Bash et al., 1999). To confirm this data, the authors
stimulated human Jurkat T cells with phorbol 12-myristate 13-acetate (PMA) plus ionomycin
to activate endogenous NF-kB. This treatment also led to an increase in Jaggedl message.
Naturally occurring CD4 CD25* regulatory T cells express high levels of Deltexl and
upregulate gene expression of Delta 1, Notch4 and Hesl upon in vitro stimulation with anti-
CD3e/anti-CD28, whereas Deltexl was downregulated (Ng et al., 2001). These cells resemble
anergic cells in vitro and can suppress the responses of CD4+CD25 T cells in coculture in a
cell contact-dependent manner (Dieckmann et al., 2001; Thornton and Shevach. 1998). The
induction of anergic T cells has been demonstrated in vitro (Groux et al., 1996; Jenkins and
Schwartz, 1987; Lamb et al., 1983; Lombardi et al., 1994). Some of the protocols to induce
anergic or hyporesponsive T cells involve the presence of IL-10 (Groux et al., 1996; Groux et
al., 1997).
In vitro activation of CD4+ T cells.
To investigate the effect of activation on expression of Notch components, CD4+ T cells were
MACS-purified from BALB/c spleens and activated by either plate-bound anti-CD3e
antibodies in the presence of soluble anti-CD28 antibodies or by treatment with PMA and
ionomycin (Fig. III.2). IL-10 was included in the stimulation with anti-CD3s/anti-CD28 to
examine whether expression of the Notch genes is affected by a
regulatory/immunosuppressive cytokine. Proliferation was measured after three days of
activation. Both, anti-CD3e/anti-CD28 and PMA/ionomycin stimulation induced CD4+ T cell
proliferation (Fig. III.2A), but at different magnitudes. The presence of IL-10 did not
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influence proliferation in this experiment, whereas in other experiments a small decrease in
proliferation was observed. However, IL-10 downregulated production of IL-2 and IFNy but
not IL-4 as measured by ELISA (Fig. I1I.2B-D). Even though PMA/ionomycin induced strong
proliferation and IL-2 production, IFNy and IL-4 levels were two- and six-fold, respectively,
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Figure III.2. In vitro activation of CD4+ T cells.
CD4+ T cells were MACS purified lfom BALB/c spleens and activated with lpg/ml anti-CD3 and
5|rg/ml anti-CD28 in the presence or absence of 50ng/ml IL-10 (+/- IL-10) or with 50ng/ml PMA
and 500ng/ml ionomycin.
[A] After 3 days, proliferation was measured by [3H]thymidine uptake during the last 8 hrs of culture
and plotted as cpm x 10"3 + standard deviation.
[BJ Culture supernatants were harvested after 24 hrs (IL-2) and after 48 hrs (IL-4 and IFNy) to
measure cytokine contents by ELISA.
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Activating CD4+ T cells in vitro leads to differential gene expression of Notch pathway
components and upregulation of cytokine transcripts.
Total RNA was extracted from CD4 T cells ex vivo (0 hrs) or after 24 or 48 hours of their
respective stimulation and gene expression was analysed by real-time PCR (Fig. III.3). The
cytokine pattern observed for IFNy and IL-4 matched the results obtained by ELISA.
However, whereas considerable amounts of IL-2 were detected in the supernatant of cells
stimulated with PMA/ionomycin. only a little was detected at the RNA level compared to anti-
CD3s/anti-CD28 activated cells. The decrease of IL-2 induced by IL-10 was also observed by
real-time PCR analysis. Jaggedl and Dcltal transcripts were downregulated, whereas Jaggcd2
transcripts were induced after 48 hours of any stimulation. Decrease in Delta3 expression did
not reach significance except at the 24-hour time point of PMA/ionomycin activation. The
Notch receptors 1 and 2 did not change greatly their expression upon any stimulation. All
activated CD4 T cells showed a pronounced downregulation of Hesl and Deltcxl, whereas
Hes5 was strongly upregulated at 24 hours upon stimulation in the presence of IL-10.
Stimulation of CD4 T cells with anti-CD3s/anti-CD28 or PMA/ionomycin induced
proliferation, cytokine production and a pronounced downregulation of Delta 1, Deltexl and
the downstream target of Notch signalling Hesl. The presence of IL-10 during stimulation
affected cytokine production but not proliferation. Furthermore, most of the Notch
components did not alter their expression in the presence of IL-10 compared to activation in
the absence of IL-10. Hes5 was the only gene analysed which showed a transient increase in
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Figure III.3. Activating CD4+ T cells in vitro leads to differential gene expression of Notch
pathway components and upregulation of cytokine transcripts.
CD4+ T cells were MACS purified from BALB/c spleens and activated with lpg/ml anti-CD3 and
5pg/ml anti-CD28 in the presence or absence of 50ng/ml IL-10 (aCD3/CD28 +/- IL-10) or with
50ng/ml PMA and 500ng/ml ionomycin (PMA). Cells were collected directly after purification (0
hrs) and 24 or 48 hrs after activation and lympholyte-treated. Total RNA was extracted and quality
was tested by RT-PCR as described in materials & methods, section 11.2.16. RNA was reverse
transcribed to cDNA and analysed by real-time PCR. Levels of mRNA transcripts are shown relative
to the levels of the internal calibrator which were CD4+ T cells taken at 0 hrs. A change in
expression of at least 3-fold or greater was considered significant.
113
Purification by positive selection using MACS-beads does not influence gene
expression of Notch pathway components in CD4+ T cells.
Generally, many genes of the Notch pathway were downregulated with all treatments
compared to C D4 T cells ex vivo. This raises concerns whether culturing of the cells alone is
responsible for this finding. Additionally, positive selection of CD4 T cells by MACS
purification may partially activate them. Therefore, an additional experiment was carried out
where two different purification methods were compared.
CD4 T lymphocytes were isolated from BALB/c spleens either by positive selection using
MACS microbeads or negative selection (depletion) using R&D columns. Cells were activated
with PMA/ionomycin and proliferation measured after 3 days (Fig. III.4A). The magnitude of
proliferation did not differ between the two purification protocols. However, positive selection
induced a small background proliferation in CD4 T cells incubated in medium. Gene
expression of ex vivo CD44 T lymphocytes, cells incubated in medium or treated with
PMA/ionomycin for 24 hours were analysed (Fig. III.4B). The expression pattern for Jagged 1,
Deltexl, Hesl and Hes5 were very similar between CD4+ T cells purified by positive or by
negative selection and only a maximal twofold difference in scale was observed between the
two purification protocols. This suggests that positive selection did not affect gene expression
of Notch pathway components. Culturing of CD4 T cells strongly decreased expression of
Deltexl and Hesl. PMA/ionomycin stimulation increased Hesl transcripts but did not
influence Deltexl expression compared to cells cultured in medium. Expression of Jagged 1
did not decrease significantly upon culturing in media but was further downregulated after
activation. Hes5 did not alter expression upon culturing or stimulation.
Positive selection of CD4+ T cells did not affect gene expression of Notch pathway
components. In contrast, culturing the cells was responsible for the downregulation seen for
Deltexl and Hesl. Taking experiment III.4 into account, activation of CD4 T cells seemed to
induce Hesl compared to cells resting in medium or to inhibit downregulation of Hesl
compared to ex vivo CD4 T cells. In summary . I have shown that certain genes of the Notch
pathway were differentially regulated upon activation implying a role for Notch signalling in
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Figure III.4. Purification by positive selection using MACS-beads does not influence gene
expression of Notch pathway components in CD4+ T cells.
CD4+ T cells were purified from BALB/c spleens by positive selection using MACS or negative
selection using the R&D kit. CD4 T cells were cultured in medium (Medium) or activated with
5()ng/ml PMA and 500ng/ml ionomycin (PMA).
[A] After 3 days, proliferation was measured by [3H]thymidine uptake during the last 8 hrs of culture
and plotted as cpm x 10"3.
[B] Cells were collected directly after purification (Ex vivo) or after 72 hrs of culturing (72 hrs
Medium & 72 1ms PMA) and lympholyte-treated. Total RNA was extracted and quality was tested by
RT-PCR as described in materials & methods, section II.2.16. RNA was reverse transcribed to cDNA
and analysed by real-time PCR. Levels of mRNA transcripts are shown relative to the levels of the
internal calibrator which were MACS purified CD4+ T cells taken at 0 hrs (Ex vivo). A change in
expression of at least 3-fold or greater was considered significant.
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III.4 Activation of CD8+ T cells leads to differential gene
expression of Notch pathway components
I have shown that components of the Notch pathway were differentially transcribed in CD4+ T
cells upon culturing and activation. The presence of these genes in CD8 T cells (Fig. III. 1)
suggests that they may also play a role during an activation process.
In vitro activation of CD8+ T cells.
CD8+ T cells were MACS-purified from BALB/c spleens and activated by either plate-bound
anti-CD3s and soluble anti-CD28 antibodies or by treatment with PMA and ionomycin (Fig.
III.5). Proliferation was measured after three days of activation. CD8 T lymphocytes
proliferated strongly to both stimuli. However, a small background proliferation of cells





Figure III.5. In vitro activation of CD8+ T cells.
CD81 T cells were MACS purified from BALB/c spleens and activated with 5pg/ml anti-CD3 and
5gg/ml anti-CD28 or with 50ng/ml PMA and 500ng/ml ionomycin. After 3 days, proliferation was
measured by [3H]thymidine uptake during the last 8 hrs of culture and plotted as cpm x 10~3 ±
standard deviation.
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Activating CD8+ T cells in vitro leads to differential gene expression of Notch pathway
components and upregulation of cytokine transcripts.
After 0 (ex vivo), 24 and 48 hours of stimulation total RNA was extracted and gene
expression was analysed by real-time PCR (Fig. III.6). Jaggedl and Deltal were
downregulated, whereas Jagged2 was upregulated after 48 hours of PMA/ionomvcin
stimulation of the CD8+ T cells as it was observed for CD4+ T lymphocytes. Differential
expression of Delta3, Notchl and Notch2 did not exceed a three-fold change. Expression
patterns of Hesl and Deltexl were almost identical between CD4+ and CD8+ T lymphocytes,
in both cell types being strongly downregulated upon stimulation. Hes5 was the only gene
exhibiting a different regulation of transcription between CD4+ and CD8+ T cells: in contrast
to CD4 T lymphocytes, CD8 T cells upregulated Hes5 transcripts after 48 hours of
PMA/ionomycin treatment.
Similar to CD4 T cells, CD8+ T lymphocytes differentially regulate expression of Notch
pathway components. They also have strongly decreased expression of Hesl and Deltexl
transcripts after being activated. However, I camiot exclude that the culturing itself rather than
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Figure III.6. Activating CD8' T cells in vitro leads to differential gene expression of Notch
pathway components and upregulation of cytokine transcripts.
CD8+ T cells were MACS purified from BALB/c spleens and activated with 5pg/ml anti-CD3 and
5pg/ml anti-CD28 (aCD3/CD28) or with 50ng/ml PMA and 500ng/ml ionomvcin (PMA). Cells
were collected directly after purification (0 hrs) and 24 or 48 hrs after activation and lympholyte-
treated. Total RNA was extracted and quality was tested by RT-PCR as described in materials &
methods, section 11.2.16. RNA was reverse transcribed to cDNA and analysed by real-time PCR.
Levels of mRNA transcripts are shown relative to the levels of the internal calibrator which were
CD8+ T cells taken at 0 hrs.
*) Sample for 48 hrs of aCD3/CD28 activation was not determined. A change in expression of at
least 3-fold or greater was considered significant.
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III.5 Discussion
Components of the Notch pathway have been studied extensively during T cell development
(Deftos et al., 2000; Radtke et al., 1999; Robey et al., 1996). Less is known about their
expression in peripheral T lymphocytes. Here, I have investigated the expression of Notch
receptors, ligands and downstream components in peripheral CD4 and CD8 T cells. Notch
receptors, ligands and targets of Notch signals were all expressed in resting T cells. In vitro
culturing with anti-CD3/anti-CD28 antibodies, PMA/ionomycin or in medium alone reduced
expression levels of Hesl and Deltexl, both targets of Notch activation, implying abrogated
Notch signalling. Therefore, 1 suggest that accessory cells are required to induce and/or
sustain Notch signalling in peripheral T lymphocytes.
Naive peripheral CD4+ and CD8+ T cells circulate through the blood and peripheral lymphoid
organs in a proliferatively and transcriptionally quiescent state until they encounter an APC
bearing a peptide bound to an appropriate MHC molecule. Activation of the TCR/CD3
complex by its natural ligand (MHC/peptide) or by crosslinking with anti-CD3 antibodies
leads to rapid activation of NF-kB NF-kB proteins are retained in the cytoplasm of
unstimulated cells in an inactive form via interactions with one or more of the seven known
IkB proteins (reviewed in Baldwin, 1996). In response to a variety of stimuli, including cell-
surface antigen receptor cross-linking and exposure to cytokines, IkB proteins are
phosphorylated and degraded and free cytoplasmic NF-kB dimers translocate rapidly to the
nucleus, where they regulate kb-dependent gene expression (May and Ghosh, 1998). Notchl
has been reported to inhibit NF-kb-induced gene expression similarly to IkB proteins (Guan
et al., 1996) by binding to the NF-kB p50 subunit and blocking its DNA binding activity
(Wang et al., 2001). Interestingly, NF-kB activates Notch signalling in neighbouring cells by
inducing expression of Jaggedl on the cell surface (Bash et al., 1999). This demonstrates that
the cross-talk between Notch and NF-kB is bi-directional, meaning that the activation of one
can influence the activation of the other.
Others and I have shown that Notch receptor, ligands and downstream components are present
in peripheral CD4 and CD8 T cells (Fig. III. 1; Hoyne et al., 2000; Ng et al., 2001).
Activation of T cells by crosslinking CD3 or stimulation with PMA/ionomycin activates NF-
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kB (Kuo and Leiden, 1999). In contrast to the finding of Bash et al., Jaggedl expression was
downregulated upon stimulation in both CD4 and CD8 T cells (Fig. III.3 & 6). There are
several possible reasons for the contradicting results. It has been shown that Notch signalling
has different outcomes depending on the cell type: Notch activation protects T cells from
TCR-mediated apoptosis (Jehn et al., 1999), but induces apoptosis in B cells (Morimura et
al., 2000). Bash and colleagues used HeLa cells, which were derived from a human epithelial
carcinoma, to induce Jaggedl expression by transfecting them with NF-kB (Bash et al.,
1999). However, they also detected Jaggedl expression in Jurkat cells after two hours of
stimulation with PMA/ionomvcin. In my system, the decrease in Jaggedl was detected at 24
hours or later after stimulation, which may be the reason for the discrepancy.
The strong downregulation of Hcsl and Deltexl upon culturing of T cells with or without
stimulation (Fig. III.3 & 4) suggests the absence of Notch signalling. In vivo T lymphocytes
are in contact with many cells and cell types, which may allow Notch activation. Upon
culturing in flat bottom wells, most of the T cells were not in contact with other cells, which
may explain the decreased level of targets of the Notch signalling pathway. Changes of Hes5
expression in the case of CD4 T cells activated in the presence of IL-10 would then be caused
by the signalling cascade from the TCR/CD3 complex, CD28 costimulation and/or signalling
by IL-10 rather than by Notch ligands expressed on adjacent cells. However, cell-to-cell
contact cannot be excluded as the reason for Hes5 upregulation.
The details of IL-10 signalling remain to be resolved. Distinct signalling pathways have been
described, one involving the JAK/STAT system and another one leading to modulation of NF-
kB activity (Moore et al., 2001). In CD4 T cells and macrophages. IL-10 inhibits NF-kB
activation (Romano et al., 1996; Wang et al., 1995). whereas IL-10 activates AP-1 and NF-
kB in CD8 T cells (Hurme et al., 1994). This is consistent with the finding that IL-10 has no
direct inhibitory effects on the proliferation of CD8 T cells activated by anti-CD3 antibodies
(Groux et al., 1998). Therefore, and because IL-10 mediated anergy can be associated with
induction of a population of regulatory CD4 T lymphoevtes (de Waal Malefit et al., 1993;
Groux et al., 1996; Groux et al., 1997), the effect of IL-10 was investigated for CD4 T cells
only. Even though IL-10 did not inhibit the proliferative response of CD4' T cells to anti-CD3
antibody-mediated stimulation, it downregulated production of IL-2 transcripts and protein
(Fig. III.2 & 3) consistent with previous reports (de Waal Malefyt et al., 1993; Taga et al.,
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1993). The differences in IL-2 transcripts between anti-CD3/anti-CD28 activated and
PMA/ionomycin activated CD4+ T cells may be explained by different kinetics. Phorbol esters
such as PMA directly activate protein kinase C (PKC) whereas the calcium ionophore
ionomycin increases cytosolic free Ca2 . In combination, they fully activate transcription
factor NF-AT, which is required for IL-2 gene transcription (reviewed in Jain et al., 1995).
These are downstream events of TCR signalling, which may be more rapidly induced by
pharmacological agents than by anti-CD3/anti-CD28 antibody stimulation. Therefore, IL-2
transcripts may have already decreased 24 hours after stimulation with PMA/ionomycin.
In summary, it can be concluded that Notch receptors and ligands are expressed in CD4 and
CD8 T cells. Activation of T lymphocytes did not have a great effect on Notchl and 2.
However, the ligands and downstream components were differentially regulated upon
culturing and/or stimulation. The marked decrease of Hesl and Deltexl transcripts in CD4 T
cells upon culturing for 24 hours in medium suggests abrogated Notch signalling. Activation
of CD4 T cells only partially restored Hesl transcription. The presence of accessory cells
expressing the Notch ligands may be required for sustained expression of Hesl and/or
Deltexl. The capacity of IL-10 to increase Hes5 transcription suggests that cytokines
additionally to Notch ligands may modulate gene expression of Notch target genes. For certain
cytokines a direct involvement in Notch signalling has been shown: G-CSF and GM-CSF
modulate signalling by Notchl and Notch2, respectively (Bigas et al., 1998).
The pronounced differential expression of Hesl and Deltexl, both targets of Notch activation
(Deftos et al., 1998; Deftos et al., 2000; Jarriault et al., 1995; Jarriault et al., 1998), suggests
a role for T lymphocytes as the receiving cells of Notch signalling. This poses the question of
the identity of the signalling cell expressing the Notch ligands. In order to become activated, T
cells require an encounter with antigen-presenting cells (APCs), which may activate Notch
signalling in T cells during the activation process. To test this hy pothesis, expression of Notch
pathway components in dendritic cells (DCs), since they are the most potent APCs, were
examined.
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IV Expression of Notch components in dendritic
cells
IV.l Introduction
Notch receptors play a pivotal role in survival, expansion and differentiation of
haematopoietic precursors. Less is known about their role in differentiated DCs. Jagged 1
expressed on APCs inhibited an immune response in vivo (Hoyne el al., 2000) implying a role
for Notch signalling in the induction of tolerance. 1 and other investigators have shown that
Notch receptors are present in CD4 and CD8 T lymphocytes (Chapter III; Hoyne et al.,
2000; Ng et al., 2001) thereby enabling these cells to receive Notch signalling. DCs are an
ideal candidate for delivering Notch signalling to T cells due to their central role in the
induction and regulation of immune responses. Therefore, Notch expression was investigated
in DCs, which were matured under various conditions. Whereas downstream components of
the Notch pathway were hardly detectable, expression of the Notch ligands Jagged 1 and
Delta 1 was differentially regulated. Thus, there may be a potential role for Notch ligands in
the interaction of DCs w ith other cell types, for example T lymphocytes.
DCs play a critical role in the initiation of many adaptive immune responses. They exist in a
quiescent state in most tissues, but certain stimuli such as microbial products or inflammatory
cytokines trigger DCs to become activated. They then migrate to the draining lymph nodes,
where they encounter T lymphocytes and induce an immune response.
DCs develop in the bone marrow (BM) and then migrate to the periphery (Barclay and
May rhofer, 1981; Katz et al., 1979). Members of the Notch family are expressed in lymphoid,
myeloid and erythroid precursors of the BM and play crucial roles during haematopoiesis
(Milner and Bigas, 1999). The first evidence for regulation of Notch signalling by cytokines
came from studies of myeloid differentiation (Bigas et al., 1998): Differentiation of myeloid
precursors was inhibited by Notch 1 in response to G-CSF or by Notch2 in response to GM-
CSF. This led to identification of the Notch cytokine response (NCR) region on the
cytoplasmic portion of Notch. Furthermore, an immobilised truncated form of Deltal induced
apoptosis in peripheral blood monocytes cultured with M-CSF, but not GM-CSF (Ohishi et
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al., 2000). These observations highlight a potentially important link between Notch and
cytokine signalling pathways.
However, members of the Notch family are not only important in the haematopoicsis of DCs,
but also in instructing T cell responses. Splenic DCs express Notchl and Jagged 1 (Hoyne et
al., 2000) Overcxprcssing Jagged 1 in a DC-enriched APC population may induce peripheral
CD4 T lymphocytes to become regulatory cells (Hoyne et al., 2000). There is increasing
evidence that certain subpopulations of DCs, such as liver-derived DCs (Thomson and Lu,
1999), CD8a lymphoid-derived DCs (Kronin et al., 2000) and 1L-10 modulated DCs
(Steinbrink et al., 1999; Steinbnnk et al., 1997) are able to downregulate immune responses.
It is, therefore, relevant to investigate the regulation of expression of Notch pathway
components in DCs.
DCs comprise as few as 0.5% of the nucleated cells in nonlymphoid tissues while lymphoid
tissues contain slightly elevated numbers (around 1%) (Vremec et al., 1992). Time-consuming
purification procedures involving density gradient centrifugation, adherence to glass or plastic
surfaces, panning, depletion or positive selection using magnetic beads and cell sorting have
been developed to obtain significant quantities of tissue-derived DCs. Purity and overall yield
are usually quite low. In vitro differentiation of DCs from murine bone marrow following
Scheicher's or Inaba's method generates a large quantity of highly enriched DCs (Inaba et al,
1992a; Scheicher et al., 1992). Therefore, these two methods of BM-derived DC cultures
were employed to study the gene expression ofNotch family members.
IV.2 Differentiation of bone marrow-derived DCs based
on Scheicher's protocol
While B lymphocytes and pre-B cells do not grow in response to GM-CSF, they represent
about 50% of the initial marrow suspension (Inaba et al., 1992a). Mainly three cell types of
myeloid cells expand in mouse bone marrow cultures in the presence of GM-CSF: (a)
Neutrophils predominate but they do not adhere to the culture surface, (b) Macrophages are
firmly adherent and express substantial levels of F4/80 antigen and little or no MHC class II.
(c) DCs are released from cellular aggregates that are attached to the marrow stroma (Inaba et
al., 1992a). The protocol used for the following study was based on the method described by
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Scheicher et al. (Scheichcr el al., 1992) and further optimised by using some of the
procedures introduced by Lutz et al. (Lutz el al., 1999): The overall cultunng time was
increased, whereas the amount of GM-CSF was decreased from day 6 onwards favouring the
generation and survival of DCs over granulocytes and B cells.
The most common stimuli used to activate DCs are TNFa and LPS. Moreover TNFa has
been widely applied to generate in vitro bone marrow-derived DCs. It was, therefore, used to
mature the immature DC (iDCs) in combination with the regulator}, cytokine IL-10.
Steinbrink and colleagues reported that treatment of DCs with 40 to 80ng/ml IL-10 achieved
maximal inhibition of allogeneic MLRs (Steinbrink et al., 1997). Therefore, 50ng/ml IL-10
was used throughout the study.
IV.2.1 Bone marrow-derived DCs were matured in the presence or
absence of IL-10
Bone marrow cells from C67BL/6 mice were cultured in GM-CSF as described in materials &
methods, section II.3.1.2. At day 10 of culture, an aliquot of the non-adherent immature DCs
(iDCs) was kept for analysis by flow cytometry and the rest was transferred into a 24-well
plate for maturation with TNFa in the presence or absence of IL-10 (mature DCs ± IL-10).
After 64 hours, matured DCs were analysed by flow cytometry (Fig. IV. 1). After 10 days the
cultured DCs (iDCs) still had a relatively immature phenotype: The majority of the cells
expressed no or low levels of the costimulatory molecule B7.2 and intermediate levels of
MHC class II molecules. TNFa-induced maturation increased the number of CD1 lc-positive
cells from 78% to 94%. The population of cells expressing intermediate level of class II and
low levels of B7.1 disappeared almost completely. Instead over 90% of the cells had B7.2hl8h
class IIhlsh phenotype.
There was a slight reduction in the levels of activation markers in DCs that were matured in
the presence of TNFa and IL-10.
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Figure IV. 1. Bone marrow-derived DCs were matured in the presence or absence of IL-10 and
analysed by flow cytometry.
Bone marrow-derived DCs from C57BL/6 mice were grown for 10 days and then matured with
50ng/ml TNFa for 64 hrs in the presence or absence of 50ng/ml IL-10 (Scheicher el al., 1992).
Immature DCs (day 10) and DCs matured in the presence (day 13, + IL-10) or absence IL-10 (day
13, - IL-10) were stained for CDllc and activation markers B7.2 and MHC class II and analysed by
flow cytometry. Regions were set using isotype staining and to differentiate between low and high
expressing cell populations for MHC class II and B7.2 staining. Numbers in the plots represent
percentages of cells within the region. Details of antibodies are given in table II.4 & II. 5.
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IV.2.2 DCs matured in the presence IL-10 are less potent
stimulators of allogeneic T cell proliferation
An exquisite function of DCs is their ability to stimulate naive allogeneic T lymphocytes as
evidenced by a mixed lymphocyte reaction (MLR) (Nussenzweig and Steinman, 1980). To
examine the stimulatory capacity of DCs matured in the presence or absence of IL-10,
C56BL/6 bone marrow cells were cultured for 10 days and then matured for 64 hours as
described above. The matured DCs were cocultured with alloreactive T cells enriched from
BALB/c spleens by depletion of granulocytes, B cells and class II-positive cells using
Dynabeads. Control T cells and DCs were incubated in medium. Figure IV.2 represents the
proliferative response of the T cells after 4 days of coculturing with DCs. As few as 100
TNFa-matured BM-derived DCs were sufficient to induce a marked proliferative response in
T cells during a MLR. A significant inhibitory effect on T cell proliferation induced by DCs
matured in the presence of IL-10 was detected at DC concentration 103 and 104 per well
(P<0.01 and P<0.05, respectively).
DCs
Figure IV.2. DCs matured in the presence IL-10 are less potent stimulators of allogeneic T cell
proliferation than those matured in the absence of IL-10.
Bone marrow-derived DCs from C57BL/6 mice were grown and matured for 64 hrs as described in
figure legend IV. 1. A MLR was carried out with varying numbers of DCs as stimulators and depleted
T cells from BALB/c spleens (lO Vwell). After 4 days, proliferation was measured by [^thymidine
uptake during the last 18 hrs of culture and plotted as cpm x 10"3 ± standard deviation.
* : P<0.05; ** : P<0.01, statistical comparison of sample data was performed by application of
ANOVA Test using the GraphPad InSlat programme (GraphPad Software Inc., www.graphpad.com)
DC = DCs matured in the absence of IL-10; DC + IL-10 = DCs matured in the presence IL-10.
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IV.2.3 Maturation of DCs with TNFa in the presence or absence of
IL-10 leads to differential gene expression of Notch pathway
components
C56BL/6 bone marrow cells were cultured for 10 days and then matured for 64 hours as
described above. Total RNA was extracted from DCs before maturation (iDCs. day 10) and
after TNFa-induced maturation in the presence or absence of IL-10 (DCs, day 13, ± IL-10).
A RT-PCR was carried out in order to assess expression of Notch pathway components (Fig.
IV.3A). Expression of Jaggcdl and Deltal was upregulated upon maturation. IL-10 treatment
had no visible effect on the TNFa-induced increase of Jagged 1 but inhibited upregulation of
Deltal. However, in another experiment Deltal expression did not increase upon maturation
of DCs and was further down regulated by the presence of IL-10 (data not shown). Jaggedl
was very weakly expressed, whereas Hesl could not be detected. Expression of Notchl and
Notch2 did not alter greatly between the various treatments.
To more accurately quantify the difference of expression, total RNA was reverse transcribed
into cDNA and analysed by real-time PCR (Fig. IV.3B). The upregulation of Jaggedl upon
maturation was also very pronounced after amplification by real-time PCR. The presence of
IL-10 increased Jaggedl expression further. Deltal expression did not alter between the
different treatments. In a second experiment, Deltal expression decreased slightly upon
maturation but did not reach a 3-fold difference (data not shown). Furthermore, expression
levels were very low. Expression of Jagged2, Notchl and Notch2 did not differ significantly
between the different treatments. Hesl and Hes5 were not detected, whereas Deltexl was
expressed in iDCs and downregulated upon maturation in the presence or absence of IL-10.
IL-10 transcripts were generally very low. Upon maturation, a small increase of IL-10
expression was observed. IL-12p70 consists of two chains, a p40 protein and a p35 protein,
which are both required for activity (Heufler et al., 1996; Macatonia el al., 1995). Transcripts
for both subunits were upregulated upon TNFa-induced maturation. The presence of IL-10
during the maturation process further increased expression of IL-12p35, but decreased IL-
12p40 compared to maturation in the absence of IL-10.
TNFa is a very potent maturation stimulus for bone marrow-derived DCs (Lutz et al., 1999;
Reid et al., 1992): TNFa-induced maturation increased cell surface expression of adhesion
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molecule CD 11c. costimulatory molecule B7.2 and MHC class II molecules. The presence of
IL-10 during the maturation process had only minimal effect on the expression of these
molecules. However, IL-10-treated DCs were less potent stimulators of an allogeneic T cell
response in vitro and produced decreased amounts of IL-12p40 compared to DCs matured in
the absence of IL-10. Interestingly, IL-12p35 was further upregulated by IL-10 compared to
DCs matured in the absence of IL-10. Transcripts for Jaggedl were strongly upregulated upon
maturation and further increased by the presence of IL-10. There was no evident Notch
signalling occurring after 64 hours of maturation as concluded from the absence of
downstream targets Hesl and Hes5 and the downregulation of Deltexl.
These data imply that members of the Notch family are differentially expressed during the
maturation process in DCs. It was of interest to investigate in more detail the kinetic of
Jaggedl upregulation and the influence of IL-10 on this process. Because of a very poor yield
of DCs with the culture method described above, I switched to a different protocol based on
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Figure 1V.3. Maturation of DCs with TNFa in the presence or absence of IL-10 leads to
differential gene expression of Notch pathway components and upregulation of Jaggedl
transcript.
Bone marrow-derived DCs from C57BL/6 mice were grown for 10 days and then matured with
50ng/ml TNFa for 48 hrs in the presence or absence of 50ng/ml IL-10 (TNFa +/- IL-10) (Scheicher
et al., 1992). Total RNA was extracted and quality was tested by RT-PCR as described in materials
& methods, section II.2.16.
[A] The RNA was reverse transcribed and amplified by RT-PCR. The PCR-amplified products were
run in a 2% agarose gel. p-Actin was used as a house keeping gene to normalise all the RNA
samples to the same amount of starting template and as a control of the PCR reaction itself.
[B] RNA was reverse transcribed to cDNA and amplified by real-time PCR as described in materials
& methods, section II.2.21. Levels of mRNA transcripts are shown relative to the levels of the
internal calibrator which were immature DCs taken at day 10 prior to maturation (iDC). A change in
expression of at least 3-fold or greater was considered significant.
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IV.3 Differentiation of bone marrow-derived DCs based
on Inaba's protocol
The current protocol was adapted from a previous publication (Inaba et al., 1992a). There
exist several differences compared to the previous protocol used, which are outlined in the
table IV. 1. The main differences in Inaba's method are the shorter culture period, the
discarding of cell-containing supernatant during feeding and the use of GM-CSF supernatant
instead of recombinant GM-CSF.
Tabic IV. 1. Comparison of DC culture techniques.
Parameter Method based on Scheicher et al. Method based on Inaba et al.
Lyses of red blood cells Yes Yes







Culture medium Complete Iscoves
DC-RPMI (= complete RPMI
without P-mercaptoethanol)
GM-CSF dose 20ng/ml rmGM-CSF*, 5% murine hybridoma (X63-gmcsf)
from day 6: lOng/ml rmGM-CSF*
Day 3 add 100% of complete RPMI + GM-
supernatant^ throughout
CSF, days 6 and 8 aspirate 50% Day 3 and 6 aspirate and discard
Feeding supernatant containing cells, wash, 80% supernatant (containing cells),
resuspend cells in fresh medium + GM- add fresh medium + GM-CSF
CSF and give back to the petri dish
Culture period before
transfer
10 days 7 days
Culture density for 2.5x10s 106
maturation (iDCs/ml)
Maturation By 50ng/ml TNFa + 50ng/ml IL-10 By 50ng/ml TNFa ± 50ng/ml IL-10
or by 1 OOng/ml LPS
Maturation period 64 hours 2-72 hours
*rmGM-CSF = recombinant murine GM-CSF (R&D Systems)
; corresponds to 10-15ng/ml GM-CSF (see Materials & Methods, section II.3.1.5)
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IV.3.1 Purity of bone marrow-derived cells at day 7
Although a lot of granulocytes and B lymphocytes were removed during the feeding steps in
Inaba's protocol, the shorter culture time and the sustained dose of GM-CSF may have a
negative effect on the purity of the iDC population on the day of transfer (day 7). Therefore,
the purity of the iDC population was analy sed by flow cytometry.
Bone marrow cells from BALB/c mice were cultured in GM-CSF as described in materials &
methods, section II.3.1.3. At day 7 of culture, purity of iDC population was analy sed by flow
cytometry (Fig. IV.4). The cells were not gated to avoid excluding the population of smaller-
sized granulocytes and lymphocytes. There were no CD 19 B220 cells (B lymphocytes),
CD4 CD3s or CD8'CD3e cells (CD4 or CD8 T lymphocytes, respectively) detected (Fig.
IV.4A). However, almost 20% of cells were positive for Ly-6G (Grl) (Fig. IV.4B) confirming
a contamination with granulocytes. Contamination of macrophages was analy sed by staining
cells for the macrophage/monocyte markers sialoadhesin (CD 169), CD 14 and F4/80. Cells
were negative for sialoadhesin and CD 14. However, a majority of cells expressed intermediate
levels of the macrophage marker F4/80.
The iDC population on day 7 of Inaba's protocol is free of lymphocytes, but contains a 20%
granulocyte contamination. All cells were negative for macrophage/monocyte markers
sialoadhesin and CD 14, whereas monocytes and macrophages showed low levels of staining
for both markers (data not shown). Over 50% of the cells were F4/80-positive, a macrophage
marker, which is also expressed on DCs (Lutz et al., 1999; Mahnke et al., 1997). Therefore,
it was concluded that the main contaminants of the iDC population were granulocytes.
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Figure IV.4. Purity of bone marrow-derived cells at day 7.
Bone marrow-derived DCs from BALB/c mice were grown based on a method described by Inaba et
at. (Inaba et at., 1992a). Immature DCs (iDCs) at day 7 were analysed by flow cytometry.
[A] Dot plots showing ungated cells double stained for B (CD19 and B220) or T cell markers (CD3e
and CD4 or CD8).
[B] Histograms showing ungated cells stained for the macrophage markers 3D6, CD 14 and F4/80
and granulocyte marker Grl. Shaded histogram represents isotype control. Numbers indicate
percentage of cells within Ml.
Quadrant grid was set using isotype controls. Numbers in the cross within dot plots represent
percentages within the corresponding quadrant. Details of antibodies are given in table II.4 & II.5.
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IV.3.2 Maturation of bone marrow-derived DCs with TNFa or
LPS upregulates costimulatory molecules and activation
markers.
To show that the remaining -80% of cells were actually immature DCs. their ability to
upregulate costimulatory molecules and activation markers upon maturation was tested. In
addition to the endogenous maturation stimulus TNFa, DCs were also matured with the
microbial stimulus LPS.
Bone marrow cells from BALB/c mice were cultured in GM-CSF as above. At day 7 of
culture, an aliquot of the non-adherent immature DCs (iDCs) were kept for analysis by flow
cytometry and the rest was transferred into a 24-well plate for maturation with TNFa or LPS.
DCs were analysed by flow cytometry after 24 hours (Fig. IV.5). Cells were double stained
for MHC class II plus costimulatory molecules B7.1, B7.2 and CD40 and adhesion molecules
ICAM-1 and CDllc. Percentages of cells staining positive for these markers were
summarised in table IV.2. Around 70 to 80% of the iDCs and matured DCs expressed MHC
class II molecules on the cell surface, which is consistent with the previously measured 20%
of granulocyte contamination. Even though percentages of MHC class 1I-, B7.1- and ICAM-
1-positive cells did not increase greatly, a visible shift to increased expression was observed
on the dot plots. The population of MHC class II1 u B7.2negat,ve cells (lower right quadrant)
present in the iDC sample decreased in TNFa-treated DCs and almost completely disappeared
in LPS-matured DCs. Instead a distinct population of MHC class IIhlsh B7.2hlgh cells appeared
in TNFa- and LPS-matured DCs. In this particular experiment, TNFa only marginally
upregulated expression of CD40, whereas LPS induced moderate CD40 expression. In other
experiments, TNFa induced low, whereas LPS induced high expression of CD40 (Table
IV.2). In contrast to earlier observations (IV.2.1) expression of CDllc decreased upon
maturation.
Here it has been shown that both stimuli. TNFa and LPS increased expression of MHC class
II molecules, costimulatory molecules B7.1 and B7.2 and adhesion molecule ICAM-1.
However, only LPS induced expression of CD40. Adhesion molecule CDllc was
downregulated upon maturation.
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Table IV.2. Maturation of DCs uprcgulates costimulatory molecules and activation markers.
Percentage of cells stained positive for the indicated markers of experiment IV.5 and the mean and
standard deviation (SD) of four independent experiments.
Cell surface marker iDC TNFa LPS
(%) Fig. 1V.5 Mean ± SD Fig. IV.5 Mean ± SD Fig. IV.5 Mean ± SD
MHC class II 70 72+6 77 80 + 6 69 76 + 8
B7.1 65 67 + 8 82 86 + 6 79 84 + 8
B7.2 33 38+6 64 67+10 67 72 + 10
ICAM-1 82 85 + 3 97 98+2 93 96 + 3
CD40 2 1 ± 1 4 26+19 23 46+ 18
CDllc 47 51+5 37 39 ± 10 26 32 ± 23
Isotype FITC
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MHC class II FITC
Figure IV.5. Maturation of bone marrow-derived DCs with TNFa or LPS up regulates
eostimulatorv molecules and activation markers.
Bone marrow-derived DCs from BALB/c mice were grown based on a method described by Inaba et
al. (1992a) (iDC) and then matured with 50ng/ml TNFa (TNFa) or lOOng/ml LPS (LPS) for 24 hrs.
The cells were double stained for MHC class II and costimulatory molecules B7.1, B7.2, CD40.
adhesion molecules ICAM-1 and CD1 lc and analysed by flow cytometry.
[A] Forward (FSC) and side scatter (SSC) plots showing the R1 gate for live cells used in subsequent
analysis.
[B] Dot plot analysis showing the FITC-conjugated isotypc control for the anti-MHC class II
antibody (FL1).
[C] Dot plot analysis with PE-conjugated antibodies (FL2) and FITC-conjugated anti-MHC class II
antibody (FL1). Quadrant grid was set using isotype controls. Details of antibodies are given in table
II.4 & II.5.
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IV.3.3 Maturation of DCs in the presence of IL-10 induces
downregulation of most costimulatory molecules and
activation markers after 24 hours
Here, the influence of IL-10 and the kinetic of the upregulation of costimulatory molecules
were investigated. Bone marrow-derived DCs were grown as described above. At day 7 an
aliquot of iDCs was kept for flow cytometry . The remaining cells were transferred to new
wells and grown in medium ± IL-10 as a control for spontaneous maturation induced by the
transfer, in TNFa ± IL-10 and in LPS. After 2, 8. 16, 24 and 48 hours, cells were analysed by
flow cytometry. At the 72 hour time point, only TNFa-matured cells were analysed. To
exclude interference of dead cells with the analysis, the viability dye 7-aminoactinomycin D
(7-AAD) staining necrotic and late apoptotic cells was added to the sample before analysis.
Cells were double stained for MHC class II molecules and B7.1, B7.2, ICAM-1 or CD40.
Staining for CD1 lc was omitted because this adhesion molecule did not indicate maturation of
DCs using Inaba's method (Table IV.2). Figure IV.6 A-C shows dot plot analysis of iDCs and
cells grown for 24 hours after the transfer as a representative example. The geometrical mean
fluorescence of MHC class II molecules, B7.1. B7.2 and ICAM-1 of class Il-positive cells
(gated on upper and lower right quadrants in figure IV. 6C) is shown in figure IV. 6D
Percentage of CD40-positive cells and of the cell population expressing high amounts of class
II and B7.2 as defined in figure IV.6F is summarised in IV.6E.
Transfer of iDCs into new wells on day 7 of culture induced moderate maturation, as seen by
upregulation of activation markers and by the increase of class IIhlsh B7.2hl8h cells.
Interestingly, addition of IL-10 slightly increased expression of CD40. Even though the
increase was small, it has been observed reproducibly. Maturation of DCs with LPS rapidly
upregulated class II. B7.1, B7.2 and ICAM-1 However, the increased expression was only
transient and all activation markers except B7.1 were downregulated after 20 hours of
maturation. Maturation with TNFa was a much slower process. Maximal expression of the
above mentioned activation markers were observed at 72 hours. Addition of IL-10 during
maturation with TNFa decreased expression of the activation markers only at 24 hours or
later. Interestingly, the presence of IL-10 during TNFa-induced maturation enhanced
expression of B7.2 and CD40 within the first 24 hours.
Looking at class IIhl8h B7.2hlsh cells (Fig. IV.6F) summarises the observations made with the
different activation markers (Fig. IV.6E): Maturation induced by LPS was much quicker, but
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only transient, whereas TNFa induced maturation of DCs with a sustained phenotype of
mature DCs. Addition of IL-10 slightly accelerated maturation of DCs within the first 24
hours before it induced a general decrease in activation markers. Transfer of iDCs at day 7
induced some degree of activation in the absence of any maturation stimuli as seen by the




Figure IV.6. Maturation of DCs in the presence of IL-10 induces downrcgulation of most
costimulatorv molecules and activation markers after 24 hours.
Bone marrow-derived DCs from BALB/c mice were grown based on a method described by Inaba et
al. (1992a). At day 7, iDCs were either incubated in medium alone (—) or in 50ng/ml 1L-10 (IL-10)
or matured with 50ng/ml TNFcx in the presence or absence of IL-10 (TNFa or TNFa + IL-10) or
with lOOng/ml LPS (LPS). At 0. 2, 8, 16, 24. 48 or 72 hrs. cells were double stained for MHC class
II and B7.1. B7.2, CD40 or ICAM-1 and analysed by flow cytometry. Dead cells were excluded by
uptake of 7-AAD. Details of antibodies are given in table II.4 & II.5.
[A]-[C], Flow cytometry analysis iDCs and of cells taken at 24 hrs are shown as a representative.
[A] Forward (FSC) and side scatter (SSC) plots showing the R1 gate for live cells used in subsequent
analysis.
[B] Dot plot analysis showing the FITC-conjugated isotype control for the anti-MHC class II
antibody (FL1).
[C] Dot plot analysis with PE-conjugated antibodies (FL2) and FITC-conjugated anti-MHC class II
antibody (FL1). Quadrant grid was set using isotype controls.
[D] Geometrical mean fluorescence for MHC class II. B7.1. B7.2 and ICAM-1 of MHC class II-
positive cells plotted against maturation time.
[E] Percentage of CD40-positive DCs or B7.2hl MHCII1" DCs (defined in figure F) plotted against
maturation time.
[F] Dot plot analysis with PE-conjugated anti-B7.2 (FL2) and FITC-conjugated anti-MHC class II
antibody (FL1). Region R2 selects for cells expressing B7.?hl and MHCUhl
IV.3.4 Downregulation of costimulatory molecules and activation
markers in the presence of IL-10 is not due to increased cell
death
The decrease in activation markers seen in DCs matured in the presence of IL-10 at later time
points may be due to the onset of apoptosis. It has been shown that IL-10 reduced viability of
human Langerhans cells (Ludewig et al., 1995).
Therefore the amount of dead cells was monitored during the maturation process by staining
with Annexin V and 7-AAD. Annexin V detects early and late apoptotic and necrotic cells
whereas 7-AAD only stains late apoptotic and necrotic cells (Vermes et al., 1995). Therefore,
cells showing Annexin V and 7-AAD staining were referred to as dead cells since distinction
between apoptosis and necrosis is not possible. Bone marrow cells were cultured and matured
as described above and analysed by flow cytometry for Anncxin V and 7-AAD staining.
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Again, iDCs and DCs cultured for 24 hours after transfer were shown as a representative
(Fig. IV.7A). Percentage of Annexin V and 7-AAD double-positive cells over the time course
arc shown in figure 1V.7C. Only in the LPS-treated culture an increase of dead cells was
observed after 24 hours of maturation. In all other cultures, percentage of dead cells did not
exceed 10%.
Therefore, I concluded that the decreased expression of activation markers in DCs matured in
the presence of IL-10 was not due to increased cell death.
iDC
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Figure IV.7. Down regulation of costimulatory molecules and activation markers in the presence
of IL-10 is not due to increased cell death.
Bone marrow-derived DCs from BALB/c mice were matured and stained for Annexin V at the same
time points as in figure IV.6. 7-AAD was added prior to flow cytometry analysis. As a positive
control for Annexin V and 7-AAD staining, an aliquot of DCs were incubated at 95°C for 2 mins
(dead cell control).
| A) Dot plot analysis with PE-conjugated Annexin V (FL2) and 7-AAD (FL3) of cells taken at 24 hrs
were shown as a representative.
|B] Dead cell control.
[C] Percentage of Annexin V and 7-AAD double-positive cells plotted against maturation time.
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IV.3.5 Immature DCs and DCs matured in the presence of IL-10
are less potent stimulators of allogeneic T cell proliferation
than those matured in the absence of IL-10.
Human IL-10 modulated DCs from peripheral blood induce an antigen-specific anergy of
CDC and CD8 T cells (Steinbrink et al., 1999; Steinbrink et al., 1997). This state of anergy
was characterised by inhibited T cell proliferation and reduced production of IL-2 and IFNy.
The stimulatory capacity of DCs matured in the presence of IL-10 was examined by earn ing
out a MLR. Bone marrow-derived DCs from BALB/c mice (H-2d) were grown and matured
for 24 hours as previously described and used in a MLR with CD4+ T cells purified from
spleens of C57BL/6 mice by MACS (H-2b). After 4 days proliferation was measured by
|H [thymidine uptake (Fig. IV.8). DCs incubated in medium alone or in IL-10 induced
moderate T cell proliferation. Increase of proliferation by TNFa-maturcd DCs was small but
significant (P<0.05), whereas LPS-treated DCs induced strong T cell activation (P<0.001).
Addition of IL-10 during TNFa-mediated maturation of DCs inhibited the stimulatory
capacity significantly (P<0.001).
LPS-matured DCs induced a stronger proliferative response in CD4 T cells than TNFa-
matured DCs. The addition of IL-10 during the maturation with TNFa reduced the capability
of the DC to activate CD4 T cells.
iDCs were matured
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Figure IV.8. Immature DCs and DCs matured in the presence of IL-10 arc less potent
stimulators of allogeneic T cell proliferation than those matured in the absence of IL-10.
Bone marrow-derived DCs from BALB/c mice were matured for 24 hrs as described in figure IV.6.
A MLR was carried out with DCs as stimulators (lO'/wcll) and MACS-purified CD4 T cells from
C57BL/6 spleens (2xl07wcll). After 4 days, proliferation was measured by [3H]thymidine uptake
during the last 18 hrs of culture and plotted as cpm x 10"3 ± standard deviation. * : P<0.05; *** :
PO.OOl statistical comparison of sample data was performed by application of ANOVA Test using
the GraphPad InStat programme (GraphPad Software Inc., www.graphpad.com).
IV.3.6 Maturation of DCs with TNFa in the presence of IL-10
blocks IL-12p40 induction.
Many groups have reported a decrease in IL-12 production if DCs were matured in the
presence of IL-10 (Bellinghausen et al., 2001; Brossart et al., 2000; Buelens et al., 1997;
Koch et a/., 1996; Takenaka et al., 1997). Therefore, the amount of heterodimeric IL-12p70
and the IL-12p40 subunit was measured in the supernatant of DC matured as described in
figure IV. 6 as an additional read-out for IL-10-induced inhibition of DC maturation.
Additionally, production of IL-10 was measured in DC incubated in medium alone or matured
with TNFa or LPS.
IL-12p70 was only detected in the cultures of LPS-matured DCs (Fig. IV.9A). The subunit
p40 was strongly induced by LPS (Fig. IV.9B) and to a much lesser extent with TNFa (Fig.
IV.9C). However, IL-10 abrogated TNFa-induced production of IL-12p40. Two hours after
transfer of iDCs, low amounts of IL-10 were detected in untreated. LPS- and TNFa-activated
DCs (Fig. IV.9D). Whereas LPS further induced production of IL-10, amount of IL-10
decreased in cultures of untreated and TNFa-treated DCs.
LPS- but not TNFa-induced maturation of DCs induced production of IL-12p70 and IL-10.


























Figure IV.9. Maturation of DCs with TNFa in the presence of IL-10 blocks IL-12p40 induction.
Bone marrow-derived DCs from BALB/c mice grown and matured as described in figure IV.6. After
0. 2. 8. 16. 24. 48 and 72 hrs. 1L-I2p70 [A], IL-12p40 ([B] and [CJ. the latter without the data for
LPS-matured DCs) and IL-10 [D] were measured in the supernatant by ELISA.
IV.3.7 Depletion of granulocytes does not activate DCs.
Having ensured that DCs were generated by Inaba s method, that they can be activated by
TNFa or LPS and that maturation in the presence of IL-10 led to observations described by
others, gene expression of components of the Notch pathways was examined. However, in
contrast to Scheicher's method, the DC generated by Inaba's protocol contained high
contamination of granulocytes (Fig. IV.4). Using paramagnetic beads, a depletion protocol
was developed to deplete granulocytes prior to RNA analysis.
It is important to examine whether the depletion had any immediate effects on the maturation
state of the DCs. Therefore, iDCs were stained for MHC class II molecules and B7.2 before
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and after depletion (Fig. IV. 10A). To control the efficiency of the depletion, cells were stained
for the granulocyte marker Grl. The anti-Grl antibody used for flow staining and depletion
originates from the same clone. Hence it cannot be used to examine the efficiency of depletion
because the anti-Grl antibody used for depletion may mask Grl molecules on non-depleted
granulocytes. To circumvent this problem, an indirect staining protocol was developed,
whereby the unconjugated depletion antibody was used as the primary antibody for flow
staining. FITC-conjugated anti-rat IgG antibody was used to detect remaining granulocytes
after the depletion process. The depletion reduced contamination of granulocytes from 33 to
9% without activating the DCs as demonstrated by the unchanged expression of class II
molecules and B7.2 (Fig. IV. 10A). The depletion of granulocytes can also be observed by the
increase of class If and B7.2+ cells in figure IV. 10A and the decreased population of class II
B7.2 cells in figure IV.10B. After 48 hours of maturation with LPS, depletion of
granulocytes led to 95% class II- B7.2-positive cells suggesting that contamination of was less
than 5%. Viability of DCs was not affected by the depletion (data not shown).
Using Dynabeads to deplete contaminating granulocytes led to an over 90% pure population
of class IT B7.2 cells. The depletion did not affect the maturation states of the DCs as judged
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Figure IV.10. Depletion of granulocytes does not activate DCs.
Bone marrow-derived DCs from BALB/c mice were grown as in figure IV.4. At day 7. iDCs were
stained indirectly for Grl (1° antibody: rat anti-Grl. 2° antibody: FITC-conjugated anti-rat IgG) or
double stained for class 11 and B7.2 before (pre) and after depletion (post) of contaminating
granulocytes using Dynabeads (materials & methods II.3.1.4). An aliquot of cells was matured with
lOOng/ml LPS for 48 hrs (LPS) and then depleted and stained for flow cytometry. Dead cells were
excluded by uptake of 7-AAD. Details of antibodies are given in table II.4 & II.5.
[A| Histograms showing iDCs stained for the indicated cell surface molecules before (pre) and after
(post) depletion. Shaded histogram represents isotype control. Numbers indicate percentage of cells
within M1.
|B] Dot plot analysis with FITC-conjugated anti-MHC class II antibody and PE-conjugated anti-B7.2
antibody. Quadrant grid was set using isotype controls. Numbers in the cross within dot plots
represent percentages within the corresponding quadrant.
IV.3.8 Maturation of DCs in the presence or absence of IL-10 leads
to differential gene expression of Notch ligands Jagged 1 and
Delta 1.
Using the depletion protocol described above, gene expression of iDCs grown according to
Inaba's method and DCs matured in medium ± IL-10, TNFa ± IL-10 or in LPS was analysed.
Prior to RNA extraction, granulocytes were depleted. Total RNA was reverse transcribed into
cDNA and analysed by real-time PCR (Fig. TV. 11). IL-12p40 transcripts were strongly
induced in DCs matured with LPS and to a much lesser extent in DCs matured with TNFa.
Interestingly, TNFa induced an early peak followed by a later rise of p40 expression. The
presence of IL-10 inhibited TNFa-mduced p40 expression. In contrast to IL-12 subunit p40,
p35 was mainly induced after 24 hours of maturation with LPS. Interestingly, the presence of
IL-10 increased transcription levels of p35 in TNFa-matured DCs. Transcription of IL-10
was increased in DCs incubated in IL-10 or in TNFa. However, in other experiments where
non-depleted DCs were analysed, LPS but not TNFa induced IL-10 expression (data not
shown). Maturation of DCs induced expression of Jagged 1. Whereas the presence of IL-10
alone did not alter level of Jagged 1 transcripts, it increased and prolonged the upregulation in
combination with TNFa. Expression of Jagged2 did not change between the different
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treatments, whereas expression of Delta3 was not detected. Expression of Delta 1 was in all
samples very low, even though it was upregulated by 1L-10 and by TNFa at early time points
or late time points, respectively. However, this upregulation was not reproducible: In a second
experiment, only TNFa but not IL-10 induced a transient upregulation, whereas LPS but not
TNFa increased Deltal transcripts in a third experiment (data not shown). Interestingly, an
increase in Delta 1 expression within the first 24 hours after transfer of iDCs correlated with
the upregulation of IL-10 transcripts. Downstream components of Notch signalling were either
not detected (Hes5 and Deltexl) or expression did not alter between the different treatments
(Hesl). Expression of Notch receptors were not further analysed because they were not
differentially regulated in DCs grown according to Schcicher's protocol and neither in
preliminary experiments with DCs cultured based on Inaba s method.
Transcript expression of IL-12p40 in TNFa- and LPS-maturcd DCs correlated with the
protein level measured by ELISA (Fig. IV.9). IL-12p35 was induced in matured DCs. The
presence of IL-10 during TNFa-induced maturation further increased transcription level.
Maturation with TNFa or LPS induced Jagged 1 transcription. IL-10 increased and prolonged
Jagged 1 expression induced by TNFa. Target of Notch signalling (Hesl. Hes5 and Deltcxl)
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Figure IV.ll. Maturation of DCs in the presence or absence of IL-10 leads to differential gene
expression of Notch ligands Jaggcdl and Deltal.
Bone marrow-derived DCs from BALB/c mice grown and matured as described in figure IV.6. After
0, 2, 8, 16, 24, 48 and 72 hrs, granulocytes were depleted using Dynabeads and total RNA was
extracted. RNA was reverse transcribed to cDNA and amplified by real-time PCR as described in
materials & methods, section section II.2.21. Levels of mRNA transcripts are shown relative to the
levels of the internal calibrator which were immature DCs taken at day 7 prior to maturation (iDC).
A change in expression of at least 3-fold or greater was considered significant.
4 IL-12p40 without the data for LPS-matured DCs
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IV.4 Discussion
DCs play a central role in the induction of immune responses. Their ability to prime naive
C D4 and CD8+ T cells constitutes a unique and critical function of DCs both in vitro and in
vivo. Although it is clear that different DC subpopulations exhibit distinct functions, there is
evidence that their functions can also be altered by the cytokine environment. For example, IL-
10 has been described to confer a tolerance inducing phenotype in DCs. The
immunosuppressive properties of IL-10 on DCs are caused by a reduction in the upregulation
of expression of MHC class II molecules and costimulatory and adhesion molecules (Buelens
et al., 1995; Sato et al., 1999; Steinbrink et al., 1997). Additionally, IL-10 inhibited
production of inflammatory cytokines (e.g. IL-ip, IL-6 and TNFa) and IL-12 (Buelens et al.,
1997; Koch et al., 1996; Sato et al., 1999). These altered properties were only seen if IL-10
was added to immature IL-10-sensitive DCs, indicating that IL-10 modulates the function of
immature DCs and inhibited their terminal differentiation whereas mature DCs are resistant to
IL-10 (Steinbrink et al., 1999; Steinbrink et al., 1997).
Here I propose that the effect of IL-10 is not simply to inhibit maturation of DCs. The
presence of IL-10 during TNFa-mediated maturation induced an initial increase of B7.2,
CD40 and of class IIh gh B7.2hlsh DCs (Fig. IV.6). Furthermore, IL-10 increased these markers
within the first 24 hours also in the absence of TNFa. After 24 hours of maturation, IL-10-
treated DCs adopted a tolerance inducing phenotype with decreased expression of
costimulatory and adhesion molecules (Buelens et al., 1995; Sato et al., 1999; Stcinbrink et
al., 1997). The effect of IL-10 was even more pronounced during LPS-mediated maturation
(G. Pcrona-Wright, personal communication). DCs matured more rapidly in the presence of
LPS in comparison to TNFa (Fig. IV.6). Consistent with this observation, the addition of IL-
10 led to a shorter and more pronounced upregulation of MHC class II molecules and B7.2.
18-24 hours after initiation of maturation. IL-10-treated DCs had downregulated expression
of these cell surface proteins. This initial upregulation of activation markers does not
contradict published data: Sato, Buelens and Steinbrink et al. described the "tolerogenic" DC
phenotypc only 2 to 4 days after addition of IL-10 (Buelens et a!., 1995; Sato el al., 1999;
Steinbrink et al., 1997). Furthermore, CD40 ligation in the presence of IL-10 did not result in
decreased expression of the human DC-specific activation marker CD83 and of B7.2 after 72
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hours of maturation (Buelens et al., 1995). This implies differential effects of 1L-10 on
different maturation signals.
Bioactive IL-12p70 is composed of p40 and p35 subunits and induced largely in macrophages
and DCs by transcriptional induction of the p40 subunit (reviewed in Gately et al., 1998).
Microbial stimuli such as LPS and the interaction of mature DCs w ith CD4 T lymphocytes
involving CD40-CD40 ligand (CD40L) activation induce p40 transcription (Cella et al.
1996; Tnnchicri, 1995). TNFa is generally not thought to be an inducer of IL-12 (Cella et al.,
1996), however, low level of IL-12p40 was induced in TNFa-matured DCs (Brunner et al.,
2000). The presence of IL-10 blocks TNFa-. LPS- and CD40-mediated p40 induction in DCs
(G. Perona-Wright, personal communication; Aste-Amezaga et al., 1998; Takenaka et al.,
1997). Whereas IL-10 also blocked expression of IL-12p35 in LPS-matured DCs or
monocytes (G. Perona-Wright, personal communication; Aste-Amezaga et al., 1998), it
increased p35 transcription in TNFa-matured DCs.
In summary, IL-10 mediates not just a blockage of the maturation-induced upregulation of
activation markers. In contrast to immature DCs, which were shown to induce regulatory T
cells with a CD4 CD25 phenotype (Jonuleit et al., 2000), IL-10-treated DCs induced anergy
in CD4 and CD8 T cells (Steinbrink et al., 1999; Steinbrink et al., 1997). Therefore. iDCs
and IL-10-treated DCs will need to possess different properties to be able to induce different T
cell responses.
In the thymus. Notch ligands are thought to contribute to the differentiation of thymocytes into
ap vs. y8 and CD8 vs. CD4 T lymphocytes (Chang et al., 2000; Kronenberg et al., 2000;
Robey et al., 1996; Washburn et al., 1997), although contradicting data exist (Deftos et al.,
1998; Deftos et al., 2000; Izon et al, 2001). Jaggedl expressed on APCs has been implicated
in the generation of regulatory CD4 T cells in vivo (Hoyne et al., 2000). It was therefore of
interest to investigate whether Notch ligands were expressed by DCs. Gene expression of bone
marrow-derived iDCs, IL-10-trcated and TNFa/LPS-matured DCs was analysed. Jaggedl
was strongly upregulated upon maturation (Fig. IV.3 & 11). An increase in Jaggedl
expression was also observed in macrophages cultured in the presence of TNFa (data not
shown by Nomaguchi et al., 2001). The presence of IL-10 during TNFa-mediated maturation
further increased levels of Jaggedl transcripts. However, the amount of Jaggedl transcripts
induced by TNFa & IL-10 did not exceed LPS-mediated Jaggedl expression. This suggests
that Jaggedl is not directly involved in the induction of anergic T cells by DCs. Furthermore,
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iDCs, which express only low levels of Jagged 1, can induce regulatory T cells (Jonuleit et al.,
2000).
Expression of Jagged2 did not change upon maturation or IL-10 treatment, whereas Delta3
was below detection levels. Similar results were obtained with BM-derived macrophages
where expression of Jagged2 or Delta 1 was "seldom affected by the stimuli" (data not shown
by Nomaguchi et al., 2001). Analysis of Deltal expression during maturation of DCs
produced variable results. This was not due to technical problems using real-time PCR
because results obtained by conventional RT-PCR matched the real-time PCR results.
Additionally, transfection of a murine fibroblast cell line (L cells) with Delta 1 led to an over
3000-fold increase of Deltal transcripts measured by real-time PCR, whereas transfection
with Jaggedl did not alter Deltal expression and thereby ensuring the specificity of the Deltal
primers and probe (Fig. V.3). Generally, DCs expressed very little Deltal as observed by high
CT values. Interestingly, upregulation of Deltal in the first 24 hours under certain conditions
correlated with upregulation of IL-10 within the same experiment. RNA analysis of DCs,
which have not been depleted of granulocytes, showed that LPS- but not TNFa-treatment
upregulated transcripts for Deltal and IL-10 in DCs (data not shown). This observation was
consistent with the detection of IL-10 in culture medium of LPS-matured DCs, which has been
described previously (Langenkamp et al., 2000).
IL-10 can be expressed by a wide range of cell types including T cells, B cells, monocytes,
macrophages, keratinocytes and many tumour cells (de Waal Malefyt et al., 1991; Del Prete
et al., 1993; Enk and Katz, 1992; Groux et al., 1997; O'Garra et al., 1992). A few groups
also reported granulocytes to produce IL-10 (Romani et al., 1997; Shimonkevitz et al., 2000).
Since granulocyte-depleted DCs did not increase IL-10 transcripts after LPS activation, I
cannot exclude that the granulocytes were the major group of IL-10 producing cells in this
culture.
Notch receptors were not differentially expressed depending on the activation status of the
DCs. Neither were there any signs of Notch signalling; Transcripts for Hes5 were not detected
in DCs grown using the culture conditions described by either Scheicher or Inaba. Even
though Hesl was expressed in DCs, it was not differentially modulated during activation of
DCs. Deltexl was detected in immature DCs cultured according to Scheichcr's but not to
Inaba s protocol. In conclusion. Notch signalling resulting in induction of Hesl, Hes5 or
Deltex 1 was not observed.
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Notch signalling has been studied in haematopoiesis. Notch activation is important in the
differentiation of haematopoietic precursor, even though the data is very controversial: Notch
may inhibit differentiation of myeloid precursors (Bigas et al., 1998; Han et al., 2000; Milner
et al., 1996) rather than promote differentiation (Schroeder and Just, 2000b). Activated
Notch 1 inhibited proliferation of progenitors (Schroeder and Just, 2000a; Walker et al.,
1999), whereas retroviral transduction of murine bone marrow cells with the intracellular
domain of Notch 1 induced immortalised mouse progenitor cell lines (Vamum-Finney et al.,
2000).
Less is known of the maturation of already differentiated myeloid cells such as monocytes to
macrophages or iDCs to mature DCs. Monocytes cultured with immobilised Delta 1 undergo
apoptosis in the presence of M-CSF (Ohishi et al., 2000), whereas they differentiate into DCs
in the presence of GM-CSF (Mizutam et al., 2000; Ohishi et al., 2001). Cheng et al. found
that Notch 1 is important for maturation of DCs (Cheng et al., 2001). They propose a role for
Notchl in maintaining the expression levels of several NF-kB subunits in DCs. In the absence
ofNotchl, TNFa-induced maturation of DCs is decreased because of the reduced level ofNF-
kB. However, TNFa-mediated maturation of DCs did not alter in the presence of immobilised
Delta 1 suggesting that activation of Notch by Delta 1 did not affect the maturation process
(Ohishi et al., 2001). Furthermore. Radtke and colleagues have shown that Notchl is not
required at all for the development of DCs in vivo (Radtke et al., 2000). In summary, the role
of Notch signalling in DC differentiation and maturation remains unclear. My results suggest
that Notch signalling mediated by induction of the Hes genes did not occur during the
maturation process due to their low levels in immature and mature DCs.
In conclusion. Notch signalling did not seem to play a major role during maturation of DCs.
However, the Notch ligands Jagged 1 and Delta 1 were differentially expressed during the
maturation process. Expression pattern of Delta 1 remains unclear and will need further
investigations. TNFa-induced maturation of DCs upregulated Jagged 1 more strongly in the
presence than in the absence of IL-10. However, it is unlikely that Jaggedl plays a major role
in the induction of anergic T cells by IL-10 modulated DCs because the same level of Jaggedl
expression existed in LPS-matured DCs. Therefore, it is possible that the role of Jaggedl
during the induction of an immune response is of a costimulatory rather than a modulating
nature. Furthermore, posttranscriptional regulation of these molecules cannot be excluded.
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So far, the expression but not the biological function of these molecules has been studied. It is
now important to investigate whether expression of Notch ligands on APCs influences the
outcome of an immune response.
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V Analysis of T cell activation by L cells expressing
Jaggedl or Deltal
V.l Introduction
In the previous chapters I have shown that DCs uprcgulate Jaggedl and differentially express
Deltal upon maturation, whereas they constitutively express Notch I and Notch2.
Downstream components of the Notch signalling pathway were either not detected or not
differentially regulated during DC maturation. In contrast, peripheral CD4 and CD8 T cells
expressing Notch receptors 1 -4 displayed differential regulation of downstream components of
the Notch signalling pathway, such as Deltex and the Hes genes, upon stimulation. By
differentially expressing Notch ligands or downstream components of the Notch pathway,
respectively, a role for DCs as the "signalling cell" and T lymphocytes as the "receiving cells"
could be envisaged.
To test this hypothesis, I used murine MHC class II-negative fibroblasts (L cells). They are
derived from an H-2k background and in addition to the class I molecules H-2Kk. H-2Dk and
H-2Lk, they express endogenous B7.1. These cells were co-transfected with the class II
molecule I-Ah and either human Jaggedl or murine Deltal and generously provided by K.
Wong (Dept. Biology, Imperial College). Human Jaggedl shares an overall amino acid
identity with murine Jaggedl of 96% (Shimizu et al., 1999) and is capable of activating
murine Notch receptors (K. Tan, unpublished data; Hoyne et al., 2000). Therefore, human
Jaggedl was used for the transfection of the L cells, since the murine counterpart was not yet
cloned at that time. I-Ab transfected L cells expressing Jaggedl or Deltal are referred to as
Jaggedl and Delta 1 L cells, respectively.
The advantage of using this artificial APC cell line is that they can be transfected with
individual components such as MHC class II molecules and Notch ligands. The transfected L
cells express MHC/peptide complexes and costimulatory molecule B7.1, which together
deliver "signal 1" and "signal 2" required for T cell activation. This creates conditions similar
to the previous in vitro activation of CD4 and CD8+ T lymphocytes by anti-CD3/anti-CD28,
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but additionally allows Notch activation in T cells by using the L cells co-transfected with
Notch ligands.
Here I have used the L cell transfectants in mixed lymphocyte reactions (MLRs). The
advantage of a MLR is the high frequency of alloreactive T cells; it has been estimated that 1 -
5% of all T cells are alloreactive, which is far higher than the frequency of T cells reactive
with a particular foreign antigenic peptide plus self-MHC molecule. An explanation for the
high frequency of alloreactive T cells is that a particular TCR is not only specific for a foreign
antigenic peptide plus self-MHC molecule but additionally can crossreact with certain
allogeneic MHC molecules (Obst et al., 1998; Smith et al., 1997). Since allogeneic cells
express on the order of 10" MHC class 1 molecules per cell, CD8 T cells bearing low-affinity
cross-reactive receptors might be able to bind by virtue of the high density of alloantigen.
Foreign antigen, on the other hand, is sparsely displayed on the membrane of an APC, limiting
responsiveness to only those T cells bearing high-affinity receptors. Therefore, transfected L
cells expressing high levels of MHC class I of the H-2k haplotype and the class 11 molecules I-
Ah should be capable of activating alloreactive CD4 and CD8 T lymphocyte derived from
another background such as, for example, H-2d.
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V.2 Phenotyping of I-Al)+ L cells co-transfected with
Jaggedl or Deltal
Phenotyping of the transfected L cells by flow cytometry.
A bicistronic transcription system consisting of an internal ribosome entry site (IRES) and
enhanced green fluorescent protein (EGFP) has been used to co-express the target gene
(Jaggedl or Deltal) together with the reporter gene EGFP (see chapter VI for more details
about EGFP; Cramcri et al., 1996; Rees el al., 1996). This allowed identification of the co-
transfected L cells by flow cytometry . After several rounds of sorting for EGFP expressing
cells, an over 95% pure population of EGFP L cells was obtained (Fig. V. 1A). Because the
gene for EGFP was set downstream of the gene of interest (Jaggedl or Deltal), Jaggedl or
Deltal have to be translated first in order to allow the translation of EGFP. Therefore, it was
possible to determine indirectly the expression of Deltal or Jaggedl by measuring the
expression of EGFP Jaggedl co-transfccted I-Ah L cells exhibited consistently a somewhat
higher level of transgene expression than the Delta 1+ co-transfected I-Ab L cells. Even though
EGFP expression in the co-transfccted cells seemed relatively low, it was an approximately
ten-fold increase compared to the I-Ab L cells.
The expression level of cell surface molecules involved in T cell activation was measured
using flow cytometry (Fig. V. 1B-D). Jaggedl and Deltal co-transfected cells expressed the
same amount of transfected MHC class II molecule I-Ab whereas the I-Ab L cells showed
slightly reduced I-Ab expression. The level of H-2Kk expression differed slightly between the
three cell types with the Deltal L cells expressing most and the Jaggedl L cells expressing
least. All three L cell types expressed same levels of B7.1.
The initiation of an immune response requires not only activation through the TCR and the
CD28 molecule on the T cells but also antigen-independent interactions between adhesion
molecules. For example ICAM-1 has been reported to function both as costimulator and as
adhesion molecule enhancing the avidity of interactions between T cells and APC (Damle et
al., 1992; Okazaki et al., 1994; Zuckerman et al., 1998). ICAM1 was not detected on the L
cells by flow cytometry (data not shown). However, it has been reported that ICAM1
expression by the APC is only essential in the case of low MHC class II expression and in the
absence of any other adhesion molecules (Altmann et al., 1989).
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Other costimulatorv molecules such as OX40L are predominantly found on professional
APCs and have not been described on fibroblasts (Lane, 2000). CD40 expression is more
promiscuous. Although its expression is mainly confined to subsets of leukocytes, endothelium
and some epithelial cell lines (reviewed in Grewal and Flavell, 1998), CD40 has also been
reported to be upregulated in fibroblasts upon IFNy exposure (Fries el al., 1995; Yellin el al.,
1995). However, CD40 expression on L cells has not been described yet.
H-2Kk PE B7.1 PE
Figure V.l. Phenotvping of the transfccted L cells by flow cytometry.
The L cells were detached using trypsin/EDTA.
IA ] EGFP expression was detected in unstained cells by the FL1 detector. Percentages of EGFP' cells
transfected with either Jagged 1 or Delta 1 are indicated in the within the histogram.
[B] Cells were stained for the transfected MHC class II molecule I-Ab.
[C] Cells were stained for the endogenous MHC class I molecule H-2Kk.
[DJ Cells were stained for the costimulatory molecule B7.1.
Isotype control for one of the transfected L cells is shown as a representative. It did not differ
between the three transfected L cell lines. Details of antibodies are given in table II.4 & II.5.
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Gene expression of Notch pathway components in transfected L cells measured by real¬
time PCR.
To phenotvpe the L cells for gene expression, total RNA was extracted and checked for
genomic DNA contamination as described in section II.2.15. Quality of RNA was ensured by
running a RNA gel (Fig. V.2A). Gene expression of Notch receptors and ligands were
analysed by RT-PCR (Fig. V.2B). As expected, only Jaggedl L cells expressed human
Jaggedl. Weak expression of endogenous Jaggedl in I-Ab and Delta 1 L cells was detected
with the primers for murine Jaggedl. In Jaggedl' L cells, the primers for murine Jaggedl
amplified both, endogenous and transgene transcripts for Jaggedl. This is due to the
crossreactivity of the primers with human Jaggedl. L cells also expressed low amount of
endogenous Delta 1. However, compared to the high expression in DeltaT L cells, the
endogenous Deltal expression in Jaggedl and 1-Ah L cells is negligible. Differences in other
components of the Notch pathway such as Notchl, 2 and 4, Jagged2 and Hesl were not
detected by RT-PCR which may be due to lack of sensitivity of this method. Therefore,
components of the Notch pathway were additionally analysed by real-time PCR (Fig. V.3).
Deltal transfected L cells showed an over 3000-fold increase in Deltal expression compared
to Jaggedl or I-Ab L cells. Comparing the increase of human Jaggedl in the Jaggedl * L cells
to the I-Ab L cells was not possible due to the complete lack of human Jaggedl expression in
1-Ab L cells. Therefore, human Jaggedl expression was normalised to the universal calibrator
described in method & material, section II.2.21. The Deltal+ and I-Ab L cells were negative
for Deltexl expression, again making normalisation impossible. Therefore, it only can be
stated that Deltexl is expressed in Jaggedl L cells, but not in Deltal or I-Ab L cells. The
expression of endogenous Jagged2 and Delta3 was slightly increased in Jagged 1 L cells,
whereas Notchl, Notch3 and Hesl did not exceed a 3-fold change in Jagged I or Deltal+ L
cells compared to I-Ab L cells. Therefore, the changes in their expression were not considered
significant (method & material, 11.2.21.4). Interestingly, Hes5 could not be detected in any of

















Figure V.2. Gene expression of Notch pathway components in transfcctcd L cells
Transfected L cells were detached with Trypsin/EDTA and total RNA was extracted.
[A] RNA was tested by running a RNA gel as described in materials & methods, section II.2.15.
[B] The RNA was reverse transcribed and amplified by RT-PCR. The PCR-amplified products were
run in a 2% agarose gel. p-Actin was used as a house keeping gene to normalise all the RNA
samples to the same amount of starting template and as a control for the PCR reaction itself. I-Ab =






























































Figure V.3. Gene expression of Notch pathway components in transfected L cells measured by
real-time PCR.
Transfected L cells were detached by trvpsin/EDTA treatment. Total RNA was extracted and tested
by running a RNA gel (Fig.V.2). RNA was reverse transcribed to cDNA and amplified by real-time
PCR. Levels of mRNA transcripts are shown relative to the levels of the internal calibrator, which
were I-Abf L cells for all genes with exception of human Jaggedl and Deltexl. *)The calibrator for
human Jaggedl and Deltexl was the corresponding universal calibrator (see materials & methods,
section II.2.21.) because these genes were not expressed in I-Ah' L cells. A change in expression of at
least 3-fold or greater was considered significant. 1-Ab = I-A1 L cells. D1 = DeltaV L cells. J1 =
JaggedF L cells.
Trypsin does not cause a decrease in cell surface expression of B7.1, MHC class I or II
molecules on the L cells.
L cells grow as an adherent monolayer. Trypsin in combination with the chelating agent
EDTA was used to detach them. One concern is that the protease trypsin may partly digest
cell surface proteins involved in T cell activation. To examine the effect of trypsin, the cells
were either treated with EDTA alone for 20 minutes or with trypsin/EDTA for 5 minutes.
Flow cytometry of B7.1, MHC class I and class II molecules showed that trypsin/EDTA did
not cause a decrease in expression of these cell surface molecules (Fig. V.4). In contrast,
EDTA produced a decreased expression of these molecules. It also was noted that EDTA-
treated cells contained more dead cells than trypsin/EDTA-treated cells, which may be due to
the prolonged treatment (20 vs. 5 minutes). Further, EDTA alone resulted in only partial






I \ \ $x
■
I-Ab PE H-2Kk PE
to2 to3 104
B7.1 PE
Figure V.4. Try psin docs not cause a decrease in cell surface expression of B7.1, MHC class I or
II molecules on the L cells.
Transfected L cells were detached using either trypsin/EDTA or EDTA alone. PE-staining for I-Ab
[A]. H-2Kk |B], B7.1 [C] (solid lines) or the corresponding isotvpe controls (dashed lines) is shown
for Delta 1+ L cells. Green lines represent the trypsin/EDTA-detached L cells, the red lines the
EDTA-detached L cells. Similar results were obtained for the other transfected cells (data not
shown). Details of antibodies are given in table II.4 & II. 5.
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V.3 I-Ab+ transfected L cells can induce a mixed
lymphocyte reaction (MLR)
Since L cells are dividing rapidly, their proliferation has to be inhibited in order to measure T
cell proliferation. Several methods exist to achieve this such as y-irradiation. chemical fixation
or DNA cross-linking reagents such as mitomycin C.
It is well known that higher doses of y-irradiation are required to block cell division in
transformed cell lines than in primary cells. However, Jagged 1 L cells required an over
twofold higher dose of y-irradiation than I-Ab L cells (data not shown). Therefore, irradiation
was considered unsuitable as a blockage of cell division in this system. It has been reported
that a 20-minute treatment with 1% paraformaldehyde inhibits the proliferation of L cells but
not their capability to activate T cells in a MLR (Lechler et al., 1985). Therefore, co-
transfected and I-Ab transfected L cells were fixed with 1% paraformaldehyde. L cell
proliferation was completely blocked after a 10-minute fixation. However, the fixed cells did
not induce activation of T cells (data not shown). The same was found for a 10-minute
fixation with 1% formaldehyde (data not shown). Following a method described by Altmann
and colleagues (Altmann et al., 1989), the cells were incubated with 1 OOpg/ml mitomycin C
for one hour. This treatment decreased proliferation substantially, but still allowed the L cells
to activate T cells. This may be due to improved exposure of MHC molecules and/or the
costimulatory molecule B7.1 on the surface of adherent L cells whereas complete inhibition of
proliferation (and the resulting loss of adherence) rendered the L cells incapable of activating
T cells.
CD4+ T cells recognise MHC class II molecules on I-Ah transfected L cells.
CD8 T cells derived from the H-2d haplotype should recognise MHC class I molecules of the
H-2k background, which are present on the L cells. Untransfected L cells, however, should not
activate alloreactive CD4 T cells due to their lack of class II molecules. The specificity of
alloreactive CD4 T cells for class II molecules was tested by comparing untransfected and I-
Ab transfected L cells as stimulators in a MLR.
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CD4f and CD8 T cells were purified by MACS from spleens of BALB/c mice (H-2 !
haplotvpe) and used as responder cells in a MLR with mitomycin C-treatcd untransfected or I-
Ab transfected L cells (Fig. V.5). Proliferation was measured on day 4. CD8 T cells
proliferated strongly in response to both types of L cells whereas CD4 T cells proliferated
only in response to I-Ab expressing cells. This shows that transfection of L cells with an
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Figure V.5. CD4+ T cells recognise MHC class II molecules on I-Ab transfected L cells.
A MLR was carried out with 5xl04/well mitomycin C-treated mitransfected or I-Ab transfected L
cells as stimulators and MACS-purified CD4 or CD8+ T cells from BALB/c (H-2d) spleens
(2xl07well). After 4 days, proliferation was measured by [3H]thymidine uptake during the last 18
hrs of culture and plotted as cpm x 10~3 ± standard deviation.
V.4 Jagged 1 downregulates secretion of IFNy by T cells
in a MLR
To investigate the effect of Jagged 1 and Delta 1 on the induction of an immune response.
Jagged 1 or Delta 1 co-transfected I-Ab L cells were used to activate allorcactive T cells in a
MLR.
161
Jaggedl but not Deltal expression in L cells downregulates release of IFNy by CD4+ T
cells in a MLR.
MACS-purified CD4 T cells from BALB/c spleens were used in a MLR with mitomycin en¬
treated Jaggedl+, DeltaT and I-Abt L cells. Proliferation was measured on day 4 (Fig. V.6A).
Jaggedl+, Delta 1+ and 1-Ab L cells induced similar levels of CD4 T cell proliferation.
Supernatants of the MLR cultures were tested for cytokine production after various time
points. There were no detectable levels of IL-4 or IL-10 produced at any time point (data not
shown). However, after 72 hours IFNy was detected in the three cultures containing the
different transfectants but at a lower level in the MLR induced by the Jaggedl L cells (Fig.
V.6B). Even though the amount of proliferation and IFNy secretion was variable between
different experiments, the decrease of IFNy secretion induced by Jaggedl L cells was
reproducible.
Figure V.6. Jaggedl but not Dcltal expression in L cells downregulates release of IFNy by CD4+
T cells in a MLR.
A MLR was carried out with varying numbers of mitomycin C-treated Jaggedl+, Deltal + or I-Ab+ L
cells as stimulators and MACS-purified CD4 T cells from BALB/c spleens (2xl07well).
|A] After 4 days, proliferation was measured by [3H]thymidine uptake during the last 18 hrs of
culture and plotted as cpm x 10"3 ± standard deviation. The background proliferation of the L cells
alone at their highest concentration did not exceed 4000 cpm (data not shown).
[B| After 72 hrs. the culture supernatants were harvested and tested for IFNy by ELISA. 1-Ab = MLR
with I-Ab L cells. Deltal = MLR with Dcltalf L cells, Jaggedl = MLR with JaggedL L cells.
Jaggedl expression in L cells downregulates release of IFNy by CD8+ T cells in a MLR.
To investigate whether the reduction of IFNy secretion by Jaggedl is CD4+ T cell-specific or a
general effect on T cells, the above mentioned experiment was repeated with CD8 T cells
purified by MACS from spleens of BALB/c mice (Fig. V.7). Secretion of IFNy was measured
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after 48 hours because CD81 T cells are known to produce a high amount. Differences in
proliferation and IFNy secretion between different experiments were frequently observed.
Therefore, two experiments are shown. In experiments #1 and #2, Jaggedl L cells had
variable effects on proliferation compared to the Delta 1 L cells but in both cases less IFNy
secretion was induced. The high variability between different experiments may be due to
incomplete inhibition of L cell proliferation. However, reduced IFNy secretion by CD8 T






















Figure V.7. Jaggedl expression in L cells downregulates release of IFNy by CD8+ T cells in a
MLR.
A MLR was carried out with varying numbers of mitomycin C-treated Jaggedl+, Deltal+ or L
cells as stimulators and MACS-purified CDS T cells from BALB/c spleens (2.\107wcll). Two
experiments are shown because of high variability between experiments.
[A] & [C], After 4 days, proliferation was measured by [3H]thymidine uptake during the last 18 hrs
of culture and plotted as cpm x 10"3 ± standard deviation. The background proliferation of the L cells
at their highest concentration did not exceed 8000 or 4000 cpm in experiment #1 and #2,
respectively.
IB] & [D], After 48 hrs. the culture supernatants were harvested and tested for IFNy by ELISA.
I-Ab = MLR with I-A1" L cells, Deltal = MLR with DeltaC L cells, Jaggcdl = MLR with Jaggcdl+ L
cells.
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Jaggedl but not Deltal expression in L cells downregulates release of IFNy by nylon
wool-enriched T cells in a MLR.
It is not entirely clear whether and to what extent purification by positive selection activates T
cells. Therefore, an alternative method of T cell enrichment was used. Splenocytes were
lympholyte-treated to deplete for dead cells and red blood cells and passed through a nylon
wool column resulting in an unfractionated population consisting of 59+5% CD4+ T cells and
20+5% CD8+ T cells (material and methods, section 11.3.6). Nylon wool-enriched T cells from
BALB/c spleens were used in a MLR with mitomycin C-treated Jaggedl+, Deltal+ or I-Ab L
cells and proliferation was measured on day 4 (Fig. V.8). Proliferation of T cells in response
to Jaggedl* or I-Ab+ L cells did not differ significantly whereas T cells in response to Deltal
L cells proliferated more strongly compared to I-Ah L cells. Again, the level of IFNy after 72
hours was greatly downregulated in the MLR with Jaggedl L cells. Small amounts of 1L-2
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Figure V.8. Jaggedl but not Deltal expression in L cells downregulates release of IFNy by
nylon wool-enriched T cells in a MLR.
A MLR was carried out with 2.5x10'' mitomycin C-trcated Jaggedl+, Deltal or I-Ab L cells as
stimulators and nylon wool-enriched T cells from BALB/c spleens (2xlOs/well).
[A] After 4 days, proliferation was measured by [3H]thymidine uptake during the last 18 hrs of
culture and plotted as cpm x 10~3 ± standard deviation.
[B] & [C] After 72 hrs. the culture supernatants were harvested and tested for IFNy [B] and IL-2 [C]
by ELISA.
I-Ab = MLR with I-Ab+ L cells. Deltal = MLR with Deltal+ L cells. Jaggedl = MLR with JaggedL L
cells.
Due to the high variability in the baseline of proliferation and IFNy production between
different experiments, a statistical assessment of the IFNy downregulation was required. Using
the GraphPad InStat programme (GraphPad Software Inc., www.graphpad.com). the paired t
test for 32 experiments led to following means, standard errors and two-tailed P values:
L cells Mean ± Standard Error
Proliferation: I-A1* L cells 37.7 ±3.8
(cpm x 10"3] Jaggedl* L cells 33.4+4.0
Deltal+ L cells 46.6 ±5.9
IFNy secretion: I-A1* L cells 1470 ± 530
[pg/ml] Jagged 1+ L cells 560 ± 300
Delta 1+ L cells 1300 ±580
Proliferation: Jaggedl vs. I-Ab P = 0.0577 Not significant
Deltal vs. I-Ab P = 0.0254 Significant
IFNy secretion: Jaggedl vs. I-Ab P = 0.0009 Very highly significant
Deltal vs. I-Ab P = 0.0506 Not significant
hi summary these results show that the Notch ligand Jaggedl expressed on I-A L cells did
not influence the proliferation of T cells whereas Deltal expressed on I-Ah L cells slightly
increased T cell proliferation. However, Deltal did not have an effect on IFNy secretion, in
contrast to Jaggedl, which downregulated IFNy secretion in T cells.
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V.5 Decreased IFNy secretion induced by Jaggedl+ L
cells is not due to a soluble factor produced by the L
cells
Downregulation of IFNy is not due to a soluble factor produced by the Jaggedl L cells.
One possibility, which may account for the decreased amount of IFNy induced by Jagged F L
cells, was the production of a soluble factor by the L cells. To investigate this possibility, L
cell-conditioned media (LCCM) was titrated into the MLR.
L cell-conditioned media was obtained by growing L cells in complete RPMI for 48 hours
before harvesting the media. Since the effect of Jaggedl on IFNy induction was also observed
in T cells enriched by nylon wool-purification, the following experiments were carried out
with this population.
Nylon wool-enriched BALB/c T cells were stimulated with mitomycin C-treated I-Ab+ L cells
in the presence of different concentrations of L cell-conditioned media (Fig. V.9). MLRs with
Jaggedl and Delta 1 L cells were included as controls. No differences in proliferation or
IFNy secretion was observed by adding conditioned medium from either Jagged 1+, Delta 1 or
1-Ah L cells to the MLR. However, proliferation and especially IFNy secretion decreased with
increasing amount of conditioned medium from all three of L cell transfectants. This was
probably caused by depletion of nutrients in the conditioned medium.
Thus I have excluded the possibility that a soluble factor secreted by the L cells is causing the
reduced IFNy production by T cells stimulated with Jagged 1+ L cells.
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Figure V.9. Down regulation of IFNy is not due to a soluble factor produced by the Jagged 1 L
cells.
L cell-conditioned medium from Jagged 1 , Deltal+ or L cells (Jagged 1, Deltal and I-Al>
LCCM. respectively) was titrated into a MLR with nylon-purified T cells (2xl05/well) and
mitomycin C-treated I-A1" L cells (2.5xl04/well) ([A] and fC]). As a control, a MLR with Jaggedl ",
Deltal+ and I-Abf L cells was performed in parallel (Jaggedl+, Deltal+ and I-Ah L cells,
respectively) ([B] and [D]).
| A] & [B], After 4 days, proliferation was measured by [3H|thymidine uptake during the last 18 hrs
of culture and plotted as cpm x 10"3 + standard deviation.
[C] & |D], After 72 hrs. the culture supernatant of the titration experiment and of the control
experiment were harvested and tested for IFNy by ELISA.
V.6 L cells co-transfected with Jaggedl or Deltal induce
Notch signalling in T cells
The readout for Notch signalling on protein level is very difficult because antibodies cannot
detect the activated intracellular portion of endogenous Notch. The most reliable measurement
for Notch signalling at present is to evaluate transcription activation of downstream targets
such as the Hes genes. It has been shown that Deltal activates transcription of Hesl through
Notch signalling (Jarriault et al., 1995; Jarriault et al., 1998). Hes5 was reduced in Notchl
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mutants and almost completely eliminated in CBF1 mutants, indicating that Hes5 is highly
responsive to Notch signalling (dc la Pompa et al., 1997). Hesl and Deltexl are upregulated
in transgenic thymocytes, which express constitutively active Notch 1 and in T cell hybridomas
retrovirally transfected with constitutively active Notch 1 (Deftos et al, 1998; Deftos et al,
2000). Chang et al. also reported an increase in Hesl transcripts in thymocytes TCRa-
negative mice expressing constitutively active Notch 1 (Chang et al, 2000). Furthermore,
monolayers of Jagged 1-expressing HeLa cells induced transcription of Hesl in cocultured
Jurkat cells (Bash et al., 1999). Therefore, upregulation of Hes transcripts was considered as
a valid readout for Notch activation. Additionally, Deltexl transcript may also be increased
upon Notch activation even though direct evidence for this pathway is still missing.
Activating T cells in a MLR with Jaggedl+, Deltal or I-A1'" L cells leads to increase of
11,-2 transcripts and differential regulation of Notch signalling genes.
A MLR was carried out with nylon wool-enriched T cells from BALB/c spleens as responders
and mitomycin C-treated L cells as stimulators. After 24, 48 or 72 hours, dead cells and cell
debris were removed by lympholyte treatment and the cells prepared for FACS sorting by
double staining with FITC-conjugated anti-CD4 and PE-conjugated anti-CD8 antibodies.
Total RNA was extracted from the sorted CD4 and CD8 T cell populations and prepared for
real-time PCR analysis (Fig. V. 10A). The sample for CD8 T cells activated by Jaggedlf L
cells at 72 hrs was lost during RNA isolation. Expression of each gene is given relative to
gene expression of the control CD4 T cells at 24 hours (Fig. V. 10B). Gene expression in
CD8 T cells are also shown relative to control CD4 T cells in order to compare relative
amounts of transcript level between CD4 and CD8+ T cells.
Hesl expression was strongly upregulated at 48 hours in CD4+ T cells and to a lesser extent
in CD8 T cells isolated from the MLR stimulated with Jaggedl L cells. CD4+ T cells sorted
from the MLR with Deltal L cells showed also an increase in Hesl transcripts. On the other
hand, there were no differences in Hes5 or Deltexl transcripts. There was very little difference
in expression of the Notch ligands or Notch receptors. IL-2 was induced in all activated CD4+
T cells and to a much lesser extent in CD8 T cells at 24 hours. IFNy was only very minimally
induced in CD4 T cells. CD8 T cells sorted from the MLR with Deltal+ or I-Abt L cells
produced a substantial amount of IFNy whereas expression of IFNy in CD8 T cells in
response to Jaggedl L cells was reduced compared to the other two. IL-10 was not induced
confirming data obtained by ELISA. IL-4 may have been induced in CD4 T cells by Delta 1
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L cells at 24 hours. Expression of IL-4 was not measured in CDS T cells because IL-4
transcripts were not detected in previous experiments.
In conclusion, there is strong evidence of Notch signalling in CD4 T cells in response to
Jaggedl and DeltaT L cells and in CD8+ T cells in response to Jaggedl L cells because the
Hesl expression is increased 40- to 90-fold. IL-2 expression is induced to similar levels in
response to all three types of L cell transfectants. IFNy transcripts were only reduced by
twofold in CD8 T cells in response to Jagged 1 L cells compared with CD8 T cells in
response to I-Ab or Deltal+ L cells. This reduction did not exceed 50% and was even less in
another experiment (data not shown).














Figure V.10 A. Activating T cells in a MLR with Jaggedl+, Deltal+ or I-Ab+ L cells leads to
increase of IL-2 transcripts and differential regulation of Notch signalling genes.
A MLR was carried out with mitomycin C-treated Jaggedl+. Deltal+ or I-Ab+ L cells as stimulators
and nylon wool-enriched T cells from BALB/c spleens. Control T cells were incubated in medium.
[A| After 24. 48 or 72 hrs. cells were lympholyte-treated. double stained with FITC-CD4 and PE-
CD8 and FACS sorted excluding dead cells and L cells by 7-AAD uptake. Dot plots #1-3 show
forward scatter (FSC) and side scatter (SSC) analysis of ungated cells. Region R1 gated for
lymphocytes. Dot plots #4-6 show ungated cells with R2 indicating viable cells. Cells falling into
lymphogate R1 are represented by red dots. Dot plot #7 shows Rl- and R2-gated cells (blue dots).
Region R3 and R4 gated for CD4+ and CD8+ T cells, respectively. Dot plots #8 and #9 show CD4
and CD8+ T cells, respectively, sorted by gating for lymphocytes (Rl), viability (R2) and expression
of CD4 or CD8 (R3 or R4, respectively). All cells are shown to include possible impurities. Sorted
CD4+ or CD8 T cells were over 98% pure. Details of antibodies are given in table II.4 & II.5.
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[B] Sorted CD4+ and CD8+ T cells were processed for total RNA extraction and RNA was tested by
RT-PCR as described in materials & methods, section 11.2.16. RNA was reverse transcribed to cDNA
and amplified by real-time PCR as described in materials & methods, section II.2.21. Levels of
mRNA transcripts are shown relative to the levels of the internal calibrator, which were control
CD4 T cells taken at 24 hrs. A change in expression of at least 3-fold or greater was considered
significant. Ctr = Control T cells incubated in medium. I-Ab = MLR with I-Ab+ L cells. J1 = MLR
with Jagged 1+ L cells. D1 = MLR with Delta 1+ L cells.
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V.7 Phenotyping of T cells activated in MLR with
Jaggedl+ and Deltal+ L cells by flow cytometry
The interaction of B7.1 with CTLA-4 downregulates responses to alloantigens in CD28-
deficient mice and in the absence of CD28, the interaction of B7.1 but not B7.2 with CTLA-4
inhibits IFNy production in vitro (Yamada et al., 2001). Therefore, it is important to
determine whether or not CTLA-4 is expressed on the cell surface of alloreactive T cells.
Only 7% of the T cells will be activated by alloantigens (Leiva et al., 1997). To investigate
the phenotype of the alloreactive T cells it is necessary to distinguish activated and resting T
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cells. It is known that T cells upregulatc selective cell surface molecules upon activation such
as the IL-2 receptor (IL-2R) a chain, CD25. The IL-2R is a trimeric receptor consisting of the
IL-2-specific a and p chains and the common y chain (Minami and Taniguchi. 1995). It
occurs in three forms that exhibit different affinities for IL-2: the low-affinity monomeric IL-
2Ra, the intermediate-affinity dimeric IL-2RPy, and the high-affinity trimeric IL-2Rapy.
Signal transduction by the IL-2R requires both the p and y chains, but only the trimeric
receptor containing the a chain as well binds IL-2 with high affinity. Because the a chain is
expressed by activated but not resting T cells, it can be used to identify activated cells by flow
cytometry.
Table V. 1 summarises the average expression of CD25, the early activation marker CD69,
CTLA-4 and the mean fluorescence of TCRp for CD4 and CD8 T cells freshly isolated (ex
vivo) from spleens. The values obtained for expression of CD25, CD69 and CTLA-4 broadly
agree with published data (Craston el al., 1997; Krummel and Allison, 1995; Sakaguchi el
al, 1995; Walunas eta/., 1994).
Table V.l. Phenotyping of ex vivo CD4+ and CD8+ T cells by flow cytometry .
CD4+ T cells CD8+ T cells
% CD25+ 6.6 ±2.8 2.1 ± 1.2
% CD69+ 20.4 + 8.8 14.3+2.8
% CTLA-4+ < 1.0 N/D
TCRP* 760 + 230 330 + 60
N/D: not determined
* Data represent geometrical mean fluorescence
Phenotyping of CD4+ T cells activated in MLR with Jaggedl+, Deltal+ or I-A1^ L cells by
flow cytometry.
Nylon wool-enriched T cells were stimulated with mitomycin C-treated L cells for 2 days
before phenotyping by flow cytometry (Fig. V.l 1). Freshly isolated cells (control T cells, day
0) and cells incubated for two days in medium (control T cells, day 2) were also analysed by
flow cytometry to check for changes of phenotype due to culturing.
To distinguish alloreactive from resting T lymphocytes, cells were gated for CD4 staining and
additionally stained for CD25 and the other molecules of interest. The quadrant grid to
separate PE-positive and -negative cells had to be set at an angle due to incomplete
compensation of the FITC-stained CD25 molecule. Over 99% of the CD4-gated cells
expressed TCRP, thus highly autofluorescent, EGFP L cells were excluded by this gating
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setting. Expression of the TCR, as measured by the mean fluorescence of TCRp, increased on
CD4r T cells cocultured with Jagged I' and with Deltal+ L cells. However, this increase was
non-specific as it was seen in CD25-positive and -negative CD4+ T cells and could not be
reproduced. Following coculture with the different L cells, the number of activated CD4 T
cells increased approximately 2-3 fold. CD4 T cells activated by Jagged 1 L cells, I-Ah L
cells or Deltal L cells increased from 3.8% to 13.3, 15.3 and 17.1%, respectively. These
changes were reproduced. Over 50% of the CD25-positive population of CD4 T cells
activated in the MLR expressed the early activation marker CD69. CTLA-4 was not detected
on the cell surface of activated CD4 T cells. Number of CD25 and CD69 CD4 T cells
decreased during the 2-day culture (control T cells, day 0 vs. day 2), which may be due to cell
death or downregulation of the molecules. There was an increase of CTLA-4 expression on
the control T cells incubated in medium for 2 days. Partly this may be due to non-specific
staining which increases on dying cells.
These data show that the CD4 T cells activated by any of the three L cell transfectants did
not differ in expression of the activation marker CD25, CD69 nor did they downregulate the
TCR or upregulate CTLA-4. A limitation to this assay was, however, that CD4 T cells
activated during the MLR could not be distinguished from effector CD4+ T cells previously
activated in vivo or from the population of regulatory CD4 T cells which constitutively
express CD25 (Sakaguchi et al., 1995).
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Figure V.ll. Phenotyping of CD4 T cells activated in MLR with Jaggedl+, Deltal+ or I-Ab+ L
cells by flow cytometry.
A MLR was carried out with mitomycin C-treated Jagged 1+, Deltal+ or I-Ab' L cells as stimulators
and T cells which were enriched from BALB/c spleens by nylon wool purification. After 2 days, cells
were triple stained for CD4 and CD25 and expression of CD69. TCRp or CTLA-4 and analysed by
flow cytometry. Control T cells were stained at day 0 or incubated in medium for 2 days.
[A] Forward scatter (FSC) and side scatter (SSC) analysis of control T cells at day 0 and day 2 and a
representative MLR at day 2 are shown. Region R1 gated for live lymphocytes.
IB) FL3 (Cy) and side scatter (SSC) analysis of Rl-gated cells of the T cell control at day 0 and a
representative MLR at day 2 stained for CD4 or isotvpc control. Region R2 was used to gate for
CD4+ T cells.
[CI Dot plot analysis with PE-conjugatcd antibodies (FL2) and FITC-conjugated anti-CD25 or
isotype control (FL1) of gated CD4 T cells of the MLRs (Jaggcdl+, Delia 11 and I-A1"). Quadrant
grid was set using isotype staining.
Numbers within dot plots represent percentage of PE-stained cells of the CD25+ population and
(percentage of PE-stained cells of the CD25 population). §) Numbers represent percentage of FITC-
staincd cells. *) Numbers represent the geometrical mean fluorescence of TCRp staining of the cell
population in the corresponding quadrant.
Details of antibodies are given in table II.4 & II.5.
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Phenotyping of proliferating T cells activated in MLR with Jaggedl+, Delta 1+ or I-Alvf L
cells by flow cytometry.
To circumvent this limitation, CFSE (carboxyfluoresccin diacetate succinimidyl ester)
labelling was used to track the proliferating population of alloreactive T cells (materials &
methods. 11.3.7).
Nylon wool-enriched T cells were labelled with CFSE and used in a MLR with mitomycin C-
treated L cells. After 4 days, cells were treated with lympholvte to remove dead cells and cell
debris which can interfere with the flow cytometry analysis, resulting in increased background
staining (Fig. V.11C, CTLA-4 staining of T cell control at day 2). Freshly isolated T cells
were used as a control (control T cells, day 0). They were not CFSE-labelled because the cells
would have been too bright to compensate for flow cytometry within the first 24 hours
(materials & methods, II.3.7; Hasbold et al., 1999). To ensure that the settings did not include
highly autofluorescent, EGFP+ L cells, the CD4- and the CD8-gated cells were stained for
TCRp expression (>99% in all samples) (Fig. V.12C & D). Quantitative comparison of cell
division is difficult because dead cells have been removed altering the proportion of
proliferating to resting cells. Further, a computer-based fitting programme would be required
to calculate the cell number per division (Flasbold et al., 1999). Therefore, percentages of
stained vs. unstained cells were given separately for proliferating cells (CFSElow) and for
resting cells (CFSEhlgh). The quadrant grid for separation of proliferating and resting cells was
set using CFSE-labelled cells incubated in medium for four days (data not shown).
Culturing CD4 T cells seemed to induce a slight upregulation of the TCR comparing the
mean fluorescence between freshly isolated CD4 T cells (control T cells, day 0) and the
resting population in the MLRs (CFSEhlsh). Activation caused a small decrease of the TCR.
However, Jagged 1 L cells did not induce downregulation of the TCR in CD4 T cells. Over
90% of the proliferating CD4" T cells (CFSElow) expressed CD25 and 70-80% CD69 (Fig.
V. 12C). 9-12% of the resting population (CFSEhlgh) showed CD25 expression whereas only
1% of the CD4 T cells ex vivo expressed CD25 (control T cells, day 0) Percentage of CD69
expressing cells did not alter between ex vivo CD4 T cells and resting CD4 T cells from the
MLRs (14-17%). All CD4 T cells, however, were negative for staining of cell surface
CTLA-4
Proliferating CD8 T cells from the culture with Delta 1 L cells expressed slightly more CD25
than CD8 T cells from cultures with Jaggedl' or I-Ab L cells (Fig. V. 12D). 10-12% of the
175
resting CD8 T cells (CFSEh,gh) expressed CD25 whereas only 1% of the ex vivo CD8 T cells
(control T cells, day 0) were CD25-positive. Over 90% of the proliferating CD8 T cells
expressed CD69. Percentage of CD69 CD8 T cells did not change between the ex vivo CD8
T cells and the resting CD8 T cells (CFSEhlsh) from the MLR with Jaggedl or I-Ab L cells.
A slightly higher percentage of the resting CD8 T cells from the MLR with Delta 1 L cells
expressed CD69. No changes of mean fluorescence of TCRp were observed in any of the
CD8 T cell populations.
Concluding lfom these data, proliferating cells had an activated phenotype (CD25+ and
CD69+), but did not express CTLA-4 excluding its involvement in the observed decrease of
IFNy secretion induced by Jagged 1. The TCR was not downregulatcd in CD4 or CD8 T
cells in response to Jagged 1 L cells excluding this as a explanation for decreased IFNy
secretion. Similar results were obtained at an earlier time point (day 3, data not shown).
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Figure V.12. Phenotvping of proliferating T cells activated in MLR with Jaggcdl+, Deltal+ or I-
Ab+ L cells by flow cytometry.
A MLR was carried out with mitomycin C-treated Jaggedl+, Deltal+ or I-Ab" L cells as stimulators
and CFSE-labelled T cells which were enriched from BALB/c spleens by nylon wool purification.
Control L cells were incubated in medium (L cell control). After 4 days, cells were stained for CD4
or CDS and expression of TCRfL CTLA-4 and costimulatory molecules CD25 and CD69 and
analysed by flow cytometry. CFSE-unlabelled control T cells were stained at day 0.
[A] Forward scatter (FSC) and side scatter (SSC) analysis with lymphocyte gate R1 of control T
cells, a representative MLR and pooled JaggedL, Deltal+ and 1-Ab+ control L cells are shown.
[B] FL3 (Cy-Chrome) and side scatter (SSC) analysis of R1-gated cells of a representative MLR
stained with anti-CD4, anti-CD8 or isotype control. Region R2 was used to gate for CD4 or CD8+ T
cells.
[CJ & [D], Dot plot analysis with PE-conjugated antibodies (FL2) and CFSE (FL1) of gated CD4 or
CD8" T cells ([C| and [D], respectively) of the MLRs (Jagged 1DeltaL and 1-Ab+), Quadrant grid
was set using isotype staining. Numbers within the dot plots represent percentage of PE-stained cells
of the proliferating population (CFSElow) and (of the resting population (CFSEhl8h)). *) Numbers
represent the geometrical mean fluorescence of TCR|3 staining of the cell population in the
corresponding quadrant.
Details of antibodies are given in table II.4 & II.5.
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V.8 Notch ligands expressed on L cells do not affect cell
death of T cells during a MLR
Notch receptors and ligands have been shown to play a controversial role in cell survival.
Notch 1 provides protection to T cell lines from TCR-mediated apoptosis (Jehn el al., 1999)
whereas constitutively active Notch 1 induces cell cycle arrest and apoptosis in B cells
(Morimura et al., 2000). Delta 1 and Jagged2 promote proliferation and decrease apoptosis of
haematopoietic progenitors (Han et al., 2000; Tsai et al., 2000). On the other hand, an
immobilised truncated form of Delta-1 induces apoptosis in monocytes in the presence M-
CSF, but not GM-CSF (Ohishi et al., 2000). In conclusion. Notch signalling can induce or
inhibit apoptosis depending on the cell type, the presence of cytokines and the experimental
system used. In my system. I have investigated induction of T cell apoptosis upon activation
by Jagged 1 expressing L cells as a potential mechanism to explain the decrease in IFNy.
Downregulation of IFNy produced by T cells in MLR with Jaggedl+ L cells is not due to
increased cell death.
T cells were cultured with L cells as described above. After 5 days, the CD4- or CD8-gated
cells were stained with Annexin V and 7-AAD (Fig. V. 13). Anncxin V detects early and late
apoptotic and necrotic cells whereas 7-AAD only stains late apoptotic and necrotic cells
(Vermes et al., 1995). Therefore, cells showing Annexin V and 7-AAD staining were referred
to as dead cells since distinction between apoptosis and necrosis is not possible. There were
only marginal differences in the numbers of dead CD4 T cells between the different MLRs In
CD8 T cells Deltal seemed to induce whereas Jagged 1 inhibited cell death compared to CD8
T cells from the MLR with I-Ab L cells. Again, one has to bear in mind that a distinction
between activated and resting T cells could not be made. Therefore, it is unclear whether
differences in cell death of alloreactive T cells were masked by cell death of resting T cells.
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Figure V.13. Downregulation of IFNy produced by T cells in MLR with Jaggedl+ L cells is not
due to increased cell death.
A MLR was carried out with mitomycin C-treated JaggedE. Delta 1+ or I-Ab+ L cells as stimulators
and nylon wool-enriched T cells from BALB/c spleens. After 5 days, cells were stained for CD4 or
CD8. Annexin V and the viability dye 7-AAD was added prior to flow cytometry analysis as
described in section II.3.9. As a positive control for Annexin V and 7-AAD staining, cells pooled
from the MLR with Jaggedl\ Delta 1' and I-Ab+ L cells were incubated at 95°C for 2 inins (dead cell
control).
[ A| Forward scatter (FSC) and side scatter (SSC) analysis of the MLRs with Jaggedl". Delta 1 and I-
Abt L cells (Jagged 1+, Delta 1' and I-Ab', respectively) are shown.
|B] FL2 (PE) and side scatter (SSC) analysis of cells of a representative MLR stained for CD4. CD8
or isotype control. Region R1 was used to gate for CD4+ or CD8+ T cells.
|C| Dot plot analysis with FITC-conjugated Annexin V (FL1) and 7-AAD (FL3) of gated CD4 or
CD8T T cells (red dots) of the MLRs (JaggedL, Delta E and I-Ab') and of ungated dead cell control
(|D|).
Numbers in the cross within dot plots represent percentages within the corresponding quadrant.
Details of antibodies are given in table II.4 & II.5.
Downregulation of IFNy produced by T cells in MLR with Jaggedl+ L cells is not due to
increased cell death of proliferating T cells.
To distinguish proliferating and resting cells, T cells were CFSE-labelled prior to adding to
the L cells. After 5 days, cells were stained for Annexin V and CD4 or CD8 and analysed by
flow cytometry (Fig. V. 14). Percentages of Annexin V-positive cells were given for resting
and proliferating cells and additionally for the entire population since no cells were removed
by lymipholvte treatment in contrast to the previous experiment with CFSE (Fig. V. 12).
In the MLR with I-Ab L cells a slightly smaller number of proliferating CD4 T cells were
Annexin V-positive compared to the MLRs with Jaggedl and Delta 1' L cells. There was no
difference in Annexin V-positive CDS* T cells between the MLR with Jaggedl or I-Ab L
cells. CD8 T cells cultured with Deltal L cells were less Annexin V-positive.
Small differences in T cell death seemed to exist between the different MLRs. Deltal
protected proliferating CD8 T cells from apoptosis, whereas both, Jaggedl and Deltal
slightly promoted apoptosis of alloreactive CD4 T cells. The same applied to the entire CD4
or CD8 T cell population and therefore, differed from the results obtained in the previous
experiment (Fig. V.13). In conclusion, the observed differences in cell death were small, not
consistent and hence regarded as insignificant. Additionally, trypan blue exclusion assays did
not give reproducible differences (data not shown).
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Figure V.14. Downregulation of IFNy produced by T cells in MLR with Jaggedl+ L cells is not
due to increased cell death of proliferating T cells.
A MLR was carried out with mitomycin C-treated Jagged 1+, Deltal4 or I-Abr L cells as stimulators
and CFSE-labelled T cells which were enriched from BALB/c spleens by nylon wool purification.
Control T cells were incubated in medium. After 5 days, cells were stained for CD4 or CD8 and
Annexin V and analysed by flow cytometry as described in section II.3.9. CD4 or CD8 T cells were
gated as seen previously.
[A] & [B|. Dot plot analysis with or without PE-conjugated Annexin V (FL2, +/- AnnV) and CFSE
(FL1) of gated CD4" or CD8^ T cells ([A] and [B], respectively) of the MLRs (JaggedL, Deltal+ and
I-A^).
[C] Dot plot analysis w ith Annexin V (+ AnnV) and CFSE of gated control CD4 and CD8 T cells.
Quadrant grid was set using control T cells for FL1 and MLR without Annexin V staining for FL2.
Numbers within the left and the right upper quadrant represent percentage of Annexin V' cells of the
proliferating population (CFSElow) and the resting population (CFSEh,gh). respectively. Numbers in
parenthesis represent percentage of Annexin V' cells of the entire population.
Details of antibodies are given in table II.4 & II. 5.
V.9 Jagged 1 does not decrease numbers of IFNy secreting
T cells activated in a MLR
Similar numbers of IFNy producing T cells are present in MLRs with Jaggedl+, Deltal+
and I-Ab+ L cells.
Supernatant of MLRs with Jagged 1+ L cells contained less IFNy than those of MLRs with
Deltal or I-Ab L cells. It is of interest to see whether this was also reflected at the level of
intracellular IFNy. MLRs were carried out with nylon wool-enriched T cells. After 4 days, the
cells were activated with PMA and ionomycin for 4 hours with monensin-containing
GolgiStop added to the final three hours. Adding PMA/ionomycin to the cultures caused a
decrease of the cell surface expression of CD4 but not CD8 in activated (MLR) and non-
activated cells (T cell control) (Fig. V.15B). A decrease in CD4 expression following
incubation with PMA alone or in conjunction with ionomycin has been reported previously
(Pelchen-Matthews et al., 1993). However, there was still a good separation between CD4+
and CD4 cells because the CD4 antibody used was conjugated to Cy-Chrome, which is a
bright fluorochrome.
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Numbers of IFNy-containing cells were low and did not change in PMA/ionomycin-activatcd
CD4 T cells present in the different MLRs (Fig. V. 15C). Interestingly, resting CD4 T cells
(control T cells) had the same number of IFNy-producing cells after PMA/ionomycin
activation. CD8 T cells had higher amount of IFNy-containing cells, but again there were no
changes between the different cultures (Fig. V. 15D). A small percentage of the resting CD8
T cells (control T cells) also produced intracellular IFNy after PMA/ionomycin activation.
In conclusion, numbers of IFNy producing CD4 or CD8 T cells did not alter in the presence
of the Notch ligands. CD4 T lymphocytes activated by the L cell transfectants did not contain
a higher percentage of IFNy-producing cells compared to the control CD4 T cells. This may
be explained by the presence of effector CD4 T cells previously activated in vivo, which
could rapidly produce IFNy upon PMA/ionomycin activation.
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Figure V.15. Similar numbers of IFNy producing T cells are present in MLRs with Jaggedl+,
Deltal+ and I-Ab+ L cells.
A MLR was carried out with mitomycin C-treated Jagged 1+, Delta 1+ or I-A1' L cells as stimulators
and nylon wool-enriched T cells from BALB/c spleens. Control T cells and control L cells were
incubated in medium. After 4 days, cells were stimulated with PMA and ionomycin (+PMA) or
further kept in media (-PMA) for 4 hrs with GolgiStop added for the final 3 hrs as described in
materials & methods, section II.3.8.2. Lympholyte-treated cells were stained for CD4 or CD8 before
fixation, permeabilisation and staining for intracellular cytokines.
[A] Forward scatter (FSC) and side scatter (SSC) analysis with lymphocyte gate R1 of a
representative MLR, pooled JaggedL, Deltal+ and I-Ab+ L cells incubated in medium (L cell control)
and T cells incubated in medium (T cell control) are shown.
[B] FL3 (Cy-Chrome) and side scatter (SSC) analysis of R1-gated cells stained with anti-CD4, anti-
CD8 or isotype control. Region R2 was used to gate for CD8+ T cells and for non-stimulated CD4+ T
cells and region R3 for PMA/ionomycin-stimulated CD4+ T cells.
[C| Histograms showing PMA/ionomvcin-stimulated cells (+PMA) gated for lymphocyte scatter (Rl)
and CD4 expression (R3) and non-stimulated cells (-PMA) gated for lymphocyte scatter (Rl) and
CD4 expression (R2).
|D| Histograms showing PMA/ionomycin-sliinulated and non-stimulated cells (+PMA and -PMA.
respectively) gated for lymphocyte scatter (Rl) and CD8 expression (R2).
Shaded histogram: Isotype control, thick red line: IFNy. Numbers within the histograms represent
percentages within the marker bounds. Markers were set using isotype control stainings.
Details of antibodies are given in table II.4 & II.5.
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Numbers of proliferating T cells producing IFNy is not downregulated in MLR with
Jagged 1+ L cells.
To distinguish in vivo activated or memory T cells from T lymphocytes stimulated in the
MLRs, cells were CFSE-labelled prior to activating them with L cells. After 5 days, cells were
PMA/ionomycin-activated and analysed as described above (Fig. V.15). Percentages of IFNy-
positive cells of the entire CD4+ population were similar as seen in the previous experiment
(Fig. V. 16A). Numbers of the alloreactive CD4 T cells (CFSElow) containing intracellular
IFNy did not differ between the MLRs with the different L cell lines. Percentages of IFNy-
producing CD8 T cells were slightly higher in response to Jagged 1+ and I-A L cells than in
response to Deltal L cells after PMA/ionomycin activation (Fig. V.16B). Interestingly, some
alloreactive CD8 T cells produced IFNy even in the absence of additional activation (-PMA).
Double the number of IFNy+ CD8 T cells were found in the culture with Jagged 1 L cells
compared to the culture with I-Ab L cells. This observation was consistently seen.
Intracellular IL-4 was not detected in proliferating CD4+ T cells (data not shown).
These data show that the number of T cells producing intracellular IFNy was not decreased in
response to Jagged 1 expressing L cells. If anything, percentage of IFNy+ CD8 T cells
activated by Jagged 1 L cells seemed to be higher in the absence of PMA/ionomycin.
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Figure V.16. Numbers of proliferating T cells producing IFNy is not downregulatcd in MLR
with Jaggedl+ L cells.
A MLR was carried out with mitomycin C-treated Jagged 1+, Deltal+ or I-Ab+ L cells as stimulators
and nylon wool-enriched T cells front BALB/c spleens. Control T cells were incubated in medium.
After 4 days, cells were stimulated with PMA and ionomycin (+PMA) or further kept in media (—
PMA) for 4 hrs with GolgiStop added for the final 3 hrs as described in materials & methods, section
11.3.8.2. Lympholvte-treated cells were stained for CD4 or CDS before fixation, permeabilisation and
staining for intracellular cytokines. The gates for lymphocyte scatter and CD4/CD8 expression were
set as previously shown (Fig. V.15).
[A] Dot plots showing PMA/ionomycin-stimulated cells (+PMA) gated for lymphocyte scatter (Rl)
and CD4 expression (R3. pink dots) and non-stimulated cells (-PMA) gated for lymphocyte scatter
(Rl) and CD4 expression (R2. blue dots).
[B] Dot plots showing PMA/ionomycin-stimulated and non-stimulated cells (+PMA and -PMA.
respectively) gated for lymphocyte scatter (Rl) and CD8 expression (R2. blue dots). Quadrant grid
was set using control T cells for FL1 and PE isotvpe control staining for FL2.
Numbers within the dot plots represent percentage of IFNy* cells of the proliferating population
(CFSElow) and (percentage of IFNy4 cells of Ihe resting population (CFSEhlRh)).
Details of antibodies are given in table II.4 & II.5.
V.10 Discussion
I and other investigators have shown that Notch receptors, ligands and downstream
components are present in T lymphocytes and APCs (chapter 111 & IV; Hoyne et ah, 2000;
Ng et al., 2001) and their expression is dependent on the activation or maturation state of the
T cells and APCs, respectively. Further, overexpression of Jagged 1 on APCs downregulates
an immune response in vivo (Hoyne et ah, 2000). It is, therefore, of interest to investigate
whether the Notch ligands expressed on APCs influence the induction of an immune response
in vitro. Murine fibroblasts co-transfected with I-Ab and either human Jagged 1 or murine
Deltal were used as APCs in MLRs. This study demonstrates that Jaggedl and Deltal can
differentially signal Notch expressed on T lymphocytes and that Jaggedl expressed by the L
cell transfectants downregulates secretion but not production of IFNy by the T cells. These
results support the idea that Notch signalling plays an important role in modelling an immune
response.
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Detection of components of the Notch pathway in the cells of the immune system at the
protein level is difficult due to lack of specific antibodies. In a transfection system, however,
detection of transcripts of the transfected molecules is not sufficient to assure protein
expression, as there is no guarantee that translation will occur. Neither does it allow selection
of the transfected cells. Therefore, the pIRES2-EGFP vector (Clontech Laboratories) was
used to co-transfect the I-Ab+ L cells with human Jagged 1 or murine Delta 1. The gene of
interest (Jagged 1 or Delta 1) was placed upstream of the internal ribosome entry site (IRES)
and the reporter gene EGFP (Crameri el al., 1996). Both genes were transcribed as a single
bicistronic mRNA (Rces et al., 1996). EGFP, situated downstream of Jaggedl or Deltal, was
translated by re-entry of ribosomes at the IRES. Thus, EGFP-positive cells were expected to
express Jaggedl or Deltal as well. This allowed identification of Jaggedl or Dcltal
expressing cells as an EGFP-positive cell population by flow cytometry . A highly purified
population of L cells expressing EGFP was obtained by FACS sorting (Fig. V.1A).
Expression of the gene of interest (human Jaggedl or murine Deltal) was confirmed by RT-
PCR and real-time PCR analysis (Fig. V.2 & V.3). Even though I-Ab L cells expressed low
levels of endogenous Jaggedl and Deltal, mRNA levels of the transfected molecules increased
greatly. In the case of Delta 1 L cells the increase was over 3000-fold. Jagged2 and Delta3
were slightly upregulated in Jaggedl expressing L cells. This did not seem to be an artefact of
real-time PCR because the upregulation was reproducible even after culturing the L cells for
several weeks in their appropriate selection medium. Expression of Notch receptors 1 and 3
did not differ between the different L cell lines. Several studies have revealed that Notch
ligands are able to activate the Notch pathway in an autocrine fashion (Doherty et al., 1996;
Wong et al., 2000). Since Notch receptors were present in L cells, expression of downstream
elements of the Notch pathway were also analysed. Expression of Hesl did not alter betw een
the different L cell lines. There was no detectable expression of Hes5 in L cells. Deltexl was
expressed only upon co-transfection of I-A L cells with Jaggedl. It is known that Notch 1
activation can lead to upregulation of Deltexl transcript (Deftos et al., 1998; Deftos et al.,
2000). Thus overexpression of Jaggedl in the L cells may activate Notch signalling and lead
to induction of Deltexl transcription.
There is conflicting data concerning which molecules are capable of providing costimulation
for primary proliferative T cell responses. In part the confusion is the result of drawing
conclusions from different in vitro systems and from the use of different rcsponder T cell
populations. Cross-linking the TCR in the presence of anti-CD28 antibodies induces a high
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proliferative responsive and cytokine production (Fig. III.2 & III.4; Baroja et al., 1989). In
MLRs. B7.1 has been shown to provide sufficient costimulation to activate alloreactive T cells
(Galvin et al., 1992). These responses arc inhibited by blocking B7 interactions (Freeman et
al., 1993). In some cases, accessory molecules appear to be sufficient to induce T cell
responses in MLRs (Wakkach et al., 2001). However, their requirement is not absolute but
may augment the T cell response (Damle et al., 1992; Hargreaves et al., 1995).
All three lines of transfected L cells expressed high levels of the MHC class II molecule I-Ab
and moderate levels of the MHC class I molecule H-2Kk and the costimulatory molecule B7.1.
Even though ICAM-1 was not expressed (data not shown), the L cells were capable to activate
T cells in a MLR confirming data by Altmann and colleagues that high levels of MHC
molecules can compensate for the lack of ICAM-1 (Altmann et al., 1989). In summary ,
phenotvping of the L cells at the RNA and protein levels did not reveal any differences
between the three different L cell lines with exception of induced Deltexl expression in
Jagged 1' L cells.
As expected, I-Ab L cells induced an alloresponse in both CD4 and CD8 T cells isolated
from mice expressing the H-2d haplotype, whereas untransfected L cells activated CD8 but
not CD4 T cells of the H-2d haplotype (Fig. V.5). The increased proliferation of CD8+ T cells
observed with the I-Ab L cells compared to untransfected L cells may be due to the higher
background proliferation of the L cells. Another explanation is the existence of additional
peptide determinants derived from the transfected I-Ab molecule: Many self-peptidcs presented
by class II molecules originate from class II molecules (Fedoseyeva et al., 1996; Murphy et
al., 1992; Rudensky and Janeway, 1993) and are recognised by alloreactive T cells (de Koster
et al., 1989; de Kostcr et al., 1992; Weber et al., 1995). Further it has been reported that
certain peptides can be presented by both class I and class II molecules (Hickling et al.,
1990). It is also known that soluble proteins can be transported into the cytosol, processed by
the proteosome and subsequently presented by class I molecules (Albert et al., 1998b;
Androlewicz, 2001). Additionally, it has been reported that CTL can recognise determinants
from I-Ab molecules (de Waal et al., 1981). It is, therefore, possible that peptides of the
transfected I-Ab molecule can be presented in context with class I and thereby increasing
allogenicity of the I-Ab L cells to CD8+ T cells compared to the untransfected L cells.
Variation in levels of proliferation within and between experiments was observed most
probably due to the incomplete inhibition of L cell proliferation and this influenced cytokine
secretion. However, complete inhibition of L cell growth obtained with different methods, such
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as fixation or overnight incubation of the L cells hi mitomycin C, rendered the L cells
incapable to activate T cells in a MLR (data not shown). Even though the amount of
proliferation and IFNy production varied, the trend of less IFNy secreted by T cells in
response to Jagged 1 L cells was consistent and confirmed by statistical analysis.
Interestingly, purified CD4+ T cells in response to I-Ab or Delta 1 L cells produced IFNy at
levels of up to 600pg/ml (Fig. V.6B). Again from comparing the results of different
experiments, marked variation in levels of IFNy secreted was observed. However, this did not
correlate with the magnitude of proliferation. The response of CD8 T cells in MLRs was
similar (Fig. V.7, Experiment #1 vs. Experiment #2). There are several explanations that may
account for these findings. In general, naive CD4 T cells are believed to produce high levels
of IFNy after their differentiation into TH1 cells (Murphy et al., 2000). Differentiation into
either TH1 or TH2 usually requires restimulation of the CD4 T cells. However, in this study,
CD4 T cells were activated in a primary MLR It is, therefore, possible that positive selection
of CD4' T cells by MACS purification induced an additional signal, which added to the
stimulation by the L cells. In a few cases, MACS purification was sufficient to induce
moderate proliferation of CD4+ T cells and high IFNy production (data not shown). The
protein ty rosine kinase Lck of the Src family is non-covalently associated with the CD4
molecule (Fig. 1.4, section 1.3). Upon TCR activation Lck rapidly phosphorylates ITAM
motifs of the CD3 cluster, w hich permits TCR association w ith the Syk family kinase ZAP-70
(Chan et al., 1992; Straus and Weiss, 1992). These events are crucial for the triggering of the
signalling cascades that stimulate nuclear transcription factors that regulate the production of
several cytokines. Cross-linking of CD4 by MACS beads may, therefore, facilitate cytokine
induction. Additionally, the CD4 molecule has been proposed to act as an IL-16 receptor
because it is an absolute requirement for signalling and functional responses to IL-16
(Cruikshank et al., 1987; Cruikshank et al, 1994). IL-16 increases expression of IL-2Ra
(CD25) and IL-2Rp on CD4 T cells and in concert with IL-2 increases proliferation and
production of IFNy (Parada et al., 1998). Cross-linking of the CD4 molecule may. therefore,
induce activation events similar to IL-16 signalling.
Even though IFNy was detected in the supernatant of CD4 T cells cocultured with L cells,
transcripts for IFNy were only marginally increased (Fig. V. 10). However, a different method
of T cell purification was used for this experiment: instead of positively selecting CD4+ T cells
by MACS, the T cells were enriched by nylon wool purification. After their activation in the
MLR. CD4 and CD8 T cells were collected by FACS sorting. Thus, the CD4 molecules
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were never cross-linked by MACS beads, which may explain the low induction of IFNy.
Additionally, FACS sorting yielded cell populations of high purity (>99%) in contrast to
MACS isolation (95±2% for CD4+ T cells). A few contaminating CD8 T cells in the MACS-
purified CD4+ T cell prep could increase the IFNy content in the supernatant of the MLR
CD4 T cells, known to produce a higher level of IL-2 than CD8 T cells, would provide IL-2
as a costimulation signal for the CD8" T cells.
Naive CD8+ T cells do not necessarily require costimulation for proliferation or effector
function (Wang et al., 2000). Activation through TCR engagement without any costimulation
induced effector function (proliferation and cytotoxicity) in CD8 T cells within 48 hours. It
also has been reported that CD8+ T cells are able to lyse L cells in a MLR (Reiss et al.,
1983). Thus. CTL-mediated killing of L cells could also influence activation of CD4~ T cells
at a later stage.
IFNy production in a MLR is dependent on IL-2 release because secretion of IFNy was almost
completely inhibited after anti-IL-2 treatment (Danzer et al., 1994). IL-2 was detected after
72 hours in the supernatant of MLRs with L cells and nylon wool enriched T cells (Fig.
V.8C). Levels of IL-2 in the supernatant correlated in general with the amount of
proliferation.
IL-2 transcription was induced at similar level in CD4 T cells activated in the MLR with
Jagged 1 . Deltal and I-Ab L cells as shown bv real-time PCR (Fig V.10). Since it has been
reported that already small amounts of IL-2 seemed to be sufficient to for maximal IFNy
release in a MLR (Danzer et al., 1994), I concluded that lack of IL-2 production was not
responsible for the decreased IFNy secretion in response to Jaggedl+ L cells.
In chapter III it has been shown that addition of IL-10 to anti-CD3/CD28-activated CD4+ T
cells reduced the levels of transcripts and protein for both IL-2 and IFNy on protein and RNA
level. It is, therefore, possible that IL-10 produced by T cells in response to Jaggedl+ L cells is
acting autocrinally causing a decrease in IFNy production. Some investigators have failed to
detect IL-10 in MLRs (Danzer et al., 1994) whereas others have reported its presence
(Toungouz et al., 1996). Toungouz and colleagues found that the mismatch of one MFIC class
II molecule induced the maximal amount of IL-10 secretion. The transfected I-Ab molecule on
MHC class Il-negative L cells represents such a single mismatch to CD4+ T cells from a H-2d
background. However, IL-10 was not detected by ELISA at any time point of the MLR. This
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may be due to detection limits of the assay. Blocking antibodies to the IL-10 receptor did not
increase the production of IFNy in response to any of the L cells (data not shown). The
absence of IL-10 may also reflect that L cells expressing class II are not the same as
conventional APCs; for instance they do not express ICAM-1. Real-time analysis of CD4 T
cells activated by the L cells revealed a small increase of IL-10 compared to non-activated
CD4 T cells, but no differences were found in response to stimulation with the different L cell
transfectants (Fig. V.10). Therefore, it was concluded that IL-10 was not responsible for the
downregulation of IFNy secretion by T cells in response to Jagged 1 L cells.
While interactions between CD28 and members of the B7 family costimulate and enhance T
cell responses, recent evidence indicates that the CD28 homologue CTLA-4 plays a role in
downregulating responses. CTLA-4 can compete for CD28/B7 interactions and thus deliver
negative signals resulting in T cell anergy (Thompson and Allison, 1997). Naive T cells were
rendered hyporesponsive to specific allogeneic antigen after coculturing with MHC-
nnsmatched stimulators in the presence of CTLA-4-Ig (Lee et al., 2001), a soluble fusion
protein of human CTLA-4 and the Fc region of IgG 1 capable of blocking T cell activation in
vitro (Lenschow et al., 1992). These antigen-specific hyporesponsive T cells were
subsequently able to actively inhibit the allogeneic responses of naive syngeneic T cells in a
cell-to-cell contact-dependent manner (Lee et al., 2001). B7.1 has been identified as the
dominant ligand for CTLA-4-mediated downregulation of alloimmune responses in vivo
(Yamada et al., 2001). CTLA-4 is stored mainly in intracellular compartments (Linsley et al.,
1996). Induction of the secretion of CTLA-4 may consequently downregulate the immune
response. Therefore, CTLA-4 upregulation after coculturing the T cells with Jagged 1 or
Delta 1 expressing L cells was investigated. However, CTLA-4 was not detected on the cell
surface of activated CD25 CD4 T cells (Fig. V. 11C) nor on proliferating CFSElow CD4+ T
cells (Fig. V.12C). This is in contrast to the results of Walunas et al. who reported that
expression of CTLA-4 was upregulated 2 to 3 days following T cell activation (Walunas et
al., 1994). Furthermore regulatory CD4CD25 T cells were found to express CTLA-4
constitutively (Read et al., 2000; Takahashi et al., 2000). However, Read et al. were using
permeabilised CD4 T cells and therefore, detected intracellular^ stored CTLA-4.
Additionally, it was proposed that CTLA-4 affect a secondary rather than a primary immune
response (Chambers et al., 1996). In conclusion, CTLA-4 activation was not considered to be
responsible for the downregulation of IFNy in T cells activated by Jaggedl+ L cells.
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Apoptosis of activated T cells is an important method of downregulating potentially-
destructive T cells responses (Van Parijs and Abbas, 1996). Mechanisms by which this occurs
include Fas-induced cell death and apoptosis induced by a lack of appropriate cytokines
(Russell. 1995). TCR-dependent apoptosis in T cell lines requires the expression of members
of the Nur77 orphan nuclear hormone receptor family (Liu et al., 1994; Woronicz el al.,
1994). It has been shown that Notch 1 interacts physically with Nur77 and that Notch 1
protects T cell lines from Nur77-dependent T cell death (Jehn el al., 1999). On the other hand,
a constitutively active form of Notch 1 induced cell cycle arrest accompanied by apoptosis in a
B cell line (Morimura el al., 2000). Here, I have shown that Jaggedl and Deltal expressed on
L cells could activate Notch signalling in T cells during the MLR as both ligands induced
transcription of Hesl (Fig. V.10). It was, therefore, of interest to examine if Notch signalling
has any influence on T cell survival since this may explain the observed downregulation of
IFNy in the MLR with Jaggedl+ L cells. O'Flahertv and colleagues reported that T cells were
resistant to apoptosis for the first 5 days after activation in a MLR even though they rapidly
acquired expression of Fas (O Flaherty et al., 2000). The maximal apoptotic response was
observed after 7 days. In this study, apoptosis was measured at day 5 in order to forestall the
maximal rate of cell death in a MLR. Jaggedl expressing L cells did not induce increased
apoptosis in CD4 or CD8+ T cells compared to I-Ab L cells (Fig. V. 13 & V. 14).
Interestingly, Annexin V binding increased progressively as CD4 T cells were dividing (Fig.
V.14A), which is consistent with data showing that apoptotic cells were generated after each
cell division in cultured cell lines (Usherwood et al., 1999). Since no reproducible differences
in T cell death were observed between the MLRs stimulated with the different transfected L
cell lines, it was concluded that neither Deltal nor Jaggedl signalling influenced T cell
survival.
Both Jaggedl and Deltal induced upregulation of Hesl in CD4 T cells, but only Jaggedl
downregulated secretion of IFNy. The different outcome of Notch signalling can be explained
in several ways. Deltal induced Hesl transcription in CD4' but not CD8' T cells.
Furthermore, the Delta 1-mediated upregulation of Hesl was over twofold less compared to
Jagged 1. It has been shown that relatively minor changes in the dosage of Notch signalling
induced phenotypic effects during invertebrate development (Artavanis-Tsakonas et al.,
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1995). Different levels of Hesl induction may, therefore, be responsible for the distinct result
of Jagged 1- and Delta 1-mediated Notch signalling. Alternatively, modulators of Notch
signalling such as Fringe may alter the outcome of Notch activation (Hicks et al., 2000; Panin
etal., 1997).
There was an apparent discrepancy between downregulation of secreted IFNy and levels of
transcripts, which were only minimally decreased in T cells responding to Jagged 1 L cells as
compared to I-Ab L cells. Therefore, 1 concluded that Notch signalling is not solely acting on
IFNy transcription. Regulation of protein expression can occur at several stages: The most
obvious is transcription, which was not the case in this study. Post-transcriptional regulation
is quite common in cytokine expression (Lindsten et al., 1989; Waldmann and Tagaya, 1999).
CD28 signalling stabilises IL-2 mRNA post-transcriptionally (Umlauf et al., 1995). If the
reason for the downregulation of secreted IFNy lies in post-transcriptional regulation, it should
also been seen in the amount of intracellular residing IFNy.
Based on an adaptation of the fixation and permeabilisation method described by Pala and
colleagues (Pala et al., 2000), intracellular residing IFNy and IL-4 was measured by flow
cytometry. An advantage of this method is that it allows analysis of IFNy-producing cells on a
single cell basis in contrast to real-time PCR or ELISA, which measure IFNy production of an
entire cell population. Interestingly, the downregulation of IFNy measured by ELISA was not
detected by intracellular cytokine staining of the entire CD4 or CD8 T cell population (Fig.
V.15). Control CD4+ T cells incubated in medium showed a similar frequency of IFNy-
containing cells than CD4+ T cells activated in the MLR. This is most probably due to effector
CD4 T cells, which were previously activated in vivo. Upon PMA/ionomycin stimulation
they were capable of producing IFNy. Intracellular IL-4 was not detected consistent with
results obtained by ELISA.
To exclude non-specific effector T cells, I made use of CFSE, a fluorescent dye, which allows
the tracking of dividing cells by flow cytometry (described in materials & methods. II.3.7).
Resting cells did not loose fluorescence. Therefore, they can be identified as the tight cell
population with the highest fluorescence in the FL1 channel (Fig. V. 14C). In the MLR
culture, the resting cells corresponded to the peak with highest level of fluorescence
(CFSEhlsh). Dividing cells show an almost exact two-fold decrease in fluorescence from peak
to peak (Lyons and Parish, 1994). In the MLR with L cells, proliferating T cells showed a
loss of fluorescence but not in clear two-fold steps. This is due to the heterogeneous
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population of allorcactive T cells displaying a TCR repertoire with various specificities and
affinities (Obst et al., 1998). It is also possible that some of the alloreactive T cells were
antigen-experienced: It has been suggested that a particular TCR is not only specific for
certain allogeneic MHC molecules but additionally can crossreact with a foreign antigenic
peptide plus self-MHC molecule (Obst et al., 1998; Srcdni and Schwartz. 1981). Antigen-
experienced T cells are known to display effector function such as proliferation much more
rapidly than naive T cells (Garcia et al., 1999; Veiga-Fernandes et al., 2000). Activation of a
mixture of antigen-experienced and naive T cells labelled with CFSE would result in a
smeared pattern rather than a multi-peak profile of proliferating T cells. It also has to be noted
that many groups using CFSE to track cell division used either TCR-transgenic T cells (de St
Groth et al., 1999; Dubois et al., 1998) or polyclonal stimuli such as anti-CD3/CD28 or LPS
(Gett and Hodgkin, 1998; Lyons and Parish, 1994).
By gating on proliferating (CFSElow) T cells, the frequency IFNy-producing cells within the
alloantigen-specific population can be measured. Again, there was no decrease in the
frequency of IFNy-producing alloreactive CD4+ or CD8+ T cells in response to Jaggedl L
cells (Fig. V.16). Levels of intracellular IFNy expressed as the mean fluorescence did not
differ neither between the alloreactive CD4 or CD8 T cells stimulated in the different MLRs
(data not shown). The standard protocol for measuring intracellular cytokines requires a four-
hour stimulation with PMA/ionomycin. PMA directly activates protein kinase C (PKC) and
together with the calcium ionophore ionomycin induces transcription factors NF-AT, API and
NF-kB. which are required for IL-2 gene transcription (section 1.3; Kuo and Leiden, 1999).
It cannot be excluded that activation with PMA/ionomycin might have negated signals of the
Notch pathways. However, other groups found Notch-mediated inhibition of NF-AT/AP1
promoter activity in Jurkat T cells stimulated with anti-TCR or PMA/ionomycin (Izon et al.,
2001). Additionally, there is accumulating evidence that the activated form of Notch interacts
physically with NF-kB, which is downstream of PKC. Activated Notch 1 inhibits NF-kB-
dependent transcription in a similar fashion as IkB (Guan et al., 1996; Wang et al., 2001).
Further it has been reported that Notch signalling is capable to inhibit the expression of
certain cytokines: The human Notch intracellular domain inhibits IL-8 expression in a human
crythroleukemic cell line (Lam et al., 2000) and CBF1 inhibits IL-6 expression by competing
for NF-kB site on the IL-6 promoter (Palmieri et al., 1999). Notch may also influence events
via Deltexl, which has been shown to inhibit Ras signalling (Ordentlich et al., 1998).
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In conclusion. Jagged 1 and Delta 1 expressing L cells induced Notch signalling leading to
increased expression of Hesl in T cells. T cells activated in a MLR with Jagged 1" L cells
produced similar levels of intracellular IFNy compared to T cells in response to Delta 1+ and I-
Ab L cells. However, IFNy was significantly reduced in the supernatant of MLRs with
JaggedL L cells. The reduction of secreted IFNy was not due to inhibition of transcription nor
translation of IFNy because the level of intracellular IFNy was not reduced.
There are several ways to explain this observation: Jagged 1-induced Notch signalling may
inhibit secretion of IFNy. This inhibition would need to be specific for the secretion of IFNy,
since it was not observed for IL-2. Cytokine secretion and division number is independent of
time for IL-2, IL-3, IL-4 and IL-10: For example, CD4 T cells having divided six times
produced the same amount of IL-4 on day 4 as on day 5 measured by either ELISA or
intracellular cytokine staining (Gett and Hodgkin, 1998). However, time appeared to have an
effect on levels of IFNy in supernatants but not when measured by the intracellular staining
method: CD4 T cells having divided six times secreted a higher level of IFNy on day 4 than
on day 5. Nonetheless, the level of intracellular IFNy of CD4 T cells after 6 divisions did not
differ between day 4 or day 5. The authors suggested an additional level of control for IFNy
secretion involving unknown factors inhibitory to IFNy release. Thanhauser et al. also
suggested a post-transcriptional regulation of IFNy release: They found that the
phosphodiesterase inhibitor pentoxify lline blocked secretion but not transcription of IFNy and
IL-2 in phytohaemagglutinm (PHA)-activated peripheral blood mononuclear cells (PBMCs)
(Thanhauser et al., 1993).
The secretory lysosomes found in haemopoietic cells provide a very efficient mechanism for
delivering the effector proteins of many immune cells in response to antigen recognition.
Although haematopoietic cells differ from conventional secretory cells (e.g. neuroendocrine),
they express proteins important for the tight regulation of secretion (Stinchcombe and
Griffiths, 2001). The best evidence that unique components in haematopoietic cells are
involved in secretory lysosome exocytosis has come from the autosomal recessive disease
Chediak-Higashi syndrome (Ward et al., 2000). The beige mouse model of this disease lacks
T- and NK-cell activity. The defect is neither an absence of T and NK cells, nor their ability
to produce lytic proteins, but rather their inability to secrete their lytic granules (Baetz et al.,
1995). Another example of regulated secretion process in T lymphocyte is the upregulation of
CTLA-4 from storage compartments upon T cell activation (Linsley et al., 1996).
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In conclusion, T lymphocytes are capable of regulating secretion and therefore, Notch may
interfere with this regulation by an unknown mechanism. Interestingly, it has been proposed
that Notch can regulate the actin cytoskcleton (Lowell and Watt, 2001; Zccchini el al1999),
which plays an essential role in forming the 'immunological synapsis' and the polarisation of
the secretory apparatus of the T cells towards contact site (Acuto and Cantrell, 2000). To
investigate whether Notch activation can inhibit secretion of IFNy, intracellular IFNy could be
measured in the absence of secretion inhibitors such as Brefeldin A or monensin. An increase
in intracellular IFNy should occur in PMA/ionomycin-activated and non-activated T cells
cocultured with Jagged 1 expressing L cells.
Another possibility to explain the downregulation of IFNy in the supernatant of MLRs with
Jagged 1 L cells would involve an increased uptake of IFNy by the T cells resulting in reduced
extracellular IFNy. The IFNy receptor is a heterodimer consisting of an a and a p chain
(reviewed in Bach et al., 1997). The a chain is thought to be expressed constitutively, whereas
P chain expression can be regulated either positively (e.g. by PMA/ionomycin activation of T
cells) or negatively (by IFNy exposure) in a stimulus-specific manner. Further experiments to
address these issues may involve analysis of expression of the IFNy receptor. Notch-induced
upregulation or inhibition of the downregulation of IFNyRp may account for the decreased
level of extracellular IFNy due to more efficient IFNy uptake.
A third, less likely explanation is the effect of IFNy on the L cells. IFNy induces formation of
a specific transcription factor, which appears to co-ordinately upregulate transcription of the
genes encoding the class I a-chain, p2-microglobulin, subunits for the proteasome (LMP) and
the transporter (TAP) (Androlewicz, 2001). This facilitates and increases antigen presentation
by class I molecules and therefore, represents an amplification loop for activation of T cells by
Delta 1 and I-Ab L cells but not by Jagged 1 L cells due to decreased IFNy in the culture
supernatant. Against this explanation stands the fact that at the time of IFNy release by the T
cells, most of the L cells have already died due to the mitomycin C treatment.
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VI Transgenic mice with inducible dendritic cell-
specific overexpression of murine Deltal or
human Jaggedl
VI.l Introduction
The generation of transgenic mice induced to overexpress either murine Deltal or human
Jaggedl specifically in DCs would provide an useful tool with which to investigate the role of
Deltal and Jaggedl in DC maturation in vivo and consequently in their regulation of an
immune response.
Targeting of transgenes to specific cells or tissues uses selected promoters to drive the
expression of the gene(s) of interest. This approach has provided insights into the biological
effector functions and interactions of a large number of proteins. However, transgenesis is not
without limitations. Potential problems may occur because the promoters that are used often
initiate gene expression in utero and drive gene expression in a largely constitutive fashion
thereafter. This confounds phenotypic interpretation by superimposing growth and/or
development-related abnormalities. This is a major disadvantage if the gene of interest plays
an important role during development, as it is the case for the Notch ligands. In an attempt to
resolve this problem, transgenic systems have been developed in which gene expression can be
externally regulated. Early attempts focused on a variety of approaches including the use of
steroid-inducible and metallothionine-based promoter systems (Mader and White, 1993;
Palmiter et al, 1982). The disadvantage of these systems in animal models is that they have
eukaryotic promoters and induction results in upregulation of endogenous genes with such
promoters as well as the transgene. More recent approaches have used tef-regulatory systems
based on wild-type and mutated tetracycline transactivator fusion proteins (Gosscn and
Bujard, 1992). Studies have demonstrated that tet-based systems can be externally regulated
after direct injection into cardiac tissue (Fishman et al., 1994), transfection into mesangial
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ceils that arc subsequently injected into visceral organs (Kitamura, 1996), and microinjection
using standard transgenic technology (Kistner et al., 1996). The "reverse tetracycline (Tc)-
controlled transactivator" (rtTA) system where doxycyclin (dox), a tetracycline homologuc,
acts as an inducer of transcription (Fig. VI. 1) can be operated in a quantitative and highly
specific way in mice. The kinetics of induction are rapid and it employs a highly regulated and
specific prokaryotic promoter system suitable for use in animals (Kistner et al., 1996). The
Pbn promoter contains the Tc-responsive element (TRE), which consists of seven copies of the
Tc operator sequence (tetO) The TRE element is between two identical minimal
cytomegalovirus (CMV) promoters (PminCMv), which lack the enhancer portion that is part of
the complete CMV promoter. Consequently, Pbi-i is silent in the absence of binding to rtTA to
the tetO sequences. PmmCMv-i controls the expression of the gene of interest, whereas PmmCMv-2
controls the expression of a reporter gene.
To ensure a DC-specific overexpression of the gene of interest, the rtTA can be put under the
control of a DC-specific promoter. For this study, the mouse CD1 lc promoter was chosen
(Brocker et al., 1997) because the expression of CD 11c p2 integrin, as detected by the
monoclonal antibody N418 (Metlay et al., 1990), was restricted to mouse DCs in spleen and
other tissues such as thymus and lymph nodes (Agger et al., 1990; Brocker, Riedinger and
Kaijalainen, 1997; Metlay et al., 1990), and therefore represents the best promoter available
for murine DC expression. In the bidirectional transcription system (Fig. VI. 1) a gene of
interest can be indirectly monitored via a reporter gene (Baron et al., 1995). This is especially
important if no antibodies exist against the gene of interest, as it is the case for most of the
Notch pathway components.
Green fluorescent protein (GFP) is a genetic reporter system derived from the bioluminescent
jellyfish Aequorea victoria which, when expressed in either eukaryotic or prokaryotic cells
and illuminated by blue or UV light, yields a bright green fluorescence (Chalfie et al., 1994;
Prasher, 1995). Therefore GFP currently represents a superior alternative to other cell lineage
markers in a broad range of applications because it is non-invasive and can hence be viewed in
real time in vitro or in situ in the developing embryo or adult. However, problems encountered
with the weak fluorescence and instability of the protein at higher temperatures have generally
precluded its use in vertebrate systems. Recently, mutagenesis of the wild-type (wt) gene has
yielded several mutant forms, which exhibit greater thermostability and increased fluorescence
(Cormack et al., 1996; Heim and Tsien, 1996) overcoming the limitations outlined above
(Hadjantonakis et al., 1998; Kato et al., 1999; Okabe et al., 1997). Fluorescence of the
enhanced green fluorescent protein (EGFP) is 35-fold stronger than that of wtGFP and the
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brightest known GFP variant (Cormack et al., 1996), and it has been codon-optimised for
optimal expression in mammalian cells.
I consequently chose the /^/-regulatory system combined with the DC-specific CD lie
promoter and EGFP reporter with which to develop transgenic murine models. Three mouse
lines were designed: the CD1 lc-rtTA line containing the rtTA under the CD11c promoter, the
EGFP-Deltal and the EGFP-Jaggedl lines containing the gene of interest under the Pb,-i
promoter. By crossing the CD1 lc-rtTA line with either of the EGFP lines, a transgenic mouse
would be generated with the capacity to overexpress EGFP and Deltal or Jagged 1 in DCs
following dox feeding.
Integrated copy of linearised pCDl Ic-rtTA regulator plasmid
rlTA
1 P

















Integrated copy of linearised pEGFP-Deltal/Jaggedl response plasmid
Figure VI.1. Schematic outline of the fc/-regulated bidirectional transcription system.
Four amino acid exchanges in the repressor of the TnlO Tc-resistance operon of Escherichia coli
convey a reverse phenotype to the repressor (r/e/R). The fusion protein (rtTA) composed of rtetR and
a C-terminal portion of protein 16 of herpes simplex virus requires dox for binding to the Tc-
responsive element (TRE). TRE consists of seven copies of the Tc-operator sequence (tetO) and is
between two identical minimal human cytomegalovirus (CMV) promoters (Pm,nCMv). which form
together the bidirectional promoter Ph-i. PminCMv lacks the enhancer that is part of the complete CMV
promoter. Consequently, Pb,-i is silent in the absence of binding of rtTA to the TRE. PmmCMv-i
controls the expression of the gene of interest (Deltal or Jagged 1), and PmmCMv-2 controls the
expression of the enhanced green fluorescent protein (EGFP).
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VI.2 Generation of constructs for regulated DC-specific
overexpression of Delta! and Jagged!
VI.2.1 Generation of the pCDl lc-rtTA vector
One line of mice was generated to express the rtTA under the control of the CD1 lc promoter,
which limits expression to DCs (Fig. VI. 1). A schematic outline of the cloning procedure is
shown in figure VI.2. The rabbit P-Globin cDNA expression cassette provided the transgene
w ith an intron and a polvadenylation signal (Kouskoff et al., 1993). It has been demonstrated
that efficient expression of a transgene requires splicing and polyadenylation of the transcribed
product (te Riele et al., 1992; Wurst and Joyner, 1993). Thus when a high level of expression
is desired an intron downstream of the transcription start site, as well as a polyadenylation
signal at its 3' end should be included. Here the P-Globin polyadenylation signal was replaced
by the SV40 polyadenylation signal included in the rtTA DNA fragment.
The pBS-CDl lc vector (Brocker et al., 1997) and the pTet-On (Clontech Laboratories) were
digested with Clal or I'vuU, respectively and the ends were blunted. After a second digest of
both constructs with EcoRl, a 8.9kb fragment of the pBS-CDllc vector containing the
CD1 lc promoter and a 1.6kb fragment consisting of the rtTA and the SV40 polyadenylation
signal, were isolated by gel extraction. The pBS-CDllc fragment was dephosphorylated to
prevent religation. The rtTA fragment was cloned into the pBS-CDllc fragment producing
the pCDllc-rtTA vector. Transformation was done in E. coli XLl-Blue MRF" competent
cells (Stratagene). Six colonies were picked and plasmid DNA was isolated.
Clones were tested by restriction digest with Xbal and Apal (Fig. VI.3). Expected lengths of
resulting fragments are listed in table VI. 1. Xbal digestion of plasmids with cloned rtTA
fragment resulted in two fragments since both the opened pBI-CDl lc and the rtTA contained
a single Xbal restriction site (Fig. VI.3A). All six clones exhibited a 5.9 and a 4.6kb fragment
confirming the correct orientation of the insert. Numbers of expected fragments with Apal
digest was not known since it was designated as a non-unique site on the restriction map of
pBI-CDl lc by T. Brocker (unpublished data). Apal digest of the original pBI-CDl lc vector
(Ctrl) resulted in three fragments suggesting a third Apal restriction site at unknown location.
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Consequently the fragments had a length of 8.9-X, X and 0.6kb. All six clones digested with
Apal displayed the expected fragments confirming successful insertion of rtTA (Fig. VI.3B).
In conclusion. 100% of the picked colonies had inserted the rtTA fragment in the correct
orientation. The DNA sample of clone #6 was sent to DNASHEF Technologies for
sequencing at the 5' and 3" cloning junctions for further confirmation.
rtTA + SV40 poly A
1.6 kb
Figure VI.2. Schematic outline for the generation of the pCDllc-rtTA vector.
The rtTA fragment containing the SV40 polyadenvlation signal (rtTA + SV40 poly A) was generated
by digesting the pTet-On plasmid (Clontech Laboratories) with EcoR\ and PvuW (blunt). It was
subsequently cloned into the EcoRl-Clal (blunt) opened pBS-CDl lc vector (Brocker et al., 1997).
The rabbit (i-Globin cDNA expression cassette containing an intron and a polyadenylation signal
(Globin) was partly replaced by the rtTA fragment. Restriction sites used for linearisation of the end
product are indicated by scissors.
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Tabic VI. 1. Expected fragments after restriction digest of pCDl lc-rtTA with Xbal and Apal.
Restriction
en/,vme
Insert in the right
orientation









8.9 kb 9.5 kb
Apal
8.9 kb - X kb
1.6 kb
X kb
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Figure VI.3. Restriction digest of pCDl lc-rtTA vector.
Six different pCDl lc-rtTA clones (#1-6) and the original pBS-CDl 1c vector as a control (Ctrl) were
digested with Xbal (A) and Apal (B) as described in materials & methods, section II.2.1. The
digested products were run in a 0.8% agarose gel. M = lkb DNA ladder
VI.2.2 Generation of the pEGFP-Jaggedl and pEGFP-Deltal
constructs
It was planned to generate two lines of mice expressing either murine Delta 1 (Bettenhausen et
al., 1995) or human Jagged 1 (Li el al, 1998; Oda el al., 1997) together with EGFP under the
control of the Pbi-i (Fig. VI. 1). Murine Jagged 1 had not been completely sequenced or cloned
at that time. Instead, the human homologue was used, which shows an overall amino acid
identity with murine Jagged 1 of 96% (Shimizu et al., 1999) and is able to bind to murine
Notch receptors (K. Tan. unpublished data; Hoyne et al., 2000). Murine Dcltal and human
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Jaggedl sequences (accession numbers X80903 and AF028593, respectively) were kind gifts
of D. Ish-Horovvicz and I. Le Roux. A schematic outline of the cloning procedure is shown in
figure VI.4.
The pBI-L-Dcltal and pBI-L-Jaggcdl constructs (K. Tan. unpublished data) were double
digested with Mini and EcoRV resulting in a 2.1 and a 3.6kb fragment of murine Delta 1 and
human Jaggedl. respectively. The pBI-EGFP vector (Clontech Laboratories) was linearised
with Nhel and the ends were blunted. A second digest with M!u\ gave rise to a 5.1kb fragment
with one cohesive and one blunt end, which were then dephosphorylated to prevent religation.
The Delta 1, Jaggedl and the linearised pBI-EGFP fragments were purified by gel extraction.
Delta 1 and Jaggedl were ligated into the pBI-EGFP vector and transformed into E. coli XL1-
Blue MRF" competent cells. Six colonies of each vector were picked and plasmid DNA was
isolated.
Clones were digested with BamYW or Notl for pEGFP-Deltal and BamWl or Sad for pEGFP-
Jaggedl to check for insertion and correct orientation of the gene of interest (Fig. VI.5).
Expected lengths of resulting fragments are listed in table VI.2. Five out of six pEGFP-Dcltal
plasmids contained the Delta 1 insert in the correct orientation as demonstrated by restriction
digest with BamHl and Notl (Fig. VI.5 A&B). Restriction digest of pEGFP-Jaggedl with
BamHl gave rise to the three expected fragments of 0.6, 0.8 and 7.4kb in five out of six
constructs confirming insertion of Jaggcdl. Sad digestion resulted in fragments of 0.3, 3.2
and 5.0kb. The expected 0.1 and 0.05kb fragments were too small to be visible on the gel. An
additional fragment marked with an arrow is visible between 8 and lOkb, which is most
probably the undigested pEGFP-Jaggedl vector (8.8kb) due to partial digestion of the vector.
It therefore can be concluded that the Jaggedl fragment was inserted in the correct orientation
in five of the six plasmids.
In summary, 83% of the picked colonies of the pEGFP-Deltal and pEGFP-Jaggedl had
inserted the Delta 1 and Jaggedl fragments, respectively, in the correct orientation. DNA
samples of the pEGFP-Deltal clone #6 and the pEGFP-Jaggcd clone #5 were sent to
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Figure VI.4. Schematic outline for the generation of the pEGFP-Dcltal/Jaggedl vectors.
The Deltal and Jaggedl fragments were generated by double digesting the pBI-L-Deltal and pBI-L-
Jaggedl. respectively (K. Tan, unpublished data) with Mlul and EcoRV. They were subsequently
cloned into the Mlul-Nhel (blunt) opened pBI-EGFP vector (Clontech Laboratories) resulting in the
pEGFP-Deltal and pEGFP-Jaggedl constructs. Black and blue scissors indicate restriction sites used
for linearisation of the pEGFP-Deltal and pEGFP-Jaggedl constructs, respectively. Red arrows
indicate restriction sites on pBI-EGFP used for cloning.
Pbn: bidirectional tctracycline-rcsponsivc promoter, Ampr: Ampicillin resistance gene, EGFP: EGFP
gene, SV40 poly A: fragment containing the SV40 polyadenylation signal, Globin poly A: fragment
containing the P-globin polyadenylation signal. MCS: multiple cloning site.
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Table VI.2. Expected fragments after restriction digest of pEGFP-Dcltal/Jaggcdl.
Vector
Restriction Insert in the right Insert in the w rong No insertion or
enzyme orientation orientation pBS-EGFP (Ctrl)
5.9 kb 5.9 kb 3.7 kb
pEGFP-Deltal BamHl 0.8 kb 0.8 kb 0.8 kb
0.6 kb 0.6 kb 0.6 kb
Noll
6.2 kb 5.0 kb
5.1 kb
1.1 kb 2.3 kb
7.4 kb 7.4 kb 3.7 kb
pEGFP-Jagged 1 BamHl 0.8 kb 0.8 kb 0.8 kb
0.6 kb 0.6 kb 0.6 kb
5.0 kb 7.8 kb 4.7 kb
3.2 kb 0.5 kb
Sacl 0.3 kb 0.3 kb 0.3 kb
0.1 kb 0.1 kb 0.1 kb
0.05 kb 0.05 kb 0.05 kb
BamUl B Notl




#\ #2 #3 #4 #5 #6 Ctrl M #1 #2 #3 #4 #5 #6 Ctrl
0.5 kb
0.3 kb
Figure VI.5. Restriction digest of pEGFP-Deltal/Jaggedl vectors.
Six different pEGFP-Dcltal (#1-6, A and B) and pEGFP-Jagged 1 clones (#1-6, C and D) were
digested with BamHl (A) or Notl (B) and BamHl (C) or Sad (D). respectively, as described in
materials & methods, section II.2.1. The original pBI-EGFP vector was included in each restriction
digest as a control (Ctrl). The digested products were run in a 0.8% agarose gel. The band marked
with a white arrow is most probably undigested pEGFP-Jaggedl vector. M = lkb DNA ladder
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VI.2.3 Upscaling and preparation of the constructs for
microinjection
The three constructs. pCDI Ic-rtTA. pEGFP-Deltal and pEGFP-Jagged 1, were upscaled for
linearisation by doing maxipreps. The pCDI lc-rtTA construct was double digested with Notl
and Xhol. whereas as pEGFP-Dcltal and pEGFP-Jagged 1 were single digested with Asel and
Aatll, respectively. Expected fragments are shown in table VI.3. Linearised fragments were
purified by gel extraction, ethanol precipitated and quantified by running on a gel together
with quantification standards (Fig. VI.6)
Table VI.3. Expected fragments after linearisation of pCDllc-rtTA, pEGFP-Deltal and
pEGFP-Jaggcdl.







pEGFP-Deltal Asel 7.3 kb
6.1 kb
1.2 kb
pEGFP-Jagged 1 AatU 8.8 kb 8.8 kb
* Fragment used for microinjection is indicated by bold letters
Quantification standards (ng)
M J D R 15 31 62 125 250 500
Figure VI.6. Quantification of linearised fragments.
Linearised fragments of pEGFP-Jagged 1 (J), pEGFP-Deltal (D) and pCDI lc-rtTA (R) were run in a
0.8% agarose gel together with quantification standards (15. 31. 62. 125. 250 and 500ng). M = lkb
DNA ladder
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Pronuclear microinjection of the DNA fragments was performed on murine fertilised zygotes
from hormonally superovulatcd females of the F1 generation of C57BL/6J x CBA/CA (H-2b k)
mated with males of the same genotype at the Babraham Institute, Cambridge. The use of this
strain of mice is known to yield a high number of high-quality oocytes, which are relatively
resistant to in vitro manipulations (Jackson and Abbott, 2000).
VI.3 Screening and breeding of the founder mice
With linear DNA up to 30% of successfully injected and transferred embryos can be
transgenic (Jackson and Abbott, 2000). However, the average lies between 10 and 20% (J
Saunders, personal communication).
I received 10, 27 and 24 founder mice of the CD 1 lc-rtTA, EGFP-Jaggedl and EGFP-Deltal
line, respectively. The founders were screened for incorporation of the microinjected genes by
PCR. Genomic DNA was isolated from tail tips and analysed by PCR (Fig. VI.7). 6 out of 27
(22%) and 7 out of 24 (29%) of the EGFP-Jaggedl and EGFP-Deltal founders were positive
for the EGFP transgene (Fig. VI.7 A&B). However, none of the CDIlc-rtTA founders
contained the transgene (Fig. VI.7C). To exclude the possibility that the DNA was lost during
the extraction process, a PCR amplifying the p-Actin gene was carried out. As demonstrated
in figure VI.7D genomic DNA was present in all samples. Therefore, it was concluded that
none of CD1 lc-rtTA founders were positive for the transgene.
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Figure VI.7. Screening of the founders.
Genomic DNA was extracted from tail tips of the founder.
| A & B] The transgene EGFP was amplified by PCR from DNA of the mouse lines EGFP-Jaggedl
and EGFP-Deltal and the products run in a 2% agarose gel. Founders #1-17 of the EGFP-Jaggedl
and EGFP-Deltal lines [A and B, respectively] are shown.
[C & D] The transgene rtTA [C] and the endogenous gene for P-Actin [D] were amplified by PCR
from DNA of the CD1 lc-rtTA line and the products were run in a 2% agarose gel.
Founders positive for the transgene are indicated in bold numbers. M = PCR marker, N = Negative
control (DNA of a wild-type mouse), P = Positive control (plasmid DNA of the corresponding gene),
W = Water control
It was decided to breed three separate lines originating from three different founders for both
of the transgenic lines, EGFP-Jaggedl and EGFP-Deltal, thereby increasing the probability of
obtaining functional transgenic mice. This strategy was necessary for several reasons:
a) In approximately 10-30% of transgenic animals integration of the transgene occurs not
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during the on-cell stage but later in development (Jackson and Abbott. 2000). The founder
mouse will then be mosaic for the transgene and germline transmission is not guaranteed, b) A
possibility exists that the random integration of the transgene may have knocked out an
endogenous gene. Many genes do not show an obvious phenotype when heterozygously
mutated. When such mice are crossed to achieve homozygosity, the resultant transgenic line
may show a phenotype caused by disruption of the genetic locus (Kilby et al., 1993). c)
Relatively rare are integrations at several sites in the mouse genome. In these cases, the
offspring of the transgenic founder are likely to cam only a subset of the integrated copies in
the founder animal, due to segregation of the chromosomes, d) Integration of 1-50 copies of
transgene is normal, but integration of up to 1000 copies has been observed (Doetschman et
al., 1988) The individual copies are usually found in a tandem array as head-to-tail fusions,
e) Additionally to the dependence on the number of copies of the transgene. the level of
expression is often influenced by the genomic sequences flanking the site at which the
transgene is integrated. Flanking sequences may contain regulatory elements of nearby genes
that act on the promoter of the transgene as an enhancer or as a repressor.
To identify founders with high copy numbers of transgenes, a PCR was carried out amplifying
the transgenes EGFP and Jagged 1 or Delta 1 together with P-Actin. which was used for
normalisation (Fig. VI.8). As expected, all EGFP-Jaggedl founders with incorporated EGFP
transgene were also positive for the transgene human Jagged 1, whereas the wild-type control
did not contain either of the transgenes (Fig. VI.8A). The primers used for Deltal were found
to be intron-spanning because they amplified a product at a higher molecular weight then
expected by running a computer-based PCR programme (DNA Strider) using the mRNA-
derived sequence of Deltal (Fig. VI.8B). The programme predicted a PCR product of 571
base pairs (bp), which was obtained with the plasmid control and the EGFP-positive founders.
The length of the intron-spanning PCR product cannot be predicted because the genomic
sequence of the murine Deltal gene has not yet been completely identified. The level of
Jagged 1 or Deltal transgene seems to be roughly proportional to the amount of EGFP
transgene. For example EGFP-Jaggedl founder #26 contained relatively high levels of both
transgenes, whereas founder #11 exhibited weak bands for both transgenes. This was expected
because the two transgenes were located on the same DNA fragment. Three transgenic
founders of both lines (EGFP-Jaggedl #17, #19 and #26 and EGFP-Deltal #8, #12 and #17)
were chosen for breeding. By picking mice exhibiting strong bands of transgenes and weak
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bands of p-Actin it was hoped to increase the probability of obtaining mouse lines with high
expression of transgenes. Each of these founders was backcrossed onto the C57BL/6
background (H-2b) for several generations giving rise to a transgenic line. e.g. the EGFP-







. - genomic Delta 1Delta 1 -transgene (571 bp)
P-Actin
Figure VI.8. Comparison of levels of transgene copies.
[A] EGFP, human Jagged 1 and P-Actin were amplified by PCR from genomic DNA of the
transgenic founders of the EGFP-Jaggcdl line.
[B] EGFP. Delta! and P-Actin were amplified by PCR from genomic DNA of the transgenic
founders of the EGFP-Delta 1 line.
The products were run in a 2% agarose gel. N = Negative control (DNA of a wild-type mouse), P =
Positive control (plasmid DNA of the corresponding gene)
#2 #4 #8 #9 #11 #12 #17 N P
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VI.4 Discussion and Outlook
With 22 and 29% of transgenic EGFP-Jaggedl and EGFP-Deltal founders, respectively,
successful generation of transgenic mice were above average (J. Saunders, personal
communication). Only 10 founders of the CD1 lc-rtTA line were received. Even in the range
of the expected average, only one or two transgenic mice were expected. It was unfortunate
that none of the founders contained the transgene. However, collaboration with M. Dallman at
Imperial College of Science, Technology and Medicine, London, was started. They were also
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generating the CDllc-rtTA mouse line in order to produce DC-specific inducible knock-out
mice using the Cre-loxP recombinase system (reviewed in Kilby et al., 1993).
First, transgenic mice will be bred onto the C57BL/6 background (H-2b). This will allow
using the Der p 1 system to investigating the role of Notch ligands in DCs during tolerance
induction. All three lines, the regulator mice (CDllc-rtTA) and the responder mice (EGFP-
Jaggedl/Delta 1) will have to be crossed to obtain homozygous transgenic lines. A
homozygous regulator mouse can then be mated with a homozygous responder mouse
producing offspring that are heterozygous for all three transgenes, rtTA, EGFP and Jagged 1
or Dcltal (referred to as CD1 lc-Jaggedl or CD1 lc-Deltal, respectively).
The CD1 lc-Jaggedl/Delta 1 mice will be examined for specificity and leakiness of transgene
expression. In theory, the rtTA should only be expressed in CD1 lc-positive cells. Brocker et
al. reported that transgenes under the control of the CDllc promoter were specifically
expressed in DCs (Brocker et al., 1997) even though other cell types can also express the
CDllc integrin (Hogg et al., 1986; Myones et al., 1988). Leakiness in the let system can
arise in two ways. Firstly, the rtTA protein may bind to the Pb,-i promoter in the absence of
dox and induce weak transgene expression. Secondly, the P^-i promoter itself may be slightly
leaky enabling low level of transcription in the absence of rtTA. To investigate these issues,
CD 1 lc-positive and -negative cells can be isolated from spleens of CD1 lc-Jaggedl /Delta 1
mice and total RNA extracted. Only CD 1 lc-positive cells should express the rtTA transgene,
whereas none of the cell types should contain EGFP transcripts. The same experiment should
be conducted with mice that have received dox in their drinking water starting at several time
points prior to being sacrificed. Kirstner et al. demonstrated that 24 hours of dox
administration is sufficient to induce maximal transcription of the rtTA-activated transgene
(Kistner et al., 1996). CD 1 lc-positive cells of dox-treated mice should express increasingly
high levels of transgene proportional to the length of dox administration ending in a plateau
where saturation was reached. In contrast, CD1 lc-negative should remain EGFP-negative.
After examining the specificity and leakiness of CD1 lc-Jaggedl/Deltal mice receiving dox in
their drinking water, the next step would be to characterise their phenotype. Cells of spleen,
lymph nodes and bone marrow would be double stained for CD! lc and other cell surface
proteins such as activation markers and costimulatory molecules and analysed by flow
cytometry. EGFP expression can be measured with the FL1 channel (Cormack et al., 1996).
CD1 lc+ cells should also be EGFP-positive. In addition to characterising their phenotype the
number of CDllc DCs and other cell types will be examined. Notch activation has been
213
shown to induce apoptosis in B cells and monocytes (Morimura et al., 2000; Ohishi et al.,
2000), whereas it protected thymocytes and haematopoietic precursors from apoptosis (Deftos
et al., 1998; Han et al., 2000). Therefore, alterations in the proportion or in the total number
of cells might be expected.
The tet system can also be applied to in vitro analysis (Gossen and Bujard. 1992). Growing
DCs derived from bone marrow of CD1 lc-Jaggedl in the presence of dox in vitro may answer
the question whether or not the observed upregulation of Jagged 1 during maturation of DCs is
directly linked to that process. If this is the case, then the induction of Jagged 1 by dox may
induce maturation, alter the expression of maturation markers and/or stimulate cytokine
production. Furthermore, it will be of interest to investigate the effect of Jagged 1 or Delta 1
overexpression in DCs on T cell activation in MLRs. The cytokine profile, especially the
secretion of IFNy, of the activated T cells would be studied. A similar analysis could be
applied in order to determine the function of Delta 1 in DCs as regards its ability to regulate
their function and maturation.
Experiments involving the transfer of DCs overexpressing Jaggedl to wild-type mice will be
of special interest because this may have implications in treating allergy, autoimmune diseases
or in prolonging transplant survival.
An experimental mouse model to study the allergic response to house dust mite (HDM) was
developed in our group (Hawrylowicz et al., 1995; Hoyne et al., 1993a). Mice of the H-2b
haplotype (C57BL/6) are high responders to the HDM protein Der p 1 and recognise four
distinct CD4 T cell epitopes on the protein (Hoyne et al., 1993b). Systemic administration of
the immunodominant peptide of Der p 1 in adjuvant induced productive immunity, whereas
the same peptide when delivered intranasally (i.n.) promoted hyporesponsiveness to all
epitopes of Der p 1, a process called linked suppression (Hoyne et al., 1993c). This
mechanism is similar to bystander suppression observed in oral tolerance (Miller et al., 1991),
in that both involve the generation of regulatory T cells. The injection of Jaggedl
overexpressing APCs pulsed with the immunodominant peptide of Der p 1 rendered mice
unresponsive to an immunogenic challenge with the intact Dcr p 1 protein (Hoyne et al.,
2000). Furthermore, regulatory CD4 T cells were induced which could transfer antigen-
specific tolerance to naive mice similar to the regulatory T cells induced by i.n. delivery of the
immunodominant Der p 1 peptide. Repeating these experiments with BM-dcrived DCs
overexpressing Jaggedl and pulsed with Dcr p 1 may induce regulatory T cells in a similar
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fashion to Jagged I APCs, which may have implications in treating atopic persons with
allergic reactions.
Most cases of organ-specific autoimmune diseases develop as a consequence of self-reactive
CD4 T cells. The TH1/TH2 balance can have an impact on whether autoimmunity develops or
not (reviewed Charlton and Lafiferty, 1995). TH1 cells have been implicated in the
development of autoimmunity, whereas TH2 cells not only protect against the induction of
disease but also against progression of established disease. Injecting DCs overexpressing
Jaggedl and pulsed with autoantigen may alter the TH1/TH2 balance by inhibiting T cells to
produce IFNy similar to the T cell response to Jagged 1 L cells (Chapter V) or induce
regulatory CD4 T cells (Hoyne et al., 2000).
It was proposed that DCs of the allograft were responsible for immunogenicity (reviewed in
Steinman. 1991). Donor DCs are potent stimulators of the direct pathway of allorecognition.
in which recipient T cells respond to peptides presented on donor MHC products or to the
donor MHC molecules themselves. Reduced DC function in the direct pathway was used to
explain the acceptance of certain allografts that have been depleted of passenger leukocytes
(Bowen et al., 1980; Talmage et al., 1976). However, depletion of donor APCs prevented the
induction of tolerance to heart and liver transplants (Josien et al., 1998; Sun et al., 1995).
Furthermore, in some cases tolerance was re-established if donor-type DCs were cotransferred
with APC-depleted grafts (Josien et al., 1998). Thus, DCs are capable to induce both,
immunogenicity or tolerance to transplants. The use of genetically engineered DCs to pre-treat
the donor allows the manipulation of the immune response towards tolerance rather than
immunogenicity. Genetically engineered DCs that for example express IL-10 (Takayama et
al, 1998), TGF-p (Lee et al., 1998), FasL (Min et al., 2000) or CTLA-4-Ig (O'Rourke et al,
2000) can induce alloantigen-specific T cell hyporesponsiveness and enhance the survival of
allografts. It will be of interest to investigate whether pre-treatment of donor animals with
Jaggedl overexpressed in donor (direct pathway) and recipient DCs pulsed with donor-
peptides (indirect pathway) will also prolong graft survival.
As described above, DCs genetically engineered to overexpress Jaggedl may have important
therapeutic implications. Human DCs can be propagated from peripheral blood mononuclear
cells, CD34 progenitors and cord blood (Caux et al., 1996; Romani et al., 1996; Sallusto and
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Lanzavecchia, 1994) and overexpression of Jagged 1 could be achieved by retroviral-mediated
gene transfer (Hoyne et al., 2000). However, viral-mediated transfections are not popular
because of the risks they bring along by administering cells containing viral DNA to patients.
Several strategies for non-viral gene transfer such as electroporation, gene gun and liposome-





DC maturation is important for their function as professional APCs because it changes their
chemokine pattern, which allows them to migrate to T cell areas in secondary lymphoid
organs, upregulates adhesion molecules necessary for a stable DC-T cell interaction and
increases the expression of MHC/peptide complexes and costimulatory molecules crucial for
the stimulation of T lymphocytes. Work presented in this thesis (chapter IV) showed that
maturation stimuli such as TNFa or LPS induced expression of Jaggedl in DCs and
differentially regulated the expression of Delta 1. The profile of Notch ligands on DCs
depended not only on the maturation state but also on the microenvironment, as shown by the
differential expression of Jaggedl if the maturation occurred in the presence of IL-10.
Therefore, the Notch ligands may add to the information brought by the DCs from the
periphery to the secondary lymphoid organs thereby contributing to the "signal 3" responsible
for the modulation of the immune response.
It has been proposed that Notch signalling may regulate the destabilisation of the actin
cytoskeleton, which is important for cell migration, although direct evidence is still missing
(Dye el al., 1998; Small et al., 2001; Zecchini et al., 1999). More important. Notch is known
to regulate differentiation of many cells including lymphocytes (see section 1.4). Therefore, it
is of interest to investigate whether Notch ligands displayed by APCs such as DCs modulate
the differentiation of naive T lymphocytes upon the initial encounter.
Notch and T lymphocytes
In chapter III, I have shown that T cells express crucial downstream components of the Notch
signalling pathway, in addition to several Notch receptors. However, upon culturing in vitro
w ithout stimulation, transcripts of targets of Notch signalling such as Hesl or Deltexl decline
rapidly and the expression of Hesl can only be partially restored by activation with anti-
CD3/anti-CD28 or PMA/ionomycin. This suggests a requirement for Notch activation by
ligands expressed on accessory cells such as APCs. Indeed, coculturing of T lymphocytes with
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transfected L cells expressing Jagged 1 or Delta 1 induces strong activation of Hesl
transcription demonstrating that peripheral T lymphocytes are able to receive Notch signalling
presumably by interacting with ligand expressing APCs. In contrast. Hes5 expression was not
affected by Jagged 1 or Delta 1 expressed on L cells. However, activation of CD4 T
lymphocytes in the presence of IL-10 upregulated Hes5 transcripts. It has been shown by
others that Hesl transcription was not affected in CBF mutants suggesting the existence of a
CBF-indepcndcnt pathway, which may not involve the Notch receptors (de la Pompa et al.,
1997). Hence, triggering of the TCR/CD28 signalling pathways in the presence of IL-10 could
be responsible for the increased expression of Hes5. Alternatively, Notch activation by ligands
expressed on neighbouring T cells cannot be excluded as the cause for the induction Hes5 in
the presence of IL-10.
Notch and cellular expansion/apoptosis
Many groups have focused on Notch signalling in thymocytes. It was suggested that Notch 1
activation protects from glucocorticoid-induced or TCR-mediated apoptosis (Deftos et al.,
1998; Jehn et al., 1999). However, in my system using peripheral T lymphocytes (chapter V),
no change of cell survival or apoptosis was observed consistent w ith data published by Wolfer
et al. (2001). Furthermore, proliferation of CD4 and CD8+ T cells in response to allogeneic L
cells was not altered in response to Jagged 1, and only slightly increased in response to Delta 1,
whereas Allman and colleagues reported a strong increase in expansion of thymocytes upon
Notch activation in the presence of TCR signalling leading to T cell leukaemia (Allman et al.,
2001). These differences may be explained by either the distinct differentiation state,
thymocytes vs. mature T lymphocytes, or by the possible activation of distinct Notch
receptors. Whereas most of the studies on Notch signalling in thymocytes were concentrated
on Notch 1, it remains unclear which Notch receptor(s) led to the upregulation of Hesl in T
cells activated by ligand expressing allogeneic L cells.
Notch and regulatory T cells
As shown in chapter V, Jagged 1-induced Notch activation in T cells decreased secretion of
IFNy during a MLR. Interestingly, Delta 1-mediated Notch activation did not alter IFNy
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secretion, even though both ligands induced the transcription of Hesl. Both Jagged 1 and
Delta 1 are able to bind to several Notch receptors albeit with different affinities (Shimizu et
al., 2000; Shimizu et al., 1999). However, it is not clear whether they also activate all the
Notch receptors they bind to. This may explain the differences of Jagged 1 vs. Delta 1 induced
Notch activation. Furthermore. Jagged 1 upregulates Hesl transcripts at a higher extent than
Delta 1.
Hoyne and colleagues reported a role for Notch signalling in the induction of CD41 Trea cells
in vivo (Hoyne et al., 2000). Naive mice were injected with Jagged 1 expressing APCs pulsed
with the immunodominant peptide of Der p 1 prior to immunogenic challenge with the whole
protein. C D4 T cells of these mice were hyporesponsive in vitro when restimulated with
peptide and could transfer tolerance to naive mice. Interestingly, these T cells were unable to
secrete IFNy consistent with my data showing that Jagged 1 decreased secretion of IFNy by T
cells stimulated in vitro. Furthermore, CD4 CD25+ Treg cells, which are known to produce
little IFNy (Jonuleit et al., 2001), express high levels of Hesl upon activation reinsuring a
possible link between Hesl upregulation and decreased secretion of IFNy (Ng et al., 2001).
Although these two Treg population have different origins, CD4 Treg cells in Hoyne's model
were induced in the periphery (Hoyne et al., 1993c), whereas CD4CD25f Treg cells are
thymus-derived (Itoh et al., 1999), both suppress naive T cells in a cytokine-independent but
cell contact-dependent manner (Dieckmann et ah, 2001; Hoyne et al., 1997; Thornton and
Shevach, 1998). This poses the question whether Notch signalling may also control
suppression of naive T lymphocytes by Treg cells. Interestingly, CD4CD25 Treg cells, but not
CD4 CD25 T lymphocytes increased expression of Deltal upon stimulation (Ng et al.,
2001). Furthermore, Deltal transcripts were induced in the draining lymph nodes of mice
tolerised by intranasal (i.n.) peptide delivery (Hoyne et al., 1999). Adoptive transfer of Deltal
transfected CD4 T cells specific for the immunodominant peptide of Der p 1 inhibited
responses to both the dominant and minor epitopes of Der p 1, a process termed 'linked
suppression". Thereby these Delta 1 CD4 T cells mediate similar effects to Treg cells induced
by i.n. peptide administration or by injection of Jaggedl expressing DCs. The phenomenon of
linked suppression remains unclear. It is possible that Treg cells transmit an inhibitory signal to
naive T lymphocytes clustered around the same APC. Alternatively, Treg cells may signal to
the APC such that they develop a tolerogenic phenotype and inhibit the expansion of T
lymphocytes reactive for the minor epitopes. Deltal expressed by Treg may well be a potential
candidate for this inhibitory signal.
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Notch and IFNy transcription
The mechanism ofNotch-induced downregulation of IFNy secretion has not been explored yet.
Notch activation interferes with several signalling pathways important for T cell activation
and cytokine production, such as NF-kB or Ras/JNK signalling. There exist controversial
reports about Notch regulating NF-kB. The activated intracellular domain of Notchl has been
shown to inhibit NF-kB activity similarly to IkB (Guan et al., 1996; Wang et al., 2001). On
the other hand, CBF1 inhibits NF-kB transcription in the absence of Notchl signalling
(Oswald et al., 1998; Palmieri et al., 1999). Therefore, Notch signalling may positively or
negatively regulate NF-kb-dependent cytokine production. Although Jagged 1 expressed on L
cells downregulated secretion of IFNy by activated T cells as shown in chapter V, it did not
seem to inhibit transcription of IFNy. Thus, I hypothesise that Jagged 1-induced Notch
signalling may interfere with the secretion rather than transcription of IFNy.
Notch and IFNy secretion
Notch activation has been shown to interact with the regulation of the cytoskeleton in
Drosophila (Buckles et al., 2001; Dye et al., 1998; Zecchini et al., 1999). During dorsal
closure of Drosophila development, Notch represses JNK independently of Su(H) (the
Drosophila homologue of CBF) activity (Zecchini et al., 1999). The authors speculate that
this inhibition may happen at the level of Rac (a GTP-binding protein), which activates JNK
signalling and modulates cytoskeletal activity (Harden et al., 1995). Interestingly, Rac-1
constitutes a major pathway involved in NF-kb-mediated TNFa secretion following LPS
challenge in macrophages (Sanlioglu et al., 2001) and is activated by Vav upon TCR/CD28
stimulation in T lymphocytes (Song et al., 1999a; Stinchcombe and Griffiths, 2001). Since
Rac-1 is important for the secretion of mediators such as cytokines, Notch signalling may
decrease IFNy secretion by repressing Rac-1 activity in T cells.
It will be of interest to investigate in more detail the role of Notch signalling in the
downregulation of IFNy secretion. The analysis of intracellular IFNy in T cells activated by
Jagged 1 expressing L cells in the absence of any secretion inhibitors such as Brefeldin A or
monensin may shed light on this issue. IfNotch activation interferes w ith secretion of IFNy, I
would expect to see increased amounts of IFNy in T cells activated by JaggedT L cells
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compared to Delta 1 or I-Ab L cells. However, if Notch interferes with IFNy secretion by
repressing Rac-1 activity, differences in intracellular IFNy will not been seen if
PMA/ionomycin are used for the induction of cytokine production: Degranulation of mast
cells expressing a dominant negative mutant of Rac-I is rescued by stimulation with
PMA/ionomycin suggesting the location of Rac-1 activity upstream of PKC and inositol
trisphosphate (iP;,)-induced increase of cytoplasmic Ca~ (Hong-Gcller and Cerione, 2000).
Therefore, regulation of Rac-1 activity will not be observed if PMA/ionomycin are used for
stimulation. It also remains unclear how Notch activation specifically regulates IFNy secretion
without influencing the release of IL-2.
Final remarks
The use of L cells as artificial APCs is very convenient because they deliver "signal 1" and
"signal 2" via MHC/peptide complexes and B7.1, respectively. However, for a more
physiological examination of the role of Notch ligands during a MLR, professional APCs such
as DCs overexprcssing the ligands will be very useful. This can be studied in future using the
transgenic mice with inducible expression of Jaggcdl or Deltal in DCs (chapter VI).
Furthermore, these mice will allow to conduct in vivo studies of the role of Jagged 1 or Deltal
during the initiation of an immune response.
Overall the work reported in this thesis has attempted to gain further insight into the role of
Notch signalling during the induction of an immune response. I have shown that Notch ligands
and receptors are expressed in DCs and T lymphocytes. However, I would like to emphasise
that these demonstrations only represent gene expression studies and that further regulation
occurring post-transcriptionally cannot be excluded.
Deltal and Jagged 1 expressed on APCs are capable to activate Notch in T cells. Jagged 1-
mduced Notch signalling downregulates the secretion of IFNy by T lymphocytes activated in a
MLR, which may be one of the mechanisms responsible for the tolerance induced by Jagged 1
transfected APCs in vivo (Hoyne el al., 2000). I believe future experiments using transgenic
mice with inducible overexpression of Jagged 1 or Delta 1 in DCs will provide a clearer
understanding of the questions I have tried to address.
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